MeSH term
Frequency | Condition_Probility | *Cleavage Stage, Ovum | 6 | 4.0 |
Embryo Transfer/*standards | 6 | 4.0 |
Female | 1466 | 1.0 |
Humans | 5044 | 2.0 |
Meta-Analysis | 6 | 3.0 |
Pregnancy | 217 | 3.0 |
Pregnancy Outcome | 7 | 2.0 |
Pregnancy Rate | 6 | 4.0 |
Pregnancy, Multiple | 6 | 4.0 |
Randomized Controlled Trials | 6 | 1.0 |
Review Literature | 6 | 4.0 |
Acute Disease | 12 | 0.0 |
Adult | 571 | 1.0 |
Bone Marrow Transplantation/*statistics & numerical data | 2 | 2.0 |
Comparative Study | 513 | 1.0 |
Cord Blood Stem Cell Transplantation/*statistics & numerical data | 2 | 2.0 |
Fetal Blood/transplantation | 2 | 2.0 |
Leukemia/*therapy | 2 | 1.0 |
Patient Selection | 2 | 1.0 |
Animals | 2018 | 2.0 |
Oligonucleotide Array Sequence Analysis | 10 | 0.0 |
Cell Culture Techniques | 14 | 3.0 |
Cell Differentiation/*physiology | 3 | 1.0 |
Motor Neurons/*physiology | 2 | 3.0 |
Stem Cells/*physiology | 2 | 3.0 |
Albumins/metabolism | 4 | 2.0 |
Albuminuria/*prevention & control | 4 | 4.0 |
Antihypertensive Agents/*therapeutic use | 4 | 1.0 |
Diabetes Mellitus, Type 2/complications/*drug therapy | 4 | 4.0 |
Hypertension/complications/*drug therapy | 4 | 3.0 |
Indoles/*therapeutic use | 5 | 3.0 |
Renin-Angiotensin System/*drug effects | 4 | 3.0 |
Magnetic Resonance Imaging | 5 | 0.0 |
Mutation | 116 | 1.0 |
Biological Markers | 20 | 1.0 |
Genes, Tumor Suppressor | 7 | 0.0 |
Oncogenes | 16 | 6.0 |
Aged | 338 | 1.0 |
Blotting, Western | 217 | 3.0 |
Bronchi/*metabolism | 3 | 9.0 |
Cells, Cultured | 873 | 5.0 |
Cyclic AMP/metabolism | 19 | 3.0 |
Enzyme-Linked Immunosorbent Assay | 92 | 2.0 |
Epidermal Growth Factor/*pharmacology | 768 | 92.0 |
Epithelial Cells/*metabolism | 7 | 5.0 |
Male | 957 | 1.0 |
Middle Aged | 488 | 1.0 |
Mucins/*metabolism | 2 | 2.0 |
Phosphotyrosine/metabolism | 40 | 9.0 |
RNA, Messenger/metabolism | 156 | 3.0 |
Recombinant Proteins | 41 | 5.0 |
Research Support, Non-U.S. Gov't | 3047 | 2.0 |
Reverse Transcriptase Polymerase Chain Reaction/methods | 2 | 0.0 |
p38 Mitogen-Activated Protein Kinases/metabolism | 4 | 13.0 |
*Persistent Vegetative State/rehabilitation | 2 | 16.0 |
Diagnosis, Differential | 6 | 0.0 |
Mice | 904 | 2.0 |
Apoptosis/drug effects/*physiology | 4 | 1.0 |
Cell Division/drug effects | 609 | 16.0 |
Cell Line, Transformed | 65 | 4.0 |
Cell Line, Tumor | 80 | 2.0 |
Cell Membrane Permeability/physiology | 3 | 15.0 |
Drug Synergism | 108 | 7.0 |
Epidermal Growth Factor/pharmacology/*physiology | 27 | 90.0 |
Mitochondria/physiology | 2 | 3.0 |
Research Support, U.S. Gov't, P.H.S. | 1722 | 2.0 |
Signal Transduction/*physiology | 63 | 5.0 |
Androgens/pharmacology | 6 | 12.0 |
DNA-Binding Proteins/genetics/metabolism | 3 | 0.0 |
Disease Progression | 22 | 0.0 |
*Endocytosis | 23 | 13.0 |
Epidermal Growth Factor/metabolism/*pharmacology | 67 | 94.0 |
Gene Expression Regulation, Neoplastic | 45 | 2.0 |
Neoplasms, Hormone-Dependent/genetics/*metabolism | 2 | 28.0 |
Prostatic Neoplasms/genetics/*metabolism | 4 | 14.0 |
Proto-Oncogene Proteins c-fos/genetics/metabolism | 2 | 7.0 |
Proto-Oncogene Proteins c-jun/genetics/metabolism | 3 | 8.0 |
RNA, Messenger/genetics/metabolism | 54 | 2.0 |
Receptor, Epidermal Growth Factor/genetics/metabolism | 17 | 33.0 |
Signal Transduction | 251 | 4.0 |
Transcription Factors/genetics/metabolism | 2 | 0.0 |
Tumor Cells, Cultured | 979 | 5.0 |
Epidermal Growth Factor/*pharmacokinetics | 5 | 83.0 |
Receptor, Epidermal Growth Factor/metabolism | 266 | 48.0 |
Enzyme Activation/drug effects | 95 | 10.0 |
Growth Substances/*pharmacology | 187 | 51.0 |
Mitogen-Activated Protein Kinase 1/metabolism | 39 | 10.0 |
Mitogen-Activated Protein Kinase 3/metabolism | 4 | 11.0 |
Protein-Serine-Threonine Kinases/metabolism | 36 | 4.0 |
Proto-Oncogene Proteins/metabolism | 47 | 4.0 |
Signal Transduction/*drug effects | 34 | 9.0 |
*Drosophila Proteins | 13 | 1.0 |
Proto-Oncogene Proteins/*genetics | 19 | 1.0 |
Receptor Protein-Tyrosine Kinases/*genetics | 2 | 0.0 |
Adolescent | 135 | 0.0 |
DNA Primers/chemistry | 16 | 1.0 |
Gastrins/metabolism | 2 | 10.0 |
Immunoenzyme Techniques | 102 | 3.0 |
Lymph Nodes/pathology | 5 | 1.0 |
Lymphatic Metastasis | 31 | 3.0 |
RNA, Messenger/*metabolism | 25 | 4.0 |
RNA, Neoplasm/metabolism | 4 | 4.0 |
Receptor, Epidermal Growth Factor/*genetics/metabolism | 29 | 55.0 |
Reverse Transcriptase Polymerase Chain Reaction | 118 | 1.0 |
Up-Regulation | 70 | 3.0 |
Cattle | 96 | 3.0 |
Chronic Disease | 21 | 1.0 |
Cytokines/*pharmacology | 21 | 5.0 |
Rats | 509 | 3.0 |
Steroids/*biosynthesis | 3 | 5.0 |
Carcinoma, Adenoid Cystic/*metabolism | 2 | 66.0 |
Immunohistochemistry | 336 | 2.0 |
Receptor, Epidermal Growth Factor/*metabolism | 379 | 48.0 |
Salivary Gland Neoplasms/*metabolism | 5 | 45.0 |
Base Sequence | 366 | 1.0 |
Binding Sites | 208 | 2.0 |
COS Cells | 70 | 2.0 |
Carotid Arteries/metabolism | 2 | 40.0 |
DNA, Complementary/genetics | 33 | 1.0 |
In Vitro | 174 | 2.0 |
Kringles | 2 | 13.0 |
Protein Binding | 189 | 2.0 |
Transfection | 322 | 2.0 |
Two-Hybrid System Techniques | 12 | 1.0 |
Antigens, CD95/metabolism | 3 | 2.0 |
Caspases/metabolism | 12 | 1.0 |
Mitochondria/metabolism | 3 | 1.0 |
NF-kappa B/metabolism | 7 | 0.0 |
Blood | 30 | 15.0 |
Cell Line | 887 | 4.0 |
Epidermal Growth Factor/*physiology | 128 | 92.0 |
Insulin/*physiology | 3 | 6.0 |
*MAP Kinase Signaling System | 11 | 10.0 |
Phosphorylation | 657 | 8.0 |
Threonine/*metabolism | 8 | 19.0 |
Carcinoma, Squamous Cell/*enzymology/pathology | 4 | 28.0 |
Cell Division | 313 | 7.0 |
Mitogen-Activated Protein Kinases/*metabolism | 50 | 9.0 |
Mouth Neoplasms/*enzymology/pathology | 2 | 50.0 |
Neoplasm Proteins/*metabolism | 21 | 4.0 |
Bacterial Toxins/*pharmacology | 2 | 6.0 |
Epithelial Cells/drug effects/*physiology | 3 | 42.0 |
Escherichia coli | 4 | 0.0 |
Epidermal Growth Factor/*analysis | 111 | 94.0 |
Follow-Up Studies | 31 | 0.0 |
Pilot Projects | 6 | 0.0 |
Prospective Studies | 27 | 0.0 |
Time Factors | 269 | 2.0 |
Transforming Growth Factor beta/*analysis | 2 | 13.0 |
Wound Healing/*physiology | 20 | 30.0 |
Binding, Competitive | 109 | 5.0 |
Endocytosis | 43 | 10.0 |
Epidermal Growth Factor/genetics/*metabolism | 18 | 75.0 |
Hepatocytes/*metabolism | 2 | 4.0 |
Hydrogen-Ion Concentration | 60 | 4.0 |
Ligands | 179 | 6.0 |
Recombinant Proteins/*metabolism | 2 | 6.0 |
Transforming Growth Factor alpha/*metabolism | 46 | 65.0 |
Amino Acid Sequence | 497 | 2.0 |
Computer Simulation | 10 | 2.0 |
DNA Primers | 56 | 1.0 |
Enzyme Activation | 202 | 5.0 |
Epidermal Growth Factor/chemistry/*metabolism | 13 | 100.0 |
Epitopes/chemistry | 3 | 4.0 |
Hydrolysis | 25 | 3.0 |
Models, Molecular | 61 | 2.0 |
Molecular Probes | 2 | 3.0 |
Molecular Sequence Data | 649 | 1.0 |
Protein Conformation | 82 | 2.0 |
Recombinant Proteins/chemistry/immunology/metabolism | 2 | 16.0 |
Epidermal Growth Factor/immunology/*metabolism | 7 | 100.0 |
Epitopes/*metabolism | 2 | 10.0 |
Mutagenesis, Site-Directed | 84 | 2.0 |
Proteoglycans/*metabolism | 2 | 3.0 |
Receptor, Epidermal Growth Factor/chemistry/genetics/*metabolism | 11 | 68.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 349 | 3.0 |
Calcitriol/pharmacology | 8 | 7.0 |
Dihydrotestosterone/*pharmacology | 10 | 31.0 |
Estradiol/pharmacology | 34 | 13.0 |
*Gene Expression Regulation, Neoplastic | 38 | 2.0 |
Prostate/metabolism | 5 | 6.0 |
Prostatic Neoplasms/genetics/*metabolism/pathology | 3 | 12.0 |
RNA, Neoplasm/biosynthesis | 2 | 1.0 |
Tissue Distribution | 76 | 2.0 |
Xenograft Model Antitumor Assays | 4 | 1.0 |
Keratinocytes/metabolism/physiology | 2 | 40.0 |
1-Phosphatidylinositol 3-Kinase/metabolism | 22 | 4.0 |
*Adaptor Proteins, Signal Transducing | 89 | 6.0 |
*Adaptor Proteins, Vesicular Transport | 31 | 12.0 |
Breast Neoplasms | 42 | 15.0 |
*DNA-Binding Proteins | 19 | 1.0 |
Epidermal Growth Factor/metabolism | 252 | 67.0 |
Growth Substances/metabolism | 21 | 16.0 |
Insulin/*metabolism | 9 | 11.0 |
Phosphoric Monoester Hydrolases/*metabolism | 2 | 2.0 |
Promoter Regions (Genetics) | 63 | 1.0 |
Proteins/metabolism | 55 | 5.0 |
Proto-Oncogene Proteins/*metabolism | 28 | 2.0 |
Receptor Protein-Tyrosine Kinases/metabolism | 21 | 8.0 |
*Repressor Proteins | 12 | 1.0 |
Signal Transduction/physiology | 40 | 4.0 |
Trans-Activators/*metabolism | 13 | 1.0 |
*Transcription Factors | 18 | 1.0 |
Aging | 9 | 2.0 |
Animals, Newborn | 16 | 2.0 |
Cell Differentiation | 84 | 2.0 |
Cell Lineage | 7 | 1.0 |
Cell Separation | 21 | 1.0 |
Coculture Techniques | 10 | 1.0 |
Epidermal Growth Factor/pharmacology | 573 | 70.0 |
Fibroblast Growth Factor 2/pharmacology | 58 | 26.0 |
Fluorescent Dyes | 18 | 4.0 |
Mesenchymal Stem Cells/*cytology | 2 | 25.0 |
Mice, Inbred C57BL | 29 | 0.0 |
Neuroglia/*physiology | 2 | 7.0 |
Neurons/*physiology | 5 | 3.0 |
Calcium/metabolism | 70 | 4.0 |
Colonic Neoplasms/*metabolism | 12 | 15.0 |
*Diet | 2 | 0.0 |
Kinetics | 510 | 6.0 |
Mitogen-Activated Protein Kinase 3 | 71 | 11.0 |
Mitogen-Activated Protein Kinases/metabolism | 75 | 7.0 |
Sodium-Hydrogen Antiporter/metabolism | 2 | 33.0 |
Dimerization | 51 | 3.0 |
Epidermal Growth Factor/*chemistry | 44 | 84.0 |
Peptide Library | 3 | 2.0 |
Polymerase Chain Reaction | 108 | 0.0 |
Receptor, erbB-2/*chemistry | 3 | 50.0 |
Receptor, erbB-3/*chemistry | 2 | 66.0 |
Recombinant Proteins/chemistry | 7 | 2.0 |
Bronchi/cytology/metabolism | 2 | 13.0 |
Cell Survival/drug effects/physiology | 3 | 3.0 |
*Intercellular Signaling Peptides and Proteins | 93 | 17.0 |
Smoking/*metabolism | 2 | 4.0 |
Cell Transplantation | 2 | 2.0 |
English Abstract | 230 | 1.0 |
Epidermal Growth Factor/*biosynthesis/genetics | 13 | 81.0 |
Fibroblasts/cytology | 24 | 11.0 |
Gene Therapy | 5 | 1.0 |
Mice, Nude | 136 | 7.0 |
Plasmids | 38 | 2.0 |
*Transfection | 16 | 6.0 |
*Wound Healing | 18 | 34.0 |
Carcinoma, Squamous Cell | 96 | 61.0 |
Enzyme Inhibitors/pharmacology | 156 | 5.0 |
Flavonoids/pharmacology | 34 | 10.0 |
Gene Expression Regulation, Neoplastic/drug effects/*physiology | 5 | 20.0 |
Lung Neoplasms | 5 | 4.0 |
MAP Kinase Signaling System/*physiology | 7 | 8.0 |
Receptor, Epidermal Growth Factor/*physiology | 83 | 56.0 |
Transcription Factor, Sp1/*metabolism | 7 | 1.0 |
Transforming Growth Factor alpha/pharmacology | 60 | 65.0 |
Tumor Necrosis Factor-alpha/pharmacology | 22 | 1.0 |
ras Proteins/*physiology | 3 | 11.0 |
CHO Cells | 63 | 2.0 |
DNA, Complementary/analysis | 5 | 1.0 |
Hamsters | 96 | 2.0 |
*Membrane Proteins | 11 | 1.0 |
*Neovascularization, Physiologic | 2 | 1.0 |
*Receptors, Lipoprotein | 2 | 1.0 |
Aged, 80 and over | 118 | 1.0 |
Receptors, Estrogen/metabolism | 16 | 5.0 |
Survival Analysis | 15 | 0.0 |
Survival Rate | 21 | 1.0 |
Electrostatics | 2 | 1.0 |
Epidermal Growth Factor/chemistry | 35 | 68.0 |
Growth Substances/*chemistry | 2 | 100.0 |
Nuclear Magnetic Resonance, Biomolecular | 8 | 4.0 |
Protein Structure, Tertiary | 111 | 2.0 |
Active Transport, Cell Nucleus | 3 | 1.0 |
Amino Acid Motifs | 20 | 2.0 |
Phosphoproteins/chemistry/*metabolism | 3 | 5.0 |
Ubiquitin/*metabolism | 6 | 3.0 |
Androstadienes/pharmacology | 24 | 9.0 |
Child | 106 | 0.0 |
Fibroblasts/drug effects | 21 | 23.0 |
Growth Hormone/*pharmacology | 7 | 9.0 |
Indicators and Reagents | 12 | 4.0 |
Mitogen-Activated Protein Kinases/physiology | 4 | 3.0 |
Precipitin Tests | 100 | 3.0 |
Protein-Tyrosine Kinase/physiology | 8 | 6.0 |
*Proto-Oncogene Proteins | 14 | 0.0 |
Syndrome | 7 | 0.0 |
Tyrosine/metabolism | 127 | 10.0 |
Growth Substances/physiology | 26 | 25.0 |
Lysophospholipids/*physiology | 2 | 33.0 |
MAP Kinase Signaling System/physiology | 6 | 7.0 |
GTP-Binding Proteins/*physiology | 4 | 3.0 |
Receptors, Cell Surface/*physiology | 13 | 6.0 |
Case-Control Studies | 42 | 0.0 |
Cytokines/*metabolism | 10 | 3.0 |
Interferon Type II/metabolism | 2 | 0.0 |
Interleukin-1/metabolism | 7 | 3.0 |
Tumor Necrosis Factor-alpha/metabolism | 6 | 0.0 |
Apoptosis/drug effects/physiology | 3 | 3.0 |
Cytokines/biosynthesis | 3 | 0.0 |
Down-Regulation/drug effects/physiology | 2 | 5.0 |
Epidermal Growth Factor/*pharmacology/therapeutic use | 3 | 100.0 |
Lipopolysaccharides/*pharmacology | 7 | 1.0 |
RNA, Messenger/biosynthesis | 56 | 3.0 |
Cell Communication/physiology | 3 | 3.0 |
Connexin 43/genetics/*metabolism | 2 | 66.0 |
*Gene Expression Regulation | 44 | 2.0 |
Recombinant Fusion Proteins/genetics/*metabolism | 3 | 21.0 |
Cycloheximide/pharmacology | 54 | 8.0 |
Dactinomycin/pharmacology | 26 | 8.0 |
Gene Expression Regulation, Neoplastic/drug effects/physiology | 4 | 10.0 |
Growth Substances/pharmacology | 44 | 22.0 |
Hormones/pharmacology | 10 | 23.0 |
Nucleic Acid Synthesis Inhibitors/pharmacology | 4 | 3.0 |
Prostate/cytology/*enzymology | 2 | 28.0 |
Protein Synthesis Inhibitors/pharmacology | 16 | 4.0 |
RNA, Messenger/drug effects/metabolism | 3 | 2.0 |
Transforming Growth Factor beta/pharmacology | 62 | 20.0 |
Biological Assay/*methods | 2 | 4.0 |
Fluorescent Antibody Technique | 73 | 2.0 |
Mice, Inbred C3H | 10 | 1.0 |
Protein-Tyrosine Kinase/antagonists & inhibitors | 28 | 13.0 |
*Pyridines | 2 | 12.0 |
Down-Regulation | 72 | 3.0 |
Proto-Oncogene Proteins/*physiology | 6 | 2.0 |
Receptor, Epidermal Growth Factor/analysis/*metabolism | 10 | 50.0 |
Ubiquitin/metabolism | 8 | 3.0 |
*Ubiquitin-Protein Ligases | 21 | 3.0 |
Breast Neoplasms/metabolism/pathology | 4 | 10.0 |
Estradiol/*pharmacology | 41 | 17.0 |
Estrogens, Non-Steroidal/*pharmacology | 2 | 11.0 |
Genistein/*pharmacology | 2 | 6.0 |
Phytoestrogens | 2 | 7.0 |
Plant Preparations | 2 | 9.0 |
Antibodies, Monoclonal | 73 | 3.0 |
Carcinoma/*pathology | 4 | 7.0 |
Cell Movement | 36 | 4.0 |
*Cell Transformation, Neoplastic | 51 | 12.0 |
Lung Neoplasms/*pathology | 4 | 5.0 |
Cell Division/physiology | 65 | 7.0 |
GTP-Binding Proteins/*metabolism | 14 | 3.0 |
Receptors, Cell Surface/*metabolism | 87 | 15.0 |
Amniotic Fluid/*chemistry | 4 | 8.0 |
Dose-Response Relationship, Drug | 322 | 5.0 |
Fibroblast Growth Factors/pharmacology | 26 | 40.0 |
Genistein/pharmacology | 9 | 8.0 |
Growth Inhibitors/pharmacology | 13 | 8.0 |
Hepatocyte Growth Factor/pharmacology | 12 | 18.0 |
Infant, Newborn | 71 | 1.0 |
Insulin-Like Growth Factor I/pharmacology | 71 | 37.0 |
Milk, Human/*chemistry | 7 | 14.0 |
Tritium/diagnostic use | 14 | 12.0 |
Neoplasm Transplantation | 88 | 7.0 |
Recombinant Proteins/pharmacology | 94 | 5.0 |
Transplantation, Heterologous | 58 | 6.0 |
Epidermal Growth Factor/*blood | 18 | 90.0 |
Statistics, Nonparametric | 14 | 1.0 |
*Cell Aging | 4 | 7.0 |
*Signal Transduction | 105 | 5.0 |
Culture Media | 113 | 16.0 |
Culture Techniques | 36 | 8.0 |
Follicle Stimulating Hormone/pharmacology | 13 | 23.0 |
Gonadotropins, Equine/pharmacology | 2 | 9.0 |
Insulin/pharmacology | 89 | 31.0 |
Selenium/pharmacology | 3 | 50.0 |
Transferrin/pharmacology | 13 | 50.0 |
Vasoactive Intestinal Peptide/pharmacology | 5 | 6.0 |
Amino Acid Substitution | 15 | 1.0 |
*Cell Adhesion | 5 | 3.0 |
Epidermal Growth Factor | 12 | 50.0 |
Epithelial Cells | 89 | 18.0 |
Laminin | 8 | 8.0 |
Polyethylene Glycols | 9 | 10.0 |
Salivary Proteins/metabolism | 2 | 22.0 |
Surface-Active Agents | 2 | 20.0 |
Aging/*metabolism | 6 | 2.0 |
Enzyme-Linked Immunosorbent Assay/methods | 3 | 1.0 |
Cell Count | 56 | 5.0 |
Cell Culture Techniques/methods | 9 | 4.0 |
Cell Cycle/physiology | 9 | 2.0 |
Cell Separation/methods | 2 | 1.0 |
Child, Preschool | 61 | 0.0 |
Fluorescent Antibody Technique, Indirect | 35 | 4.0 |
Gelatinase A/metabolism | 2 | 3.0 |
Gelatinase B/metabolism | 2 | 3.0 |
RNA, Messenger/biosynthesis/genetics | 15 | 2.0 |
Apoptosis | 30 | 1.0 |
Multigene Family | 15 | 1.0 |
Receptors, Estrogen/drug effects/genetics/metabolism | 2 | 22.0 |
Reproducibility of Results | 15 | 1.0 |
Somatomedins/pharmacology | 6 | 60.0 |
Tamoxifen/pharmacology | 7 | 7.0 |
3T3 Cells | 130 | 6.0 |
RNA, Messenger/genetics | 64 | 2.0 |
Trans-Activation (Genetics)/*physiology | 4 | 3.0 |
Transcription Factors/*physiology | 2 | 0.0 |
Actins/*metabolism | 13 | 5.0 |
Cell Death | 9 | 2.0 |
Cyclooxygenase Inhibitors/pharmacology | 6 | 8.0 |
Epithelial Cells/metabolism | 17 | 5.0 |
Gastric Mucosa/metabolism | 3 | 6.0 |
Immunoblotting | 78 | 3.0 |
In Situ Nick-End Labeling | 10 | 1.0 |
Indomethacin/*pharmacology | 5 | 12.0 |
Mitomycin/pharmacology | 2 | 2.0 |
Necrosis | 5 | 1.0 |
Protein-Tyrosine Kinase/*antagonists & inhibitors | 35 | 22.0 |
Rats, Sprague-Dawley | 71 | 3.0 |
Drosophila | 7 | 2.0 |
Fucose/*metabolism | 4 | 40.0 |
Fucosyltransferases/*metabolism | 2 | 33.0 |
Membrane Proteins/*metabolism | 16 | 3.0 |
N-Acetylglucosaminyltransferases/*metabolism | 3 | 25.0 |
Substrate Specificity | 50 | 2.0 |
Boron Neutron Capture Therapy/*methods | 4 | 66.0 |
Epidermal Growth Factor/administration & dosage/*metabolism | 2 | 100.0 |
Rats, Inbred F344 | 14 | 3.0 |
Receptor, Epidermal Growth Factor/genetics/*metabolism | 66 | 41.0 |
Algorithms | 3 | 0.0 |
*Models, Molecular | 3 | 2.0 |
Receptor, Epidermal Growth Factor/*chemistry/metabolism | 9 | 90.0 |
Calcium/*metabolism | 50 | 7.0 |
Cytoskeleton/*metabolism | 7 | 5.0 |
Homeostasis/*physiology | 2 | 4.0 |
Isoenzymes/antagonists & inhibitors/genetics/*physiology | 2 | 100.0 |
Oligonucleotides, Antisense/pharmacology | 12 | 4.0 |
Alanine/*metabolism | 2 | 33.0 |
Biological Transport | 44 | 3.0 |
Caco-2 Cells/*physiology | 2 | 100.0 |
Cell Aging | 7 | 7.0 |
*Cell Differentiation | 10 | 4.0 |
Intestinal Absorption/physiology | 3 | 21.0 |
Chromatography, High Pressure Liquid | 65 | 3.0 |
Heat | 7 | 1.0 |
Protein Denaturation | 8 | 3.0 |
Protein Folding | 18 | 3.0 |
Protein Isoforms | 10 | 1.0 |
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 8 | 3.0 |
Thermodynamics | 11 | 3.0 |
Growth Substances/genetics/physiology | 3 | 60.0 |
Oncogenes/physiology | 3 | 18.0 |
Prognosis | 71 | 1.0 |
Receptors, Growth Factor/genetics/physiology | 2 | 18.0 |
Cell Movement/drug effects/*physiology | 10 | 20.0 |
DNA/biosynthesis | 161 | 27.0 |
Dexamethasone/pharmacology | 35 | 7.0 |
Epithelial Cells/physiology | 4 | 5.0 |
Glucocorticoids/pharmacology | 8 | 6.0 |
MAP Kinase Signaling System/drug effects | 5 | 5.0 |
Mouth Neoplasms | 5 | 27.0 |
Salivary Proteins/*physiology | 3 | 75.0 |
Antineoplastic Agents/pharmacology | 24 | 4.0 |
Apoptosis/*drug effects | 32 | 4.0 |
Carrier Proteins/genetics/*metabolism | 9 | 2.0 |
Cell Survival/drug effects | 42 | 3.0 |
Epithelial Cells/cytology/drug effects/physiology | 2 | 25.0 |
Insulin-Like Growth Factor I/metabolism | 22 | 11.0 |
Mice, Inbred ICR | 9 | 3.0 |
Mice, Knockout | 15 | 0.0 |
Quinazolines/*pharmacology | 8 | 8.0 |
Receptor, Epidermal Growth Factor/*antagonists & inhibitors | 25 | 20.0 |
Trans-Activation (Genetics) | 25 | 1.0 |
Endocytosis/physiology | 13 | 17.0 |
KB Cells | 16 | 19.0 |
*Phospholipid Transfer Proteins | 2 | 1.0 |
Phospholipids/*metabolism | 3 | 2.0 |
Cytokines/*genetics | 3 | 2.0 |
Epidermal Growth Factor/genetics | 39 | 58.0 |
Gene Frequency | 6 | 0.0 |
Genes | 4 | 1.0 |
Genotype | 16 | 0.0 |
Interleukin-1/genetics | 3 | 4.0 |
Retrospective Studies | 20 | 0.0 |
Transforming Growth Factor beta/genetics | 9 | 9.0 |
Tumor Necrosis Factor-alpha/genetics | 3 | 1.0 |
Endocytosis/*physiology | 12 | 11.0 |
Endosomes/metabolism | 11 | 9.0 |
Green Fluorescent Proteins | 17 | 1.0 |
Guanosine Triphosphate/metabolism | 11 | 3.0 |
Luminescent Proteins | 3 | 5.0 |
Microscopy, Fluorescence | 54 | 3.0 |
Proteins/*metabolism | 39 | 4.0 |
Recombinant Fusion Proteins/metabolism | 49 | 3.0 |
Cell Division/drug effects/physiology | 46 | 16.0 |
Fibroblast Growth Factor 2/*pharmacology | 28 | 24.0 |
Fibroblasts/cytology/*drug effects/metabolism | 2 | 14.0 |
Insulin-Like Growth Factor I/*pharmacology | 41 | 28.0 |
Microtubules/metabolism | 3 | 2.0 |
Platelet-Derived Growth Factor/*pharmacology | 35 | 37.0 |
Cell Differentiation/*genetics | 2 | 2.0 |
Cell Membrane/*metabolism | 19 | 6.0 |
DNA, Complementary/genetics/isolation & purification | 3 | 2.0 |
Gene Expression Regulation/*physiology | 5 | 1.0 |
Microtubule-Associated Proteins/metabolism | 5 | 3.0 |
*Nerve Tissue Proteins | 5 | 1.0 |
Protein Structure, Tertiary/genetics | 9 | 3.0 |
*Receptors, Cell Surface | 12 | 3.0 |
Sequence Homology, Amino Acid | 131 | 1.0 |
Sequence Homology, Nucleic Acid | 44 | 1.0 |
Neoplasm Proteins/genetics/metabolism | 2 | 1.0 |
Parathyroid Hormone-Related Protein | 10 | 11.0 |
Prostatic Neoplasms/*metabolism | 15 | 12.0 |
Recombinant Proteins/metabolism | 68 | 2.0 |
Transcription, Genetic | 92 | 1.0 |
Rats, Wistar | 38 | 3.0 |
Antibodies, Monoclonal/immunology | 26 | 1.0 |
Lymphocytes/metabolism | 2 | 0.0 |
Macrophages/metabolism | 2 | 0.0 |
Membrane Glycoproteins/analysis | 4 | 1.0 |
Receptors, Cell Surface/*chemistry/*metabolism | 2 | 25.0 |
Epidermal Growth Factor/*metabolism | 346 | 88.0 |
*Protein-Serine-Threonine Kinases | 32 | 3.0 |
*Epidermal Growth Factor | 30 | 63.0 |
Gene Expression Regulation, Developmental | 16 | 1.0 |
*Homeodomain Proteins | 3 | 1.0 |
*Membrane Glycoproteins | 35 | 3.0 |
Neoplasm Proteins/*genetics | 8 | 0.0 |
*Zebrafish Proteins | 2 | 0.0 |
Adenocarcinoma/therapy | 2 | 22.0 |
Antibodies, Monoclonal/*pharmacology | 6 | 3.0 |
Antigens, CD31/biosynthesis | 2 | 8.0 |
Antineoplastic Agents/*pharmacology | 60 | 6.0 |
Breast Neoplasms/metabolism | 15 | 12.0 |
Carcinoma/metabolism | 8 | 14.0 |
Absorption | 2 | 1.0 |
Disease Models, Animal | 28 | 1.0 |
Epidermal Growth Factor/*therapeutic use | 17 | 85.0 |
Short Bowel Syndrome/*drug therapy/metabolism | 2 | 100.0 |
Treatment Outcome | 19 | 0.0 |
Cysteine/chemistry | 4 | 3.0 |
DNA, Complementary/metabolism | 19 | 1.0 |
Hela Cells | 93 | 1.0 |
MAP Kinase Signaling System | 23 | 8.0 |
Plasmids/metabolism | 12 | 1.0 |
Guanidines/pharmacology | 4 | 9.0 |
Protein-Tyrosine Kinase/metabolism | 93 | 10.0 |
Protein-Tyrosine-Phosphatase/antagonists & inhibitors/metabolism | 3 | 21.0 |
Signal Transduction/drug effects/*physiology | 15 | 7.0 |
Models, Chemical | 9 | 2.0 |
Caco-2 Cells | 26 | 7.0 |
Diglycerides/metabolism | 7 | 15.0 |
Gene Expression Regulation, Enzymologic | 12 | 1.0 |
HT29 Cells | 6 | 3.0 |
Microtubules/drug effects/*metabolism | 3 | 17.0 |
Oxidative Stress/physiology | 3 | 4.0 |
Protein Kinase C/genetics/*metabolism | 3 | 10.0 |
Protein Kinase C/antagonists & inhibitors/*metabolism | 13 | 14.0 |
Protein-Serine-Threonine Kinases/antagonists & inhibitors/metabolism | 8 | 9.0 |
Proto-Oncogene Proteins c-raf/drug effects/metabolism | 2 | 50.0 |
Receptor, Epidermal Growth Factor/drug effects/metabolism | 31 | 73.0 |
Dynamins | 6 | 14.0 |
Fibroblasts/metabolism | 63 | 6.0 |
src-Family Kinases/antagonists & inhibitors/metabolism | 2 | 15.0 |
1-Phosphatidylinositol 3-Kinase/metabolism/physiology | 2 | 20.0 |
Cell Membrane/metabolism | 135 | 8.0 |
Cell Survival/physiology | 10 | 5.0 |
Proto-Oncogene Proteins/metabolism/*physiology | 4 | 8.0 |
Receptor, Epidermal Growth Factor/physiology | 52 | 66.0 |
Bone Neoplasms | 2 | 9.0 |
Carcinoma, Hepatocellular | 6 | 1.0 |
Gene Expression Regulation/drug effects | 36 | 4.0 |
Liver Neoplasms | 6 | 2.0 |
Osteosarcoma | 5 | 5.0 |
Trans-Activation (Genetics)/*drug effects | 7 | 7.0 |
Transforming Growth Factor beta/*pharmacology | 54 | 13.0 |
Carbohydrate Sequence | 8 | 2.0 |
Dogs | 32 | 2.0 |
Structure-Activity Relationship | 94 | 3.0 |
Neurons/*metabolism | 4 | 1.0 |
Transcription Factor AP-1/metabolism | 12 | 4.0 |
Histamine/pharmacology | 6 | 10.0 |
Receptor, Epidermal Growth Factor/*analysis | 120 | 33.0 |
Bromodeoxyuridine/diagnostic use | 3 | 14.0 |
*Immediate-Early Proteins | 4 | 1.0 |
Keratinocytes/*drug effects/metabolism | 4 | 19.0 |
Thrombin/*pharmacology | 7 | 6.0 |
Tumor Cells, Cultured/drug effects/metabolism | 22 | 11.0 |
Zinc Fingers | 5 | 0.0 |
Growth Substances/chemistry/*metabolism | 2 | 28.0 |
Keratinocytes/*physiology | 7 | 20.0 |
Peptides/*metabolism | 21 | 10.0 |
Receptors, Growth Factor/metabolism | 10 | 8.0 |
Arsenic/pharmacology | 2 | 33.0 |
Bronchi/cytology | 3 | 10.0 |
DNA-Binding Proteins/metabolism | 22 | 1.0 |
MAP Kinase Kinase 1 | 19 | 11.0 |
MAP Kinase Kinase 2 | 9 | 18.0 |
MAP Kinase Signaling System/drug effects/*physiology | 5 | 12.0 |
Mitogen-Activated Protein Kinase Kinases/antagonists & inhibitors | 9 | 19.0 |
NF-kappa B/*metabolism | 3 | 0.0 |
Protein-Serine-Threonine Kinases/antagonists & inhibitors | 6 | 6.0 |
Proto-Oncogene Protein p21(ras)/*metabolism | 4 | 9.0 |
Quinazolines/pharmacology | 20 | 25.0 |
Receptor, Epidermal Growth Factor/antagonists & inhibitors/*metabolism | 19 | 57.0 |
Vanadium/pharmacology | 6 | 66.0 |
Zinc/pharmacology | 6 | 9.0 |
Finasteride/*therapeutic use | 2 | 25.0 |
Glycoproteins/metabolism | 15 | 9.0 |
Receptor, erbB-2/metabolism | 22 | 13.0 |
Transforming Growth Factor alpha/metabolism | 35 | 48.0 |
Infant | 57 | 0.0 |
Infant Food/*analysis | 2 | 18.0 |
Milk/*chemistry | 2 | 13.0 |
*Gene Expression Regulation, Developmental | 7 | 1.0 |
Proto-Oncogene Proteins/genetics | 8 | 1.0 |
*Cell Count | 2 | 28.0 |
Eosinophil Granule Proteins | 2 | 0.0 |
*Ribonucleases | 2 | 0.0 |
Down-Regulation/drug effects | 25 | 9.0 |
Enzyme Inhibitors/*pharmacology | 31 | 4.0 |
Receptor, Epidermal Growth Factor/*antagonists & inhibitors/metabolism | 10 | 22.0 |
DNA/analysis | 20 | 2.0 |
Milk, Human/*physiology | 5 | 100.0 |
Proto-Oncogene Proteins c-jun/analysis | 2 | 22.0 |
RNA/analysis | 9 | 3.0 |
Antineoplastic Combined Chemotherapy Protocols/*pharmacology | 2 | 4.0 |
Apoptosis/drug effects | 17 | 2.0 |
Neoplasm Metastasis | 30 | 2.0 |
Receptors, Vascular Endothelial Growth Factor | 7 | 1.0 |
Signal Transduction/*drug effects/physiology | 6 | 10.0 |
Eukaryotic Initiation Factor-4E | 2 | 1.0 |
Gene Expression | 134 | 2.0 |
Tensile Strength | 3 | 15.0 |
*Computer Simulation | 2 | 2.0 |
Genes, fos/genetics | 11 | 22.0 |
Models, Biological | 73 | 2.0 |
Software | 7 | 2.0 |
DNA-Binding Proteins/*metabolism | 19 | 0.0 |
Endosomes/*metabolism | 14 | 13.0 |
Immunoglobulin G/pharmacology | 5 | 8.0 |
Mammals | 8 | 2.0 |
Protein Transport/physiology | 8 | 7.0 |
*Saccharomyces cerevisiae Proteins | 7 | 0.0 |
Sheep | 11 | 1.0 |
Transcription Factors/*metabolism | 8 | 0.0 |
*Vesicular Transport Proteins | 4 | 2.0 |
Antineoplastic Agents/*therapeutic use | 17 | 4.0 |
Drug Therapy, Combination | 10 | 0.0 |
Epidermal Growth Factor/*antagonists & inhibitors | 14 | 63.0 |
Estrogen Antagonists/*therapeutic use | 2 | 10.0 |
Quinazolines/therapeutic use | 3 | 17.0 |
Body Weight | 6 | 0.0 |
Embryonic and Fetal Development/*physiology | 6 | 12.0 |
Epidermal Growth Factor/*genetics | 62 | 83.0 |
Insulin-Like Growth Factor I/*genetics | 2 | 8.0 |
Pregnancy Trimester, First | 11 | 4.0 |
Pregnancy Trimester, Second | 7 | 3.0 |
Pregnancy Trimester, Third | 9 | 4.0 |
Socioeconomic Factors | 2 | 1.0 |
Transforming Growth Factor beta/*genetics | 2 | 2.0 |
Cloning, Molecular | 137 | 1.0 |
Exons | 24 | 0.0 |
In Situ Hybridization | 60 | 2.0 |
Introns | 11 | 0.0 |
Neurons/physiology | 2 | 1.0 |
Phylogeny | 14 | 1.0 |
Gene Expression Regulation, Enzymologic/drug effects | 5 | 3.0 |
Gene Expression Regulation, Neoplastic/drug effects | 31 | 7.0 |
Isoenzymes/*genetics | 2 | 0.0 |
Prostaglandin-Endoperoxide Synthase/*genetics | 3 | 10.0 |
Tetradecanoylphorbol Acetate/pharmacology | 154 | 8.0 |
1-Phosphatidylinositol 3-Kinase/*metabolism | 16 | 5.0 |
Butadienes/pharmacology | 8 | 14.0 |
Culture Media, Serum-Free/pharmacology | 12 | 10.0 |
Glutathione Transferase/metabolism | 11 | 1.0 |
Nitriles/pharmacology | 24 | 22.0 |
Phosphoproteins/*metabolism | 24 | 5.0 |
Proto-Oncogene Protein c-met/metabolism | 6 | 8.0 |
src Homology Domains | 30 | 5.0 |
Down-Regulation/*drug effects | 2 | 3.0 |
Endocytosis/drug effects | 10 | 16.0 |
Genes, Reporter/genetics | 4 | 1.0 |
Macromolecular Substances | 46 | 2.0 |
Protein Binding/drug effects | 15 | 4.0 |
Cell Cycle | 28 | 2.0 |
Clinical Trials | 14 | 1.0 |
Loss of Heterozygosity | 2 | 0.0 |
Receptor Protein-Tyrosine Kinases/*metabolism | 19 | 7.0 |
Receptor, Epidermal Growth Factor/*biosynthesis/physiology | 3 | 75.0 |
*Down-Regulation | 13 | 4.0 |
Epidermal Growth Factor/antagonists & inhibitors/*metabolism | 6 | 85.0 |
Lung/cytology/*metabolism | 2 | 6.0 |
Mitogen-Activated Protein Kinase 1/*metabolism | 17 | 14.0 |
Tyrphostins/pharmacology | 31 | 20.0 |
Cercopithecus aethiops | 26 | 2.0 |
Epidermal Growth Factor/*metabolism/pharmacology | 50 | 84.0 |
GTP Phosphohydrolases/metabolism | 5 | 3.0 |
Peptides | 3 | 4.0 |
Protein-Serine-Threonine Kinases/*metabolism | 14 | 2.0 |
Recombinant Fusion Proteins/genetics/metabolism | 11 | 1.0 |
Cell Death/drug effects/physiology | 2 | 4.0 |
Estrogens/physiology | 2 | 6.0 |
Phosphorylation/drug effects | 81 | 9.0 |
Response Elements/physiology | 2 | 6.0 |
Tyrosine/*metabolism | 39 | 11.0 |
Antineoplastic Agents, Hormonal/*pharmacology | 4 | 7.0 |
Breast Neoplasms/*pathology | 28 | 13.0 |
Drug Resistance, Neoplasm | 6 | 1.0 |
Epidermal Growth Factor/*biosynthesis | 21 | 72.0 |
Phenotype | 63 | 0.0 |
Protein-Tyrosine Kinase | 17 | 48.0 |
Receptors, Estrogen/analysis | 29 | 8.0 |
Tamoxifen/*pharmacology | 10 | 15.0 |
*Polymorphism, Genetic | 11 | 0.0 |
Risk Factors | 13 | 0.0 |
5' Untranslated Regions/genetics | 2 | 1.0 |
Genetic Predisposition to Disease | 6 | 0.0 |
Melanoma/*genetics | 4 | 2.0 |
Skin Neoplasms/*genetics | 2 | 1.0 |
Cell Membrane/drug effects/metabolism | 15 | 17.0 |
Detergents/pharmacology | 4 | 3.0 |
G(M1) Ganglioside/metabolism | 2 | 10.0 |
Mitogens/*pharmacology | 34 | 30.0 |
Phosphoprotein Phosphatase/*metabolism | 5 | 5.0 |
Phosphotyrosine/*metabolism | 7 | 11.0 |
Proto-Oncogene Proteins c-raf/metabolism | 10 | 11.0 |
Swine | 59 | 4.0 |
1-Phosphatidylinositol 3-Kinase/antagonists & inhibitors | 8 | 9.0 |
Cell Survival | 36 | 3.0 |
Hepatectomy | 4 | 5.0 |
Interleukin-6/*physiology | 2 | 2.0 |
Liver/*enzymology | 4 | 0.0 |
Liver Regeneration | 5 | 10.0 |
Mice, Inbred BALB C | 60 | 2.0 |
Microscopy, Confocal | 27 | 2.0 |
Mitogen-Activated Protein Kinases/antagonists & inhibitors | 6 | 10.0 |
Oxidative Stress | 8 | 2.0 |
Rabbits | 75 | 2.0 |
Tumor Necrosis Factor-alpha/*physiology | 6 | 2.0 |
p38 Mitogen-Activated Protein Kinases | 19 | 2.0 |
Ovarian Neoplasms/*drug therapy/pathology | 2 | 8.0 |
Quinazolines/*therapeutic use | 4 | 11.0 |
Receptor, Epidermal Growth Factor/drug effects/*physiology | 7 | 46.0 |
Signal Transduction/drug effects | 48 | 7.0 |
Simian virus 40/physiology | 5 | 26.0 |
*Ultraviolet Rays | 15 | 6.0 |
Endothelial Growth Factors/genetics | 3 | 3.0 |
Epidermal Growth Factor/analysis | 46 | 79.0 |
Fibroblast Growth Factor 2/analysis | 7 | 20.0 |
Intercellular Signaling Peptides and Proteins/genetics | 2 | 7.0 |
Ki-67 Antigen/analysis | 3 | 1.0 |
Lymphokines/genetics | 3 | 3.0 |
Receptor, Epidermal Growth Factor/analysis | 67 | 35.0 |
Receptor, erbB-2/analysis | 5 | 5.0 |
Vascular Endothelial Growth Factor A | 37 | 1.0 |
Vascular Endothelial Growth Factors | 36 | 1.0 |
Biological Markers/analysis | 12 | 1.0 |
Carrier Proteins/metabolism | 16 | 2.0 |
Electrophoresis, Polyacrylamide Gel | 123 | 3.0 |
Fallopian Tubes/drug effects/*metabolism | 2 | 66.0 |
Phosphoproteins/metabolism | 31 | 4.0 |
Progesterone/*pharmacology | 14 | 17.0 |
Transcription, Genetic/*drug effects | 19 | 5.0 |
Enzyme Inhibitors/metabolism | 7 | 3.0 |
Estradiol/*metabolism | 4 | 6.0 |
Estrogen Receptor alpha | 6 | 2.0 |
Gene Expression Regulation | 84 | 2.0 |
Genes, Reporter | 26 | 1.0 |
Luciferases/genetics/metabolism | 4 | 1.0 |
Receptors, Estrogen/*metabolism | 11 | 5.0 |
*Transcription, Genetic | 19 | 0.0 |
Receptor, Epidermal Growth Factor/*genetics/*metabolism | 7 | 46.0 |
Signal Transduction/genetics/physiology | 3 | 6.0 |
Actins/metabolism | 16 | 3.0 |
Antigens, CD29/*metabolism | 4 | 10.0 |
Carcinoma/metabolism/pathology | 3 | 17.0 |
*Chemotaxis/drug effects | 2 | 28.0 |
Cytoskeleton/metabolism | 8 | 3.0 |
Nerve Tissue Proteins/*metabolism | 8 | 2.0 |
Protein Transport | 12 | 1.0 |
Dexamethasone/*pharmacology | 15 | 6.0 |
RNA, Messenger/genetics/*metabolism | 7 | 5.0 |
Epidermal Growth Factor/antagonists & inhibitors/pharmacology | 9 | 75.0 |
Epidermal Growth Factor/*genetics/metabolism | 11 | 68.0 |
Glycoproteins/*genetics/metabolism | 2 | 5.0 |
Growth Substances/*genetics/metabolism | 2 | 9.0 |
Helicobacter pylori/*isolation & purification | 2 | 22.0 |
RNA, Messenger/*genetics | 13 | 3.0 |
Transforming Growth Factor alpha/*genetics/metabolism | 7 | 70.0 |
Cohort Studies | 4 | 0.0 |
Mutation/*genetics | 4 | 0.0 |
*Polymorphism, Single-Stranded Conformational | 2 | 1.0 |
Receptors, LDL/*genetics | 14 | 8.0 |
Antibodies, Monoclonal/diagnostic use | 22 | 2.0 |
Lung Neoplasms/*radionuclide imaging | 2 | 100.0 |
Radioimmunodetection | 4 | 23.0 |
Receptor, Epidermal Growth Factor/*immunology | 24 | 42.0 |
Analysis of Variance | 40 | 1.0 |
Collagen/biosynthesis/*drug effects | 2 | 100.0 |
DNA/biosynthesis/*drug effects | 2 | 22.0 |
Fibroblasts/*drug effects | 4 | 21.0 |
Flow Cytometry | 80 | 1.0 |
Radiopharmaceuticals/diagnostic use | 3 | 5.0 |
Receptor, Epidermal Growth Factor/*drug effects | 11 | 55.0 |
Statistics | 11 | 2.0 |
Actins/physiology | 6 | 17.0 |
Microfilaments/physiology | 2 | 20.0 |
Space Flight | 2 | 18.0 |
Weightlessness | 2 | 40.0 |
Alleles | 15 | 0.0 |
Polymorphism, Restriction Fragment Length | 8 | 0.0 |
Age Factors | 21 | 0.0 |
DNA-Binding Proteins/*physiology | 6 | 1.0 |
Osmotic Pressure | 2 | 3.0 |
Protein-Tyrosine Kinase/*physiology | 5 | 3.0 |
Trans-Activators/*physiology | 6 | 2.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/metabolism | 47 | 13.0 |
Carcinoma/pathology/*physiopathology | 3 | 50.0 |
Glycogen Synthase Kinase 3 | 5 | 5.0 |
Intestinal Mucosa/cytology | 4 | 30.0 |
Isoenzymes/genetics/metabolism | 4 | 2.0 |
Proto-Oncogene Proteins/genetics/metabolism | 2 | 1.0 |
Receptors, Cell Surface/genetics/metabolism | 2 | 3.0 |
*Trans-Activators | 8 | 1.0 |
Endosonography/*trends | 2 | 100.0 |
Forecasting | 7 | 2.0 |
Cytosol/metabolism | 19 | 3.0 |
Fatty Acids, Monounsaturated/*pharmacology | 2 | 22.0 |
Hydroxymethylglutaryl-CoA Reductase Inhibitors/*pharmacology | 2 | 3.0 |
Indoles/*pharmacology | 5 | 5.0 |
Lovastatin/pharmacology | 3 | 8.0 |
Neoplasm Invasiveness | 62 | 5.0 |
Pancreatic Neoplasms/*drug therapy/pathology | 3 | 30.0 |
rhoA GTP-Binding Protein/metabolism | 2 | 2.0 |
Lysosomes/metabolism | 16 | 11.0 |
Protein Sorting Signals | 3 | 4.0 |
Receptor, Epidermal Growth Factor/*chemistry/genetics/*metabolism | 6 | 75.0 |
Sequence Alignment | 54 | 1.0 |
Molecular Conformation | 2 | 0.0 |
Cyclosporine/*adverse effects | 2 | 12.0 |
Hyperplasia/chemically induced/pathology | 2 | 66.0 |
Immunosuppressive Agents/*adverse effects | 2 | 5.0 |
Keratinocytes/metabolism | 14 | 12.0 |
Periodontal Index | 4 | 8.0 |
Receptor, Epidermal Growth Factor/analysis/*biosynthesis | 3 | 13.0 |
Stem Cells/*drug effects/physiology | 2 | 40.0 |
Wound Healing/*drug effects | 29 | 64.0 |
Culture Media, Conditioned/metabolism | 4 | 13.0 |
Cytokines/pharmacology | 12 | 3.0 |
Gelatinase B/*biosynthesis/genetics | 2 | 28.0 |
Interleukin-1/pharmacology | 30 | 4.0 |
Cell Cycle/*physiology | 8 | 2.0 |
Cyclin D1/metabolism | 7 | 4.0 |
Cyclin-Dependent Kinases/metabolism | 7 | 2.0 |
DNA Probes | 19 | 1.0 |
Fibroblast Growth Factors/*pharmacology | 19 | 41.0 |
Gene Expression Profiling | 10 | 0.0 |
Hepatocyte Growth Factor/*pharmacology | 19 | 11.0 |
Transcription Factors/metabolism | 14 | 0.0 |
Antigens, CD/*metabolism | 2 | 0.0 |
Breast Neoplasms/*metabolism/pathology | 18 | 9.0 |
Cell Differentiation/drug effects | 63 | 5.0 |
Membrane Glycoproteins/*metabolism | 2 | 0.0 |
Mitogen-Activated Protein Kinase Kinases/metabolism | 11 | 6.0 |
Peptides/pharmacology | 16 | 8.0 |
Receptor, erbB-3/metabolism | 6 | 20.0 |
Receptors, Estrogen/genetics | 4 | 6.0 |
Trans-Activators/metabolism | 17 | 1.0 |
Receptor, Epidermal Growth Factor/drug effects | 17 | 85.0 |
Gastric Acid/secretion | 6 | 13.0 |
Gene Expression/drug effects | 35 | 4.0 |
Luciferases/genetics | 8 | 2.0 |
Protein Subunits | 4 | 1.0 |
Central Nervous System/embryology/growth & development/metabolism | 2 | 100.0 |
Isotope Labeling/methods | 2 | 8.0 |
Receptors, Cell Surface/*analysis | 20 | 17.0 |
Antigens, CD/metabolism | 6 | 0.0 |
Breast/*metabolism | 4 | 6.0 |
*Caenorhabditis elegans Proteins | 5 | 4.0 |
*Interleukin-6 | 9 | 2.0 |
Lymphokines/*metabolism | 5 | 1.0 |
Membrane Glycoproteins/metabolism | 9 | 1.0 |
Receptors, Cytokine/metabolism | 2 | 2.0 |
Cell Proliferation/drug effects | 3 | 3.0 |
Neovascularization, Pathologic/*drug therapy | 2 | 4.0 |
Binding Sites/physiology | 4 | 2.0 |
*Sequence Deletion | 3 | 0.0 |
Collagen/*biosynthesis | 11 | 28.0 |
Transforming Growth Factor beta/*biosynthesis | 4 | 17.0 |
Fluorescent Dyes/chemistry | 3 | 12.0 |
Cell Transformation, Neoplastic | 30 | 5.0 |
Cytokines/*physiology | 14 | 7.0 |
DNA Replication/drug effects | 40 | 22.0 |
Genes, erbB-1 | 2 | 11.0 |
MAP Kinase Signaling System/drug effects/physiology | 4 | 12.0 |
Fibroblasts/*metabolism | 17 | 10.0 |
RNA Stability | 2 | 3.0 |
RNA, Messenger/analysis/genetics | 11 | 2.0 |
Sequence Deletion | 22 | 1.0 |
Amnion/*cytology | 3 | 27.0 |
Basement Membrane/metabolism | 3 | 4.0 |
Coculture Techniques/methods | 2 | 10.0 |
Epithelial Cells/*cytology/metabolism | 2 | 12.0 |
Growth Substances/*metabolism | 47 | 31.0 |
Tissue Donors | 4 | 1.0 |
Tissue Inhibitor of Metalloproteinase-1/metabolism | 2 | 7.0 |
Transforming Growth Factor beta/metabolism | 13 | 6.0 |
Endometrium/*metabolism | 8 | 9.0 |
Menstrual Cycle/physiology | 2 | 5.0 |
Polycystic Ovary Syndrome/*metabolism | 6 | 23.0 |
Stromal Cells/metabolism | 3 | 3.0 |
Up-Regulation/drug effects | 12 | 3.0 |
Carcinogens/toxicity | 2 | 3.0 |
Cell Transformation, Neoplastic/drug effects | 8 | 22.0 |
Gene Expression Regulation/*drug effects | 29 | 4.0 |
Mitosis | 17 | 3.0 |
Carrier Proteins/*metabolism | 20 | 2.0 |
Clathrin/metabolism | 4 | 8.0 |
Escherichia coli/metabolism | 2 | 0.0 |
Gene Library | 19 | 1.0 |
Protein-Tyrosine Kinase/*metabolism | 66 | 8.0 |
cdc42 GTP-Binding Protein/*metabolism | 2 | 2.0 |
Epidermal Growth Factor/*biosynthesis/physiology | 2 | 100.0 |
Heparin/pharmacology | 7 | 2.0 |
Lipopolysaccharides/pharmacology | 7 | 0.0 |
Gangliosides/metabolism | 2 | 11.0 |
Insects | 3 | 1.0 |
Receptor, Epidermal Growth Factor/*chemistry/*metabolism | 7 | 77.0 |
Carcinoma, Squamous Cell/*metabolism/ultrastructure | 3 | 100.0 |
DNA, Viral/analysis | 5 | 1.0 |
Epithelial Cells/drug effects/metabolism | 5 | 5.0 |
Growth Inhibitors/*pharmacology | 14 | 7.0 |
Isoenzymes/*metabolism | 9 | 3.0 |
Prostaglandin-Endoperoxide Synthase/*metabolism | 8 | 12.0 |
Prostate/cytology | 2 | 16.0 |
Receptors, Androgen/metabolism | 4 | 9.0 |
Embryonic and Fetal Development/*drug effects | 3 | 23.0 |
Epidermal Growth Factor/analysis/*pharmacology | 2 | 100.0 |
Follicular Fluid/*chemistry | 5 | 20.0 |
Arginine | 4 | 4.0 |
HL-60 Cells | 7 | 1.0 |
K562 Cells | 3 | 0.0 |
Metalloendopeptidases/metabolism | 6 | 9.0 |
Physical Stimulation | 3 | 6.0 |
Serine | 4 | 4.0 |
Chromatography, Affinity | 30 | 3.0 |
Reference Values | 73 | 1.0 |
Estradiol/blood | 8 | 1.0 |
Progesterone/blood | 6 | 2.0 |
Adenylate Cyclase/*metabolism | 9 | 16.0 |
*Carbazoles | 2 | 28.0 |
Cyclic AMP/*metabolism | 16 | 7.0 |
Cyclic AMP-Dependent Protein Kinases/antagonists & inhibitors | 2 | 7.0 |
Estradiol/*analogs & derivatives/pharmacology | 3 | 6.0 |
Estrogen Antagonists/pharmacology | 16 | 17.0 |
Indoles/pharmacology | 18 | 8.0 |
Mitogen-Activated Protein Kinases/drug effects/metabolism | 4 | 9.0 |
Pyrroles/pharmacology | 3 | 6.0 |
Receptors, Cell Surface/drug effects/*metabolism | 18 | 37.0 |
*Receptors, G-Protein-Coupled | 3 | 1.0 |
Catalytic Domain | 7 | 2.0 |
Hydroxylation | 3 | 0.0 |
Incidence | 6 | 0.0 |
Membrane Proteins/metabolism | 29 | 5.0 |
*Protein Processing, Post-Translational | 13 | 5.0 |
Breast Neoplasms/*drug therapy/pathology | 6 | 15.0 |
Cell Cycle/drug effects | 36 | 6.0 |
Cell Movement/drug effects | 50 | 13.0 |
Doxorubicin/*pharmacology | 4 | 5.0 |
Phosphatidic Acids/*pharmacology | 2 | 22.0 |
Blotting, Northern | 181 | 4.0 |
Epidermal Growth Factor/physiology | 74 | 86.0 |
Sequence Analysis, DNA | 34 | 0.0 |
Tumor Necrosis Factor-alpha/physiology | 3 | 1.0 |
Bronchoalveolar Lavage Fluid/*chemistry | 2 | 3.0 |
Endothelial Growth Factors/*analysis | 3 | 1.0 |
Gestational Age | 43 | 4.0 |
Lymphokines/*analysis | 3 | 1.0 |
Protein Isoforms/analysis | 2 | 4.0 |
Autocrine Communication/*physiology | 4 | 14.0 |
Breast/*cytology | 10 | 28.0 |
Cell Movement/*physiology | 6 | 2.0 |
Culture Media, Serum-Free | 51 | 13.0 |
Cell Adhesion | 45 | 3.0 |
Phosphoproteins/*physiology | 2 | 2.0 |
*Proteins | 11 | 2.0 |
Receptor, Epidermal Growth Factor/analysis/chemistry/*metabolism | 2 | 100.0 |
Breast Neoplasms/prevention & control | 2 | 25.0 |
Cell Cycle/*drug effects | 13 | 7.0 |
Epidermal Growth Factor/*drug effects | 2 | 66.0 |
Estrogen Replacement Therapy | 2 | 4.0 |
Estrogens | 2 | 8.0 |
Postmenopause | 3 | 1.0 |
Tumor Cells, Cultured/drug effects | 68 | 11.0 |
Tyrphostins/*pharmacology | 5 | 20.0 |
*Cell Division | 19 | 11.0 |
Interleukin-1/*pharmacology | 19 | 4.0 |
*Neoplasm Invasiveness | 6 | 8.0 |
*Translocation, Genetic | 2 | 0.0 |
Protein-Tyrosine Kinase/genetics/*metabolism | 8 | 5.0 |
Receptor, Epidermal Growth Factor/genetics | 27 | 24.0 |
Epitopes | 13 | 1.0 |
Genetic Vectors | 32 | 2.0 |
Luciferases/metabolism | 6 | 0.0 |
*Milk Proteins | 6 | 1.0 |
Peptides/chemistry | 10 | 2.0 |
Tyrosine/chemistry/metabolism | 3 | 17.0 |
Adenoviridae/genetics | 8 | 1.0 |
Cell Death/*drug effects | 3 | 9.0 |
Epithelial Cells/drug effects/enzymology | 4 | 22.0 |
Glucose/metabolism | 8 | 3.0 |
Hydrogen Peroxide/*pharmacology | 6 | 10.0 |
Oxidants/*pharmacology | 3 | 13.0 |
Cell Aging/drug effects | 2 | 18.0 |
Epidermal Growth Factor/antagonists & inhibitors/*pharmacology | 15 | 93.0 |
Follistatin | 5 | 33.0 |
Oocytes/*physiology | 3 | 8.0 |
Ovary/*physiology | 2 | 5.0 |
Transforming Growth Factor alpha/*pharmacology | 42 | 73.0 |
Nerve Growth Factors/metabolism | 2 | 3.0 |
*Trans-Activation (Genetics) | 8 | 1.0 |
Cell Differentiation/drug effects/physiology | 4 | 4.0 |
Lymphokines/*pharmacology | 2 | 0.0 |
NG-Nitroarginine Methyl Ester/pharmacology | 3 | 6.0 |
Pregnancy Proteins/*pharmacology | 2 | 11.0 |
Endothelium, Vascular/cytology/*metabolism | 2 | 1.0 |
Umbilical Veins | 8 | 1.0 |
Adrenal Gland Neoplasms | 2 | 12.0 |
JNK Mitogen-Activated Protein Kinases | 24 | 4.0 |
Mitogen-Activated Protein Kinases/antagonists & inhibitors/metabolism | 8 | 8.0 |
Nerve Tissue Proteins/*genetics | 3 | 0.0 |
Nuclear Proteins/*genetics | 2 | 0.0 |
PC12 Cells | 21 | 6.0 |
Peptides/*genetics | 4 | 4.0 |
Pheochromocytoma | 3 | 13.0 |
Proto-Oncogene Proteins/antagonists & inhibitors/metabolism | 2 | 9.0 |
Receptors, Growth Factor/*physiology | 6 | 20.0 |
Signal Transduction/genetics | 10 | 3.0 |
Amino Acid Substitution/genetics | 6 | 2.0 |
Disulfides/*metabolism | 3 | 13.0 |
Epidermal Growth Factor/chemistry/genetics | 3 | 75.0 |
Membrane Proteins/genetics/*metabolism | 5 | 1.0 |
Receptors, LDL/genetics | 2 | 2.0 |
Subcellular Fractions/metabolism | 11 | 3.0 |
Antineoplastic Agents/*pharmacology/therapeutic use | 3 | 3.0 |
Receptor, Epidermal Growth Factor/*biosynthesis | 41 | 35.0 |
Androgens/pharmacology/*physiology | 2 | 40.0 |
Neoplasms, Hormone-Dependent/genetics/*metabolism/pathology | 2 | 28.0 |
Antibodies | 25 | 5.0 |
RNA, Messenger/analysis | 112 | 3.0 |
Carcinoma, Squamous Cell/genetics/*metabolism | 4 | 20.0 |
Cell Adhesion Molecules/*genetics | 2 | 2.0 |
Gene Amplification | 45 | 6.0 |
Liver/metabolism | 18 | 2.0 |
Receptor, Epidermal Growth Factor/*genetics | 72 | 31.0 |
Genes, src | 4 | 17.0 |
Protein-Tyrosine Kinase/*genetics | 10 | 4.0 |
Collagen | 23 | 13.0 |
Fibronectins | 3 | 13.0 |
Mitogen-Activated Protein Kinases/*physiology | 7 | 9.0 |
Mitogen-Activated Protein Kinase 7 | 5 | 33.0 |
Mitogen-Activated Protein Kinases/genetics/*metabolism | 2 | 4.0 |
Receptor, erbB-2/genetics/*metabolism | 5 | 15.0 |
*Calcium Signaling | 2 | 4.0 |
Extracellular Space | 2 | 8.0 |
Gap Junctions/drug effects/*physiology | 2 | 100.0 |
Intracellular Fluid/metabolism | 4 | 3.0 |
Solubility | 25 | 1.0 |
Mice, Transgenic | 27 | 0.0 |
Transforming Growth Factor alpha/*genetics | 8 | 17.0 |
*Receptor, Epidermal Growth Factor | 3 | 42.0 |
Hydatidiform Mole/*metabolism | 2 | 50.0 |
Placenta/metabolism | 20 | 11.0 |
Uterine Neoplasms/*metabolism | 11 | 34.0 |
DNA, Neoplasm/drug effects | 3 | 9.0 |
Mice, SCID | 5 | 0.0 |
Neoplasms/drug therapy | 3 | 5.0 |
Circular Dichroism | 9 | 2.0 |
*Exons | 4 | 1.0 |
Magnetic Resonance Spectroscopy | 33 | 6.0 |
Spectrophotometry, Ultraviolet | 5 | 2.0 |
Questionnaires | 2 | 0.0 |
United States | 5 | 0.0 |
Dementia, Multi-Infarct/*genetics | 3 | 30.0 |
NIH 3T3 Cells | 7 | 2.0 |
Nuclear Proteins/*metabolism | 9 | 1.0 |
Proto-Oncogene Proteins/*genetics/metabolism | 5 | 3.0 |
Receptors, Cell Surface/*genetics/metabolism | 12 | 14.0 |
Receptors, Immunologic/*metabolism | 3 | 1.0 |
Receptors, Estrogen/biosynthesis/*physiology | 2 | 50.0 |
Signal Transduction/drug effects/physiology | 18 | 7.0 |
Somatomedins/physiology | 7 | 63.0 |
Stimulation, Chemical | 42 | 8.0 |
Suramin/*pharmacology | 5 | 23.0 |
Testosterone/pharmacology | 9 | 15.0 |
Detergents | 7 | 6.0 |
Ileum/*metabolism | 3 | 27.0 |
Lipids/*metabolism | 6 | 2.0 |
Microvilli/metabolism | 6 | 20.0 |
Phosphoproteins/physiology | 2 | 3.0 |
Sodium-Hydrogen Antiporter/*metabolism | 4 | 25.0 |
Combined Modality Therapy | 6 | 0.0 |
Receptor, Epidermal Growth Factor/antagonists & inhibitors/metabolism | 10 | 62.0 |
Drug Combinations | 24 | 4.0 |
Endothelial Growth Factors/pharmacology | 3 | 2.0 |
Extracellular Matrix/drug effects/metabolism | 3 | 17.0 |
Fibroblasts/drug effects/physiology | 3 | 15.0 |
Lymphokines/pharmacology | 6 | 3.0 |
Chimeric Proteins/chemistry/metabolism | 3 | 5.0 |
Peptide Fragments/*chemistry | 3 | 9.0 |
Recombinant Proteins/chemistry/isolation & purification/metabolism | 5 | 6.0 |
DNA Mutational Analysis | 23 | 0.0 |
Peptide Mapping | 32 | 7.0 |
Phosphopeptides/chemistry | 2 | 10.0 |
Spectrum Analysis, Mass | 19 | 3.0 |
Transformation, Genetic | 5 | 2.0 |
ras Proteins/metabolism | 15 | 9.0 |
Gene Deletion | 13 | 0.0 |
Receptor, Epidermal Growth Factor/chemistry/*physiology | 3 | 100.0 |
Bone Marrow/pathology | 3 | 0.0 |
Species Specificity | 39 | 1.0 |
Tumor Necrosis Factor-alpha/*analysis | 2 | 0.0 |
Genes, erbB-2/genetics | 3 | 11.0 |
*Mutation | 27 | 0.0 |
Peptides/*chemistry | 4 | 8.0 |
Fibroblasts/drug effects/*metabolism | 15 | 31.0 |
Organ Culture Techniques | 33 | 8.0 |
Receptor, Epidermal Growth Factor/antagonists & inhibitors | 10 | 26.0 |
Contact Inhibition | 5 | 26.0 |
Heterotrimeric GTP-Binding Proteins/metabolism | 3 | 8.0 |
Nuclear Proteins/metabolism | 8 | 0.0 |
Oncogene Protein pp60(v-src)/metabolism | 4 | 50.0 |
Receptors, Cell Surface/metabolism | 52 | 12.0 |
Biological Markers/analysis/blood | 2 | 6.0 |
Growth Substances/*analysis/blood | 2 | 100.0 |
Postoperative Period | 3 | 0.0 |
Saliva/*chemistry | 11 | 28.0 |
Radioligand Assay | 78 | 17.0 |
Alternative Splicing | 16 | 1.0 |
Vascular Endothelial Growth Factor Receptor-1 | 2 | 0.0 |
Cysteine/genetics | 3 | 2.0 |
Family Health | 2 | 0.0 |
Pedigree | 16 | 0.0 |
Repetitive Sequences, Nucleic Acid | 17 | 2.0 |
Antibodies, Monoclonal/pharmacology | 30 | 4.0 |
Cell Adhesion/*drug effects | 3 | 5.0 |
Cell Movement/*drug effects | 16 | 17.0 |
Collagen Type IV/pharmacology | 2 | 66.0 |
Cytoskeleton/drug effects/metabolism | 5 | 17.0 |
Receptors, Collagen | 2 | 2.0 |
Electrophoresis | 2 | 0.0 |
Genes, ras/genetics | 6 | 5.0 |
Glucose/*pharmacology | 2 | 2.0 |
Proto-Oncogene Proteins/*genetics/*metabolism | 2 | 4.0 |
Transcription Factors/*genetics | 7 | 0.0 |
*Mucins | 5 | 7.0 |
*Muscle Proteins | 9 | 3.0 |
*Neuropeptides | 7 | 5.0 |
Peptides/*pharmacology | 45 | 22.0 |
Proteins/*pharmacology | 3 | 4.0 |
Eflornithine/*pharmacology | 2 | 33.0 |
Epithelial Cells/metabolism/pathology | 2 | 4.0 |
Hydroxyurea/pharmacology | 2 | 3.0 |
Nocodazole/pharmacology | 3 | 2.0 |
Ornithine Decarboxylase/antagonists & inhibitors/metabolism | 2 | 33.0 |
Polyamines/*metabolism | 8 | 30.0 |
Apoptosis/physiology | 6 | 1.0 |
Cell Adhesion Molecules/*physiology | 2 | 1.0 |
Integrins/physiology | 5 | 7.0 |
Neovascularization, Physiologic/*physiology | 5 | 4.0 |
Alanine/genetics/metabolism | 2 | 15.0 |
Cell Membrane/drug effects/enzymology/metabolism | 2 | 20.0 |
Protein Isoforms/genetics/metabolism | 5 | 2.0 |
Protein Kinase C/*metabolism | 36 | 12.0 |
Protein Transport/drug effects | 4 | 6.0 |
Glycosylation | 21 | 2.0 |
Protein C/metabolism | 7 | 7.0 |
Thrombin/chemistry/*metabolism | 2 | 100.0 |
Urinary Plasminogen Activator/chemistry/*metabolism | 2 | 50.0 |
Receptor, erbB-2/*analysis | 3 | 3.0 |
Stomach Neoplasms/*chemistry/pathology | 4 | 28.0 |
Transforming Growth Factor alpha/analysis | 13 | 40.0 |
Adenocarcinoma/*genetics | 2 | 1.0 |
Oncogenes/genetics | 4 | 5.0 |
*Reverse Transcriptase Polymerase Chain Reaction | 2 | 3.0 |
Stomach Neoplasms/*genetics | 2 | 1.0 |
Oligonucleotides, Antisense/genetics/*pharmacology | 3 | 23.0 |
Stomach Neoplasms/*pathology | 6 | 12.0 |
Membrane Glycoproteins/*physiology | 2 | 0.0 |
Peptide Fragments/pharmacology | 12 | 5.0 |
Protein Structure, Tertiary/physiology | 2 | 1.0 |
Umbilical Veins/cytology | 6 | 2.0 |
DNA-Binding Proteins/*genetics | 7 | 0.0 |
Mice, Transgenic/genetics | 2 | 3.0 |
Vascular Endothelial Growth Factor A/*genetics | 2 | 4.0 |
*Evolution | 2 | 1.0 |
Biotinylation | 6 | 4.0 |
Immunoprecipitation | 3 | 1.0 |
Membrane Glycoproteins/*chemistry | 3 | 9.0 |
Receptor, Epidermal Growth Factor/*chemistry | 5 | 33.0 |
Family | 2 | 0.0 |
Interleukin-8/genetics | 2 | 3.0 |
Receptor, Epidermal Growth Factor/antagonists & inhibitors/*genetics | 3 | 50.0 |
*Apoptosis | 18 | 1.0 |
Drug Antagonism | 6 | 13.0 |
MAP Kinase Signaling System/*drug effects | 7 | 18.0 |
Mitogen-Activated Protein Kinases/*antagonists & inhibitors/*metabolism | 2 | 50.0 |
Neoplasms/enzymology/pathology | 2 | 40.0 |
Somatostatin/pharmacology | 3 | 6.0 |
Bronchi/*cytology | 2 | 13.0 |
Bucladesine/pharmacology | 20 | 10.0 |
Epithelial Cells/cytology/drug effects/metabolism | 5 | 20.0 |
Isoquinolines/pharmacology | 10 | 8.0 |
*Sulfonamides | 5 | 9.0 |
Morphogenesis | 9 | 4.0 |
Neoplasm Proteins/*physiology | 6 | 6.0 |
Cold | 5 | 4.0 |
Culture Media, Conditioned | 30 | 8.0 |
Fetus | 27 | 4.0 |
Epidermal Growth Factor/blood | 16 | 94.0 |
Growth Substances/*blood | 4 | 15.0 |
Hydrocortisone/*blood | 2 | 1.0 |
Insulin-Like Growth Factor Binding Protein 3/*blood | 2 | 7.0 |
Chromones/pharmacology | 16 | 7.0 |
Morpholines/pharmacology | 14 | 5.0 |
Transforming Growth Factor beta/*metabolism | 9 | 3.0 |
Microfilament Proteins/metabolism | 2 | 2.0 |
Protein-Tyrosine-Phosphatase/antagonists & inhibitors | 8 | 22.0 |
Receptor, erbB-2/*metabolism | 20 | 13.0 |
src-Family Kinases/metabolism | 3 | 1.0 |
Mucins/*genetics | 2 | 1.0 |
Promoter Regions (Genetics)/genetics | 11 | 1.0 |
Epidermal Growth Factor/*genetics/*metabolism | 3 | 100.0 |
Keratinocytes/cytology | 6 | 17.0 |
Mitogens/pharmacology | 19 | 7.0 |
Point Mutation/*genetics | 2 | 0.0 |
Cell Differentiation/physiology | 17 | 3.0 |
Growth Substances/*biosynthesis | 11 | 25.0 |
Keratinocytes/*cytology/*metabolism | 3 | 27.0 |
Protein Precursors/*biosynthesis/genetics | 3 | 30.0 |
Skin/cytology/metabolism | 4 | 10.0 |
Tissue Inhibitor of Metalloproteinase-1/biosynthesis | 4 | 26.0 |
DNA, Complementary | 30 | 1.0 |
Carrier Proteins/*physiology | 4 | 1.0 |
Epithelial Cells/drug effects/*metabolism | 3 | 13.0 |
Flavonoids/*pharmacology | 5 | 6.0 |
Homeostasis/drug effects | 3 | 13.0 |
*Symporters | 5 | 5.0 |
Blood Platelets/*secretion | 2 | 18.0 |
*Fibroblast Growth Factors | 21 | 24.0 |
Platelet Activation | 2 | 1.0 |
Wound Healing/*drug effects/physiology | 4 | 44.0 |
Insulin-Like Growth Factor I/*metabolism | 15 | 11.0 |
Prostatic Neoplasms | 5 | 8.0 |
Thapsigargin/pharmacology | 6 | 5.0 |
Tumor Necrosis Factor-alpha/*metabolism | 5 | 0.0 |
1-Phosphatidylinositol 3-Kinase/antagonists & inhibitors/*metabolism | 5 | 8.0 |
Blotting, Western/methods | 4 | 2.0 |
Colon/*metabolism | 5 | 9.0 |
Chromatography | 3 | 1.0 |
Culture Media, Conditioned/pharmacology | 13 | 7.0 |
Epidermal Growth Factor/*chemistry/*physiology | 2 | 100.0 |
Mitogens | 9 | 13.0 |
Receptor, Epidermal Growth Factor/chemistry/metabolism | 3 | 42.0 |
Epidermal Growth Factor/isolation & purification/*metabolism | 6 | 100.0 |
Gastric Mucosa/drug effects/*metabolism | 2 | 40.0 |
Helicobacter Infections/drug therapy/*metabolism | 3 | 100.0 |
*Helicobacter pylori | 5 | 4.0 |
Receptor, Epidermal Growth Factor/isolation & purification/*metabolism | 14 | 93.0 |
Metallothionein/genetics | 3 | 8.0 |
RNA, Messenger/analysis/biosynthesis | 10 | 4.0 |
Transgenes | 3 | 0.0 |
Brain Neoplasms/*pathology | 5 | 6.0 |
Epidermal Growth Factor/chemistry/*pharmacology | 3 | 100.0 |
Gene Expression Regulation, Neoplastic/*drug effects | 18 | 6.0 |
Glioblastoma/pathology | 3 | 16.0 |
Glioma/*pathology | 8 | 15.0 |
Neoplasm Proteins/*biosynthesis/genetics | 6 | 3.0 |
1-Phosphatidylinositol 3-Kinase/chemistry/*metabolism | 2 | 28.0 |
Peptides/metabolism | 11 | 5.0 |
Proline/metabolism | 2 | 3.0 |
Adenosine Triphosphate/metabolism | 32 | 7.0 |
Cysteine/genetics/metabolism | 2 | 11.0 |
Disulfides/metabolism | 6 | 16.0 |
Mutation/genetics | 10 | 0.0 |
Pliability | 2 | 9.0 |
Glomerulonephritis, IGA/metabolism | 2 | 40.0 |
Platelet-Derived Growth Factor/pharmacology | 77 | 39.0 |
Adenosine Triphosphate/pharmacology | 7 | 10.0 |
Calcium Signaling/physiology | 3 | 8.0 |
Receptors, Muscarinic/*metabolism | 3 | 8.0 |
Receptors, Platelet-Derived Growth Factor/*metabolism | 2 | 10.0 |
Pancreatic Neoplasms/metabolism/*pathology | 4 | 13.0 |
Promoter Regions (Genetics)/physiology | 4 | 2.0 |
Antibodies, Monoclonal/*chemistry | 3 | 7.0 |
Epidermal Growth Factor/*immunology | 6 | 75.0 |
Surface Plasmon Resonance | 8 | 4.0 |
Receptor, erbB-3/*metabolism | 2 | 9.0 |
Skin/cytology/enzymology | 4 | 36.0 |
*Infant, Premature | 3 | 5.0 |
Intestinal Mucosa/*metabolism/pathology | 2 | 12.0 |
Cell Membrane Permeability/drug effects | 4 | 7.0 |
Enzyme Activators/pharmacology | 2 | 10.0 |
Hydrogen Peroxide/pharmacology | 7 | 3.0 |
Isoenzymes/antagonists & inhibitors/genetics/*metabolism | 2 | 14.0 |
Protein Kinase C/antagonists & inhibitors/genetics/*metabolism | 2 | 22.0 |
3' Untranslated Regions | 2 | 1.0 |
Endometrium/*chemistry | 3 | 13.0 |
Protein Precursors/genetics | 9 | 9.0 |
RNA, Messenger/*analysis | 17 | 3.0 |
Mice, Inbred A | 3 | 5.0 |
Protein Kinase C/antagonists & inhibitors | 11 | 8.0 |
Protein-Serine-Threonine Kinases/genetics/metabolism | 4 | 3.0 |
Glycoproteins/biosynthesis/genetics | 4 | 20.0 |
Growth Substances/biosynthesis/genetics | 2 | 12.0 |
Receptor, Epidermal Growth Factor/biosynthesis/genetics/*metabolism | 5 | 83.0 |
Receptor, erbB-2/biosynthesis/genetics | 4 | 20.0 |
Transforming Growth Factor alpha/biosynthesis/genetics | 2 | 66.0 |
Tumor Markers, Biological/*biosynthesis/genetics | 2 | 6.0 |
Neovascularization, Pathologic | 9 | 2.0 |
Blood Coagulation/*drug effects | 2 | 1.0 |
Cell Membrane/drug effects/physiology | 2 | 11.0 |
Drug Interactions | 46 | 3.0 |
Serum Albumin, Bovine/pharmacology | 5 | 15.0 |
Burns/*metabolism | 2 | 25.0 |
Nitric Oxide/metabolism | 3 | 1.0 |
Mutagenesis | 16 | 1.0 |
Neoplasm Proteins/chemistry/genetics/*metabolism | 2 | 9.0 |
Point Mutation | 21 | 1.0 |
Xenopus | 4 | 0.0 |
*Xenopus Proteins | 2 | 0.0 |
Kidney Function Tests | 2 | 1.0 |
Recurrence | 5 | 0.0 |
GTP Phosphohydrolases/*metabolism | 2 | 1.0 |
Inositol Phosphates/metabolism | 15 | 11.0 |
Fibroblast Growth Factors/*metabolism | 2 | 5.0 |
Genes, Dominant | 9 | 0.0 |
Endothelial Growth Factors/*metabolism | 4 | 1.0 |
Embryo Implantation/*physiology | 3 | 8.0 |
Endometrium/*physiology | 4 | 26.0 |
Neovascularization, Physiologic/physiology | 3 | 5.0 |
Benzoates/*pharmacology | 2 | 18.0 |
Retinoids/*pharmacology | 8 | 14.0 |
Tretinoin/*pharmacology | 22 | 6.0 |
Tumor Cells, Cultured/drug effects/physiology | 2 | 25.0 |
Cell Differentiation/drug effects/*physiology | 6 | 9.0 |
Cell Division/drug effects/*physiology | 7 | 26.0 |
Dopamine/analysis | 2 | 13.0 |
Embryo | 11 | 3.0 |
Nerve Tissue Proteins/pharmacology | 2 | 4.0 |
Neurons/*cytology | 3 | 5.0 |
Stem Cells/*cytology/drug effects | 2 | 14.0 |
Hepatocyte Growth Factor/analysis | 2 | 40.0 |
Interleukin-8/analysis | 4 | 9.0 |
Osmolar Concentration | 14 | 1.0 |
Substance P/*pharmacology | 3 | 9.0 |
Transforming Growth Factor alpha/*physiology | 16 | 76.0 |
Colony-Stimulating Factors/metabolism | 2 | 28.0 |
Fibroblast Growth Factors/metabolism | 4 | 7.0 |
Hepatocyte Growth Factor/metabolism | 4 | 7.0 |
Insulin-Like Growth Factor II/metabolism | 4 | 14.0 |
Intestines/*metabolism | 5 | 6.0 |
Binding, Competitive/drug effects | 2 | 3.0 |
Cell Adhesion/drug effects | 25 | 5.0 |
Epidermal Growth Factor/metabolism/pharmacology | 44 | 73.0 |
Fibroblasts/cytology/drug effects/metabolism | 7 | 12.0 |
Cytokines/physiology | 9 | 4.0 |
Gene Expression/physiology | 13 | 4.0 |
Protein Kinase C/metabolism | 43 | 9.0 |
Response Elements/genetics | 2 | 1.0 |
Antineoplastic Agents, Phytogenic/*pharmacology | 4 | 2.0 |
Cervix Neoplasms/*enzymology/pathology | 2 | 40.0 |
Enzyme Activation/physiology | 7 | 4.0 |
Paclitaxel/*pharmacology | 2 | 3.0 |
Interleukin-8/*biosynthesis | 2 | 3.0 |
Tumor Necrosis Factor-alpha/*pharmacology | 26 | 2.0 |
Binding, Competitive/physiology | 3 | 9.0 |
Chelating Agents/chemistry | 3 | 30.0 |
Sensitivity and Specificity | 25 | 0.0 |
*Gene Transfer Techniques | 14 | 3.0 |
Kidney Neoplasms/genetics | 2 | 2.0 |
Cisplatin/*pharmacology | 11 | 8.0 |
Cataract Extraction | 2 | 14.0 |
Cytoskeletal Proteins/*metabolism | 6 | 3.0 |
Extracellular Matrix Proteins/*metabolism | 5 | 8.0 |
Signal Transduction/*genetics | 3 | 2.0 |
DNA | 19 | 1.0 |
*Frameshift Mutation | 3 | 1.0 |
Microfilament Proteins/*genetics | 6 | 4.0 |
Mutagenesis, Insertional | 4 | 1.0 |
Polymorphism, Genetic | 9 | 0.0 |
Antibodies, Monoclonal/metabolism | 9 | 2.0 |
Binding Sites, Antibody | 3 | 0.0 |
Carcinoma/immunology | 2 | 13.0 |
Bladder Neoplasms/metabolism/*pathology | 3 | 21.0 |
Neoplasm Recurrence, Local | 5 | 1.0 |
Neoplasm Staging | 40 | 1.0 |
Receptor, erbB-2/*biosynthesis | 5 | 10.0 |
Receptor, erbB-3/*biosynthesis | 2 | 33.0 |
Cytoskeleton/drug effects/*metabolism | 7 | 36.0 |
Intestinal Mucosa/*physiology | 5 | 19.0 |
Permeability | 2 | 1.0 |
Amyloid beta-Protein Precursor/*metabolism | 2 | 2.0 |
Epithelium, Corneal/cytology/drug effects/*metabolism | 2 | 100.0 |
Mitogen-Activated Protein Kinase Kinases/physiology | 3 | 13.0 |
Protein Kinase C/physiology | 11 | 6.0 |
Jurkat Cells | 3 | 0.0 |
Receptor, Epidermal Growth Factor/immunology/*metabolism | 14 | 58.0 |
Receptors, Tumor Necrosis Factor/*metabolism | 2 | 0.0 |
Crystallization | 5 | 2.0 |
Interleukin-8/genetics/metabolism | 2 | 9.0 |
Receptor, Epidermal Growth Factor/metabolism/*physiology | 7 | 43.0 |
Epidermal Growth Factor/*chemistry/metabolism | 16 | 100.0 |
Microfilament Proteins/chemistry | 2 | 28.0 |
Mesocricetus | 7 | 4.0 |
Blood Pressure/drug effects | 3 | 0.0 |
Digestive System/drug effects | 2 | 18.0 |
Epidermal Growth Factor/administration & dosage/*toxicity | 2 | 100.0 |
Injections, Intravenous | 6 | 0.0 |
Kidney/drug effects/pathology | 2 | 20.0 |
Mitogens/administration & dosage/*toxicity | 2 | 100.0 |
Organ Size/drug effects | 10 | 11.0 |
Peptide Fragments/administration & dosage/*toxicity | 2 | 100.0 |
Toxicity Tests | 2 | 8.0 |
Epidermal Growth Factor/*urine | 49 | 98.0 |
Mucoproteins/*urine | 2 | 33.0 |
Enzyme Activation/genetics | 6 | 6.0 |
Estrenes/pharmacology | 7 | 17.0 |
Genes, Tumor Suppressor/*genetics | 3 | 0.0 |
Pyrrolidinones/pharmacology | 5 | 9.0 |
Plasmids/genetics | 4 | 0.0 |
Promoter Regions (Genetics)/drug effects | 5 | 4.0 |
DNA/chemistry/genetics | 4 | 0.0 |
DNA, Complementary/chemistry/genetics/isolation & purification | 2 | 3.0 |
Fibroblast Growth Factor 2/metabolism | 6 | 6.0 |
Genes, Structural/genetics | 7 | 2.0 |
Chromosome Mapping | 36 | 0.0 |
*Gene Expression | 38 | 3.0 |
Karyotyping | 29 | 1.0 |
Membrane Glycoproteins/*genetics | 3 | 0.0 |
Sequence Homology | 5 | 1.0 |
Dopamine/physiology | 2 | 3.0 |
Feedback | 7 | 3.0 |
Gonadal Steroid Hormones/physiology | 3 | 17.0 |
Growth Substances/*physiology | 62 | 45.0 |
Hyperplasia | 20 | 5.0 |
Gene Expression/*physiology | 5 | 6.0 |
*Genes, erbB | 2 | 18.0 |
src-Family Kinases/*metabolism | 5 | 3.0 |
Estradiol/biosynthesis | 2 | 11.0 |
Microscopy, Electron | 65 | 3.0 |
Progesterone/biosynthesis | 6 | 13.0 |
Antibodies, Monoclonal/therapeutic use | 7 | 3.0 |
Cisplatin/toxicity | 3 | 15.0 |
Drug Screening Assays, Antitumor | 18 | 5.0 |
Regression Analysis | 9 | 0.0 |
Tumor Cells, Cultured/*drug effects/metabolism | 4 | 14.0 |
Epidermal Growth Factor/*antagonists & inhibitors/pharmacology | 6 | 75.0 |
Pancreatic Neoplasms/*metabolism/pathology | 6 | 12.0 |
Biological Transport/drug effects/physiology | 2 | 6.0 |
Carbon Radioisotopes/diagnostic use | 4 | 7.0 |
Dipeptides/*pharmacokinetics | 2 | 100.0 |
Intestinal Mucosa/cytology/*metabolism | 2 | 9.0 |
Fibrocystic Breast Disease/*metabolism/pathology | 2 | 40.0 |
Multivariate Analysis | 7 | 0.0 |
ROC Curve | 2 | 1.0 |
Risk | 3 | 0.0 |
Animals, Newborn/*growth & development | 5 | 45.0 |
Behavior, Animal/drug effects | 2 | 4.0 |
Injections, Subcutaneous | 6 | 1.0 |
Protein Kinase C/antagonists & inhibitors/metabolism | 9 | 9.0 |
Cell Extracts/pharmacology | 2 | 10.0 |
Keratinocytes/*cytology/metabolism | 7 | 53.0 |
Skin/*cytology | 3 | 6.0 |
Epithelium, Corneal/*pathology | 2 | 100.0 |
Liposomes | 10 | 3.0 |
Protein-Tyrosine Kinase/chemistry/*metabolism | 2 | 5.0 |
Receptor, Epidermal Growth Factor/chemistry/*metabolism | 19 | 52.0 |
Temperature | 48 | 4.0 |
Recombinant Proteins/genetics/metabolism | 8 | 1.0 |
Serine/metabolism | 11 | 3.0 |
Membrane Proteins | 2 | 5.0 |
Mice/genetics | 2 | 3.0 |
Receptors, Transforming Growth Factor beta/genetics | 2 | 3.0 |
Carcinoma, Non-Small-Cell Lung/*drug therapy | 2 | 7.0 |
Lung Neoplasms/*drug therapy | 4 | 8.0 |
Burns/*drug therapy | 2 | 50.0 |
Growth Substances/*therapeutic use | 3 | 23.0 |
*CDC2-CDC28 Kinases | 9 | 1.0 |
Cell Adhesion/physiology | 6 | 2.0 |
Cell Adhesion Molecules/*metabolism | 5 | 1.0 |
Cyclin D1/*metabolism | 2 | 3.0 |
Cyclin E/*metabolism | 2 | 5.0 |
Cyclin-Dependent Kinases/antagonists & inhibitors/metabolism | 2 | 3.0 |
Fibroblasts/*cytology/drug effects/physiology | 2 | 100.0 |
Serum Albumin, Bovine/metabolism | 2 | 9.0 |
Cell Communication | 9 | 3.0 |
Embryonic and Fetal Development/physiology | 5 | 5.0 |
Glutathione/metabolism | 7 | 3.0 |
Ovarian Neoplasms/*metabolism | 6 | 10.0 |
Neoplasms/*therapy | 4 | 3.0 |
Surface Properties | 5 | 2.0 |
Transfection/*methods | 4 | 6.0 |
Administration, Oral | 9 | 0.0 |
Potassium/analysis | 5 | 29.0 |
Salivary Proteins/analysis/drug effects | 2 | 100.0 |
Secretory Rate/drug effects | 2 | 2.0 |
Sodium/analysis | 5 | 33.0 |
8-Bromo Cyclic Adenosine Monophosphate/pharmacology | 14 | 14.0 |
*Neoplasm Metastasis | 2 | 2.0 |
Tretinoin/pharmacology | 26 | 8.0 |
Cell Size/drug effects | 9 | 10.0 |
Organoids/metabolism | 2 | 50.0 |
Protease Inhibitors/pharmacology | 12 | 5.0 |
Thiophenes/pharmacology | 4 | 11.0 |
*Activin Receptors, Type I | 2 | 8.0 |
Receptors, Transforming Growth Factor beta/*metabolism | 2 | 7.0 |
Luteinizing Hormone/blood | 3 | 0.0 |
Prolactin/blood | 3 | 0.0 |
Sperm Count | 3 | 4.0 |
Sperm Motility | 2 | 4.0 |
Spermatogenesis/physiology | 2 | 6.0 |
Testosterone/blood | 4 | 0.0 |
Estradiol/analogs & derivatives/pharmacology | 8 | 26.0 |
Ethinyl Estradiol/pharmacology | 2 | 7.0 |
*JNK Mitogen-Activated Protein Kinases | 5 | 5.0 |
Mitogen-Activated Protein Kinase Kinases/*metabolism | 4 | 7.0 |
Biological Markers/urine | 5 | 7.0 |
Gastric Mucosa/*metabolism/pathology | 2 | 15.0 |
Receptors, Growth Factor/*metabolism | 10 | 9.0 |
Stomach Ulcer/*metabolism/pathology | 2 | 50.0 |
Carrier Proteins/chemistry/*physiology | 3 | 8.0 |
Ubiquitins/metabolism | 3 | 2.0 |
Hypertrophy | 13 | 12.0 |
Pancreatic Neoplasms/*pathology | 10 | 27.0 |
Cervix Neoplasms/*metabolism/pathology | 3 | 16.0 |
Receptor, Epidermal Growth Factor/biosynthesis/*metabolism | 9 | 40.0 |
Cell Line/drug effects | 6 | 12.0 |
Epithelial Cells/drug effects | 6 | 18.0 |
Milk, Human/*metabolism | 4 | 36.0 |
Fibroblasts/enzymology | 8 | 4.0 |
Platelet-Derived Growth Factor/metabolism/*physiology | 2 | 100.0 |
Adenocarcinoma/genetics/pathology | 2 | 4.0 |
Antibodies/pharmacology | 23 | 6.0 |
Breast Neoplasms/*genetics/*pathology | 3 | 4.0 |
DNA, Neoplasm/biosynthesis | 28 | 27.0 |
Estradiol/*analogs & derivatives/*pharmacology | 3 | 15.0 |
Receptors, Estrogen/physiology | 4 | 14.0 |
Adenosine Diphosphate Ribose/metabolism | 4 | 7.0 |
Cell Division/*drug effects | 76 | 25.0 |
GTP-Binding Proteins/genetics/metabolism | 2 | 6.0 |
Gonadorelin/*pharmacology | 2 | 5.0 |
Pertussis Toxin | 18 | 11.0 |
Protein-Tyrosine-Phosphatase/*metabolism | 13 | 10.0 |
Virulence Factors, Bordetella/pharmacology | 20 | 10.0 |
Macaca fascicularis | 7 | 2.0 |
Tyrosine/chemistry | 3 | 2.0 |
Protein Biosynthesis/drug effects | 6 | 9.0 |
Proto-Oncogene Proteins c-fos/biosynthesis/*genetics | 2 | 33.0 |
Transcription, Genetic/drug effects | 26 | 4.0 |
Antibodies, Monoclonal/*pharmacology/therapeutic use | 2 | 11.0 |
Clinical Trials, Phase I | 4 | 6.0 |
Neovascularization, Pathologic/drug therapy | 2 | 7.0 |
Spectrometry, Fluorescence/*methods | 2 | 13.0 |
Actins/drug effects/metabolism | 2 | 22.0 |
Biological Assay | 18 | 6.0 |
Integrin alpha6beta4 | 2 | 10.0 |
Neoplasm Metastasis/*physiopathology | 3 | 10.0 |
Tumor Cells, Cultured/drug effects/*metabolism | 10 | 43.0 |
Staurosporine/pharmacology | 3 | 1.0 |
Molecular Weight | 161 | 5.0 |
Octoxynol | 9 | 15.0 |
DNA Primers/genetics | 17 | 1.0 |
RNA, Messenger/*genetics/*metabolism | 2 | 4.0 |
Glycoproteins/physiology | 4 | 13.0 |
Membrane Proteins/physiology | 3 | 3.0 |
Neoplasm Proteins/physiology | 2 | 3.0 |
Neoplasms/*pathology | 4 | 7.0 |
Transforming Growth Factor alpha/physiology | 13 | 50.0 |
Endothelial Growth Factors/metabolism | 3 | 1.0 |
Lymphokines/metabolism | 3 | 1.0 |
Mitogen-Activated Protein Kinase 1/antagonists & inhibitors | 2 | 11.0 |
Platelet-Derived Growth Factor/metabolism | 17 | 26.0 |
Prostatic Neoplasms/metabolism | 9 | 17.0 |
Thymidine/metabolism | 91 | 26.0 |
Tyrosine/chemistry/*metabolism | 3 | 30.0 |
ras Proteins/*metabolism | 12 | 7.0 |
Prostate/*metabolism | 6 | 8.0 |
Prostatic Hyperplasia/metabolism | 6 | 18.0 |
Tumor Cells, Cultured/metabolism | 26 | 13.0 |
Growth Substances/*pharmacology/physiology | 4 | 50.0 |
Nerve Growth Factors/pharmacology | 13 | 15.0 |
Neurons/cytology/*drug effects | 2 | 13.0 |
Stem Cells/cytology/*drug effects | 2 | 22.0 |
Peptide Fragments/*chemistry/metabolism | 2 | 9.0 |
Solutions | 10 | 5.0 |
Spectrometry, Fluorescence | 11 | 2.0 |
Epidermal Growth Factor/*analysis/blood | 4 | 100.0 |
Carcinoma, Squamous Cell/*metabolism/pathology | 9 | 10.0 |
Esophageal Neoplasms/*metabolism/pathology | 4 | 17.0 |
Esophagus/cytology | 2 | 40.0 |
Biotransformation | 3 | 0.0 |
Catalysis | 10 | 1.0 |
Cross-Sectional Studies | 5 | 0.0 |
Iodine Radioisotopes | 49 | 13.0 |
Receptors, Transferrin/metabolism | 6 | 8.0 |
Transferrin/metabolism | 8 | 4.0 |
Astrocytes/cytology | 3 | 20.0 |
Fetus/cytology | 6 | 9.0 |
Glial Fibrillary Acidic Protein/analysis | 3 | 1.0 |
Neurofilament Proteins/analysis | 2 | 9.0 |
Stem Cells/*cytology | 4 | 4.0 |
*Genetic Vectors | 10 | 3.0 |
Models, Genetic | 11 | 0.0 |
Transduction, Genetic | 12 | 3.0 |
Fibroblast Growth Factors/*analysis | 4 | 50.0 |
Interleukin-1/*analysis | 2 | 6.0 |
Interleukin-6/*analysis | 2 | 5.0 |
Genes, APC | 3 | 3.0 |
1-Phosphatidylinositol 3-Kinase/physiology | 5 | 4.0 |
Antibodies, Monoclonal/*immunology | 13 | 1.0 |
G1 Phase/*drug effects | 2 | 2.0 |
Apoptosis/*drug effects/physiology | 4 | 3.0 |
Receptor, Epidermal Growth Factor/antagonists & inhibitors/physiology | 5 | 62.0 |
Tetrachlorodibenzodioxin/*pharmacology | 7 | 11.0 |
Transforming Growth Factor alpha/*biosynthesis/genetics | 9 | 56.0 |
Estrogen Receptor Modulators/*pharmacology | 2 | 8.0 |
DNA, Complementary/chemistry/genetics | 6 | 1.0 |
*Gene Duplication | 3 | 2.0 |
Skin/metabolism | 14 | 7.0 |
Adaptor Protein Complex 2 | 2 | 22.0 |
Adaptor Protein Complex alpha Subunits | 4 | 8.0 |
Adaptor Proteins, Vesicular Transport | 6 | 8.0 |
Endocytosis/drug effects/*physiology | 4 | 18.0 |
Peptide Fragments/genetics/metabolism | 6 | 5.0 |
Protein Binding/physiology | 5 | 1.0 |
Cell Movement/physiology | 8 | 3.0 |
Endothelium, Vascular/cytology/*physiology | 2 | 3.0 |
Consensus Sequence | 15 | 2.0 |
Epidermal Growth Factor/chemistry/metabolism | 4 | 80.0 |
Repetitive Sequences, Amino Acid | 5 | 4.0 |
Neuregulin-1/*metabolism | 2 | 14.0 |
Receptor Protein-Tyrosine Kinases/*physiology | 3 | 4.0 |
Calcitonin Gene-Related Peptide/pharmacology | 2 | 6.0 |
Ethanol/toxicity | 2 | 33.0 |
Prostatic Neoplasms/metabolism/*pathology | 11 | 16.0 |
Adenoma/metabolism | 3 | 7.0 |
Carcinoma, Papillary/metabolism | 3 | 27.0 |
Cell Nucleus/*metabolism | 4 | 0.0 |
Goiter, Nodular/metabolism | 2 | 50.0 |
Graves' Disease/metabolism | 3 | 15.0 |
Thyroid Gland/*metabolism | 6 | 14.0 |
Thyroid Neoplasms/metabolism | 3 | 15.0 |
Thyroid Gland/metabolism | 2 | 3.0 |
Cluster Analysis | 2 | 1.0 |
Extracellular Matrix/*metabolism | 7 | 7.0 |
Extracellular Matrix Proteins/metabolism | 8 | 8.0 |
Gene Expression Regulation/drug effects/physiology | 3 | 4.0 |
Immunophenotyping | 5 | 0.0 |
Urinary Plasminogen Activator/*secretion | 2 | 50.0 |
Amino Acids/metabolism | 3 | 3.0 |
Epidermal Growth Factor/*pharmacology/physiology | 10 | 100.0 |
Intestine, Small/drug effects/metabolism/*surgery | 2 | 100.0 |
Microvilli/drug effects/metabolism | 3 | 37.0 |
Random Allocation | 10 | 2.0 |
Receptors, Virus/genetics/*metabolism | 2 | 6.0 |
Cell Membrane/enzymology | 28 | 11.0 |
Cell Movement/drug effects/physiology | 5 | 8.0 |
Chromosomes, Human, Pair 19 | 3 | 1.0 |
Inflammation | 3 | 0.0 |
Macrophages/*metabolism | 2 | 0.0 |
RNA/metabolism | 8 | 1.0 |
Chloramphenicol O-Acetyltransferase/metabolism | 3 | 2.0 |
Genes, Dominant/genetics | 2 | 1.0 |
Insulin/metabolism/pharmacology | 5 | 27.0 |
Retroviridae/genetics | 10 | 2.0 |
Cyclic AMP-Dependent Protein Kinases/*metabolism | 5 | 5.0 |
Fibroblasts | 33 | 5.0 |
Receptor, Epidermal Growth Factor/drug effects/physiology | 4 | 100.0 |
*Chromosomes | 2 | 3.0 |
Meiosis | 3 | 2.0 |
Mice, Inbred Strains | 22 | 2.0 |
Ovarian Follicle/*cytology | 3 | 100.0 |
Oxygen/*metabolism | 2 | 1.0 |
Puberty | 3 | 4.0 |
Interleukin-4/pharmacology | 2 | 0.0 |
Isoenzymes/antagonists & inhibitors/metabolism | 5 | 7.0 |
Mitogen-Activated Protein Kinases/antagonists & inhibitors/*metabolism | 5 | 6.0 |
Catalytic Domain/genetics | 3 | 5.0 |
Proto-Oncogene Proteins c-raf/*metabolism | 5 | 14.0 |
Carcinogens/*pharmacology | 12 | 18.0 |
Drug Resistance | 20 | 3.0 |
Hela Cells/drug effects | 2 | 7.0 |
Neoplasm Proteins/drug effects/metabolism | 2 | 28.0 |
Receptor, Epidermal Growth Factor/*drug effects/metabolism | 22 | 73.0 |
Tetradecanoylphorbol Acetate/*pharmacology | 39 | 12.0 |
Thyroid Hormones/*blood | 2 | 3.0 |
Cytokines/*biosynthesis | 4 | 1.0 |
Receptors, Growth Factor/biosynthesis | 2 | 7.0 |
Cell Division/*physiology | 15 | 7.0 |
*Gene Expression Regulation, Neoplastic/drug effects | 4 | 7.0 |
Receptor, Epidermal Growth Factor/analysis/*genetics/physiology | 2 | 100.0 |
Regeneration | 8 | 13.0 |
Amniotic Fluid/*metabolism | 3 | 7.0 |
Epidermal Growth Factor/*blood/metabolism | 2 | 100.0 |
Fetal Blood/metabolism | 2 | 3.0 |
Fetal Growth Retardation/*metabolism | 2 | 10.0 |
Molecular Chaperones/metabolism | 2 | 4.0 |
Cyclic AMP/biosynthesis | 6 | 4.0 |
GTP-Binding Proteins/metabolism | 10 | 3.0 |
Mouth Neoplasms/*pathology | 3 | 13.0 |
Trypsin/chemistry | 2 | 11.0 |
Epithelial Cells/cytology/physiology | 2 | 6.0 |
Phosphorylation/radiation effects | 4 | 13.0 |
Protein Binding/radiation effects | 3 | 27.0 |
Protein Kinases/metabolism | 39 | 9.0 |
Signal Transduction/radiation effects | 2 | 22.0 |
Ultraviolet Rays | 8 | 1.0 |
Microinjections | 4 | 1.0 |
rab5 GTP-Binding Proteins/*metabolism | 2 | 16.0 |
Breast/metabolism | 5 | 5.0 |
Breast Neoplasms/*metabolism | 45 | 15.0 |
Genes, erbB-2 | 6 | 7.0 |
Receptor, erbB-2/drug effects/*metabolism | 4 | 80.0 |
Membrane Proteins/chemistry/genetics/*metabolism | 2 | 3.0 |
RNA, Small Interfering | 2 | 3.0 |
Dihydrotestosterone/pharmacology | 11 | 14.0 |
Receptors, Androgen/*physiology | 3 | 10.0 |
Mammary Glands, Animal/*embryology | 2 | 18.0 |
Keratinocytes/drug effects/*metabolism | 9 | 33.0 |
Trans-Activation (Genetics)/drug effects | 4 | 1.0 |
*Up-Regulation | 6 | 2.0 |
Biomechanics | 3 | 2.0 |
Sex Characteristics | 4 | 0.0 |
Gene Expression Regulation/drug effects/*physiology | 3 | 3.0 |
Receptors, Retinoic Acid/metabolism | 2 | 2.0 |
Triiodothyronine/pharmacology | 4 | 8.0 |
Endopeptidases/physiology | 2 | 13.0 |
Fibroblast Growth Factors/physiology | 9 | 50.0 |
Growth Substances/genetics/*physiology | 4 | 23.0 |
Neovascularization, Pathologic/*metabolism | 3 | 2.0 |
Platelet-Derived Growth Factor/physiology | 23 | 58.0 |
Transforming Growth Factors/physiology | 10 | 83.0 |
Saliva/*metabolism | 7 | 21.0 |
Collagen/biosynthesis | 8 | 16.0 |
*Extracellular Matrix Proteins | 10 | 7.0 |
Proteoglycans/biosynthesis | 2 | 18.0 |
Fibroblast Growth Factor 2/*metabolism | 6 | 11.0 |
Platelet-Derived Growth Factor/*metabolism | 6 | 25.0 |
Digestion/*physiology | 2 | 16.0 |
Epidermal Growth Factor/biosynthesis | 10 | 83.0 |
Membrane Proteins/biosynthesis | 2 | 3.0 |
Pepsin A/metabolism | 3 | 20.0 |
Stomach Neoplasms/*metabolism | 4 | 8.0 |
Carcinoma, Squamous Cell/*enzymology | 6 | 31.0 |
Isoenzymes/genetics/*metabolism | 3 | 3.0 |
Amino Acid Motifs/genetics | 2 | 3.0 |
LDL-Receptor Related Protein 1 | 4 | 3.0 |
Endothelium, Vascular/cytology | 3 | 1.0 |
Extracellular Matrix/metabolism | 11 | 5.0 |
Metalloendopeptidases/*metabolism | 4 | 4.0 |
Proto-Oncogene Protein c-met/*metabolism | 2 | 3.0 |
Phosphates/metabolism | 7 | 8.0 |
Prolactin/*genetics | 2 | 6.0 |
Promoter Regions (Genetics)/*genetics | 3 | 0.0 |
Regulatory Sequences, Nucleic Acid | 12 | 2.0 |
Gastritis/*metabolism/microbiology | 2 | 66.0 |
Glycoproteins/biosynthesis | 3 | 10.0 |
Neoplasm Proteins/biosynthesis | 5 | 6.0 |
Transforming Growth Factor alpha/biosynthesis | 6 | 42.0 |
Longitudinal Studies | 5 | 0.0 |
*Peritoneal Dialysis, Continuous Ambulatory | 4 | 3.0 |
*Biflavonoids | 2 | 20.0 |
Carcinogens/pharmacology | 4 | 4.0 |
Catechin/*analogs & derivatives/pharmacology | 2 | 28.0 |
Neoplasms/etiology | 3 | 7.0 |
Protein p53/physiology | 3 | 3.0 |
Transcription Factor AP-1/physiology | 2 | 4.0 |
Fluorescein-5-isothiocyanate | 4 | 2.0 |
*Macrolides | 3 | 8.0 |
Animals, Newborn/*physiology | 2 | 18.0 |
Mice, Inbred BALB C/genetics | 2 | 50.0 |
Protein-Tyrosine-Phosphatase/metabolism | 11 | 8.0 |
Receptor, erbB-2/physiology | 3 | 37.0 |
Exons/genetics | 7 | 0.0 |
Hypercholesterolemia/*genetics | 2 | 11.0 |
Mutation, Missense | 3 | 0.0 |
Polymorphism, Single-Stranded Conformational | 4 | 0.0 |
Thailand | 2 | 1.0 |
Adenocarcinoma/*metabolism | 20 | 20.0 |
Biological Transport/physiology | 4 | 2.0 |
Maleimides/pharmacology | 10 | 10.0 |
Amino Acids/chemistry | 4 | 3.0 |
Recombinant Proteins/chemistry/metabolism | 20 | 3.0 |
Threonine/metabolism | 10 | 10.0 |
Gastric Mucosa/cytology/drug effects/*metabolism | 3 | 100.0 |
Glycoproteins/genetics | 8 | 8.0 |
Growth Substances/genetics | 7 | 11.0 |
Oxidative Stress/*physiology | 4 | 4.0 |
Transforming Growth Factor alpha/genetics | 8 | 30.0 |
Octreotide/pharmacology | 2 | 8.0 |
Pancreatic Neoplasms/*metabolism | 12 | 16.0 |
Somatostatin/*analogs & derivatives/pharmacology | 4 | 33.0 |
Interleukin-1/*metabolism | 2 | 2.0 |
Glycoproteins/*genetics | 11 | 5.0 |
Ovary/*metabolism | 3 | 5.0 |
Alkyl and Aryl Transferases/*antagonists & inhibitors | 2 | 5.0 |
Protein Isoprenylation | 2 | 2.0 |
Transforming Growth Factors/analysis | 4 | 57.0 |
Clone Cells | 29 | 2.0 |
Plant Proteins/metabolism | 2 | 10.0 |
Potassium Channels/metabolism | 2 | 5.0 |
Base Sequence/genetics | 6 | 1.0 |
Caco-2 Cells/metabolism | 2 | 22.0 |
Carrier Proteins/*genetics | 3 | 0.0 |
Genome | 3 | 1.0 |
Charcoal/pharmacology | 2 | 50.0 |
Drug Carriers | 12 | 9.0 |
Neoplasms, Hormone-Dependent | 2 | 40.0 |
Disulfides/chemistry | 11 | 16.0 |
Protein Processing, Post-Translational | 30 | 3.0 |
Protein Structure, Secondary | 32 | 3.0 |
Saccharomyces cerevisiae | 3 | 1.0 |
*Cell Cycle Proteins | 8 | 0.0 |
Protein Biosynthesis | 43 | 3.0 |
Receptors, Fibroblast Growth Factor/metabolism | 4 | 8.0 |
Skin/cytology | 17 | 10.0 |
*Tumor Suppressor Proteins | 15 | 1.0 |
Cholecalciferol/pharmacology | 2 | 6.0 |
Extracellular Matrix/physiology | 13 | 14.0 |
Hydrocortisone/pharmacology | 21 | 26.0 |
Integrin alpha2 | 2 | 10.0 |
Integrin alpha3 | 2 | 11.0 |
DNA Fragmentation | 7 | 2.0 |
DNA/analysis/biosynthesis | 4 | 57.0 |
Epidermal Growth Factor/*metabolism/physiology | 6 | 85.0 |
Receptor, Epidermal Growth Factor/*metabolism/physiology | 4 | 40.0 |
Transforming Growth Factor alpha/metabolism/physiology | 2 | 100.0 |
Ribosomal Protein S6 Kinases/*metabolism | 2 | 8.0 |
Epithelial Cells/*drug effects/metabolism | 2 | 11.0 |
Lung/physiology | 2 | 8.0 |
Vanadium/*pharmacology | 2 | 100.0 |
Genes, jun | 9 | 11.0 |
Isoenzymes/metabolism | 15 | 2.0 |
MAP Kinase Kinase 5 | 2 | 66.0 |
1-Phosphatidylinositol 3-Kinase/antagonists & inhibitors/*physiology | 2 | 6.0 |
*Carrier Proteins | 6 | 1.0 |
Enzyme Precursors/metabolism | 2 | 1.0 |
Mice, Mutant Strains | 6 | 0.0 |
Phosphatidylinositol Phosphates/metabolism | 5 | 10.0 |
Phospholipase C/chemistry/*metabolism | 2 | 33.0 |
Proteins/pharmacology | 6 | 9.0 |
Thrombin/pharmacology | 11 | 4.0 |
X Chromosome | 4 | 0.0 |
Calcium-Binding Proteins/*metabolism | 4 | 4.0 |
Fibroblasts/physiology | 6 | 5.0 |
Receptor, Epidermal Growth Factor/drug effects/metabolism/*physiology | 2 | 66.0 |
Ubiquitins/*metabolism | 2 | 1.0 |
CCAAT-Enhancer-Binding Proteins | 2 | 1.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/*physiology | 4 | 16.0 |
Response Elements | 5 | 2.0 |
Transcription Factor, Sp1/metabolism | 5 | 1.0 |
Gastrins/*genetics | 3 | 27.0 |
*MAP Kinase Kinase Kinase 1 | 10 | 7.0 |
Promoter Regions (Genetics)/*drug effects | 3 | 6.0 |
Protein Kinases/*metabolism | 34 | 9.0 |
Gamma Rays | 3 | 1.0 |
*Genes, jun | 4 | 9.0 |
Proteins/genetics | 6 | 0.0 |
Radiation Tolerance | 3 | 3.0 |
Phosphoric Monoester Hydrolases/metabolism | 3 | 3.0 |
Antibody Specificity | 27 | 1.0 |
Immunization | 2 | 0.0 |
Receptor, Epidermal Growth Factor/immunology | 8 | 42.0 |
Embryonic and Fetal Development | 11 | 3.0 |
Histocytochemistry | 18 | 2.0 |
Isotope Labeling | 2 | 2.0 |
Pentetic Acid/chemistry | 2 | 50.0 |
Radiopharmaceuticals/chemistry/*metabolism | 2 | 100.0 |
Thromboplastin/*metabolism | 6 | 3.0 |
Cell Division/genetics | 9 | 2.0 |
Protein p53/biosynthesis/genetics | 3 | 6.0 |
Receptor, Epidermal Growth Factor/biosynthesis | 14 | 30.0 |
Receptor, erbB-2/biosynthesis | 2 | 8.0 |
Cyclic AMP/pharmacology | 10 | 9.0 |
DNA-Binding Proteins/genetics | 3 | 0.0 |
Protirelin/pharmacology | 3 | 2.0 |
Proto-Oncogene Proteins c-fos/*genetics | 3 | 12.0 |
Trans-Activation (Genetics)/drug effects/*physiology | 2 | 18.0 |
8-Bromo Cyclic Adenosine Monophosphate/*pharmacology | 2 | 13.0 |
Endometrium/*cytology | 3 | 15.0 |
Prolactin/secretion | 3 | 2.0 |
Wound Healing/drug effects/physiology | 3 | 60.0 |
Aging/*physiology | 5 | 1.0 |
Microscopy, Electron, Scanning | 17 | 5.0 |
Blotting, Southern | 48 | 1.0 |
Skin Physiology | 4 | 11.0 |
Databases | 2 | 2.0 |
Hypercholesterolemia, Familial/*genetics | 5 | 11.0 |
Cell Differentiation/genetics | 2 | 0.0 |
Collagen/metabolism | 12 | 4.0 |
*Disease Models, Animal | 2 | 0.0 |
Genes, Lethal | 3 | 3.0 |
Linkage (Genetics) | 10 | 0.0 |
Muscle, Smooth, Vascular/metabolism/pathology | 2 | 11.0 |
Organ Specificity/genetics | 3 | 2.0 |
Endothelial Growth Factors/*biosynthesis | 2 | 1.0 |
Fibroblast Growth Factor 2/*biosynthesis | 3 | 13.0 |
Lymphokines/*biosynthesis | 2 | 0.0 |
Menstrual Cycle/*physiology | 6 | 11.0 |
Proto-Oncogene Proteins/*biosynthesis | 3 | 1.0 |
Receptor Protein-Tyrosine Kinases/*biosynthesis | 2 | 3.0 |
Receptors, Growth Factor/*biosynthesis | 2 | 8.0 |
Naphthalenes/pharmacology | 4 | 5.0 |
Patch-Clamp Techniques | 3 | 0.0 |
Protein-Tyrosine Kinase/antagonists & inhibitors/metabolism | 9 | 13.0 |
Anisomycin/pharmacology | 2 | 6.0 |
*Genes, fos | 5 | 7.0 |
DNA/metabolism | 25 | 1.0 |
Neuregulin-1/metabolism | 2 | 15.0 |
Proto-Oncogene Proteins c-myc/biosynthesis | 2 | 6.0 |
Neoplasms/*drug therapy/physiopathology | 2 | 25.0 |
Protein-Tyrosine Kinase/*antagonists & inhibitors/metabolism | 7 | 17.0 |
Receptor, Epidermal Growth Factor/*antagonists & inhibitors/physiology | 3 | 20.0 |
Brain/metabolism | 12 | 1.0 |
Neutrophils/immunology | 2 | 1.0 |
Transforming Growth Factor alpha/*immunology | 2 | 66.0 |
Ovarian Neoplasms/*chemistry/pathology | 2 | 15.0 |
Recombinant Proteins/therapeutic use | 7 | 2.0 |
Antigens, Protozoan/*genetics/*immunology | 2 | 100.0 |
Brain Neoplasms/*metabolism/pathology | 2 | 4.0 |
Neoplasm Proteins/metabolism | 11 | 2.0 |
RNA, Neoplasm/genetics | 12 | 3.0 |
Up-Regulation/*drug effects | 3 | 4.0 |
Integrins/*physiology | 3 | 3.0 |
Estrogens/*physiology | 6 | 15.0 |
Insulin-Like Growth Factor I/pharmacology/*physiology | 3 | 25.0 |
Proto-Oncogene Proteins/genetics/*physiology | 2 | 2.0 |
Acetylation | 2 | 0.0 |
Histones/metabolism | 2 | 0.0 |
Androgen Antagonists/pharmacology | 5 | 14.0 |
Cell Cycle Proteins/metabolism | 3 | 0.0 |
Cell Line, Tumor/cytology/drug effects | 2 | 66.0 |
Receptor, Epidermal Growth Factor/*antagonists & inhibitors/*metabolism | 2 | 22.0 |
Tumor Suppressor Proteins/metabolism | 2 | 1.0 |
Interferon-alpha/*pharmacology | 5 | 3.0 |
Metalloendopeptidases/*biosynthesis/genetics | 5 | 31.0 |
Receptor, Epidermal Growth Factor/*biosynthesis/genetics | 12 | 37.0 |
Poly(ADP-ribose) Polymerases/metabolism | 4 | 3.0 |
DNA, Neoplasm/*analysis | 4 | 2.0 |
*Genes, erbB-2 | 2 | 2.0 |
Light | 9 | 4.0 |
Double-Blind Method | 14 | 0.0 |
Epidermal Growth Factor/*administration & dosage | 15 | 93.0 |
Recombinant Proteins/administration & dosage | 5 | 5.0 |
Aging/metabolism | 5 | 3.0 |
Chickens | 21 | 2.0 |
Darkness | 3 | 10.0 |
Granulocyte-Macrophage Colony-Stimulating Factor/physiology | 2 | 7.0 |
Protein-Serine-Threonine Kinases/genetics/*metabolism | 4 | 1.0 |
Carbocyanines | 2 | 11.0 |
Diffusion | 6 | 7.0 |
Energy Transfer | 6 | 10.0 |
Fluorescence | 7 | 2.0 |
Immunoglobulins, Fab | 3 | 5.0 |
Microspheres | 3 | 1.0 |
Hirudins/chemistry | 2 | 100.0 |
Oxidation-Reduction | 13 | 0.0 |
Guanosine 5'-O-(3-Thiotriphosphate)/pharmacology | 4 | 5.0 |
rac1 GTP-Binding Protein/*metabolism | 2 | 2.0 |
Cell Transformation, Neoplastic/*genetics | 6 | 3.0 |
Diglycerides/biosynthesis | 4 | 22.0 |
Sphingomyelin Phosphodiesterase/pharmacology | 2 | 12.0 |
Endothelial Growth Factors/physiology | 5 | 8.0 |
Lymphokines/physiology | 5 | 5.0 |
Transforming Growth Factor beta/physiology | 18 | 18.0 |
Epidermal Growth Factor/biosynthesis/genetics | 3 | 75.0 |
Calcium/pharmacology | 24 | 11.0 |
Microfilament Proteins/*genetics/*metabolism | 2 | 25.0 |
Epidermal Growth Factor/pharmacology/physiology | 5 | 71.0 |
Insulin-Like Growth Factor I/pharmacology/physiology | 2 | 66.0 |
Carcinoma | 8 | 21.0 |
DNA-Binding Proteins/genetics/*metabolism | 2 | 0.0 |
*Point Mutation | 10 | 0.0 |
Biological Transport/drug effects | 16 | 6.0 |
Endocytosis/*drug effects | 8 | 36.0 |
rab5 GTP-Binding Proteins/genetics/*metabolism | 2 | 25.0 |
Phorbol Esters/pharmacology | 15 | 13.0 |
Epidermal Growth Factor/*chemistry/genetics/*metabolism | 5 | 83.0 |
In Situ Hybridization, Fluorescence | 5 | 0.0 |
Lysophospholipids/pharmacology | 6 | 14.0 |
Prostatic Neoplasms/*physiopathology | 3 | 30.0 |
Baculoviridae/genetics | 2 | 1.0 |
*Peptide Library | 2 | 3.0 |
Enzyme Inhibitors/chemical synthesis/pharmacology | 2 | 18.0 |
Chromosomes, Human, Pair 1 | 2 | 0.0 |
Insulin/*pharmacology | 33 | 15.0 |
Heparin/metabolism | 10 | 8.0 |
Receptors, Cell Surface/genetics/*physiology | 4 | 7.0 |
Adenylate Cyclase/metabolism | 4 | 2.0 |
Cyclic AMP-Dependent Protein Kinases/metabolism | 7 | 3.0 |
Arthritis, Rheumatoid/pathology | 2 | 16.0 |
Cells, Cultured/drug effects/metabolism | 2 | 4.0 |
*Gene Expression Regulation/drug effects | 8 | 4.0 |
Interferon Type II/pharmacology | 11 | 1.0 |
RNA, Neoplasm/biosynthesis/genetics | 3 | 5.0 |
Synovial Fluid/cytology | 2 | 8.0 |
T-Lymphocytes/drug effects/metabolism | 2 | 5.0 |
Endothelial Growth Factors/analysis | 2 | 2.0 |
Growth Substances/*analysis | 12 | 38.0 |
Leiomyoma/*pathology | 2 | 22.0 |
Lymphokines/analysis | 2 | 2.0 |
Receptor Protein-Tyrosine Kinases/analysis | 2 | 4.0 |
Receptors, Growth Factor/*analysis | 2 | 10.0 |
Uterine Neoplasms/*pathology | 4 | 17.0 |
Drug Stability | 9 | 4.0 |
Thymidine/pharmacokinetics | 7 | 43.0 |
Melanoma, Experimental/drug therapy/pathology | 2 | 33.0 |
Mice, Inbred DBA | 5 | 1.0 |
Endothelium, Vascular/immunology | 2 | 4.0 |
Macrophages/immunology | 3 | 1.0 |
Reoperation | 2 | 1.0 |
Staining and Labeling/methods | 2 | 1.0 |
Antibodies, Monoclonal/administration & dosage/pharmacology | 2 | 33.0 |
Epidermal Growth Factor/administration & dosage/*pharmacology/physiology | 2 | 100.0 |
Injections, Intraventricular | 3 | 2.0 |
Serum Albumin/metabolism | 2 | 1.0 |
Epidermal Growth Factor/genetics/pharmacology | 5 | 100.0 |
*Molecular Chaperones | 4 | 2.0 |
*Digestive Physiology | 8 | 24.0 |
*Cytoskeletal Proteins | 3 | 2.0 |
Epidermal Growth Factor/*antagonists & inhibitors/metabolism | 5 | 83.0 |
Carbachol/pharmacology | 7 | 7.0 |
Diglycerides/pharmacology | 4 | 11.0 |
Extracellular Space/metabolism | 4 | 6.0 |
Muscarinic Agonists/pharmacology | 2 | 5.0 |
Muscarinic Antagonists/pharmacology | 2 | 13.0 |
Salivary Glands/cytology/drug effects/*metabolism | 2 | 66.0 |
Actins/genetics | 8 | 6.0 |
Epidermal Growth Factor/genetics/*physiology | 7 | 87.0 |
Liver/pathology | 3 | 1.0 |
Platelet-Derived Growth Factor/analysis | 8 | 32.0 |
Wound Healing | 24 | 21.0 |
Salivary Proteins/*analysis | 2 | 25.0 |
Fibronectins/biosynthesis | 3 | 20.0 |
Leucine/metabolism | 9 | 13.0 |
Myocardium/*cytology/metabolism | 2 | 22.0 |
Growth Substances/*genetics | 14 | 13.0 |
Prostate/cytology/*metabolism | 2 | 18.0 |
DNA/genetics/metabolism | 4 | 1.0 |
Interleukin-6/*pharmacology | 6 | 2.0 |
Recombinant Fusion Proteins/physiology | 7 | 2.0 |
Cytoskeletal Proteins/metabolism | 10 | 3.0 |
Growth Substances/*metabolism/pharmacology | 5 | 55.0 |
Insulin-Like Growth Factor I/metabolism/pharmacology | 3 | 33.0 |
Integrins/*metabolism | 10 | 6.0 |
Protein-Tyrosine Kinase/antagonists & inhibitors/*metabolism | 11 | 19.0 |
Fluorescence Polarization | 3 | 5.0 |
Horses | 2 | 1.0 |
Nerve Growth Factors/*genetics | 3 | 5.0 |
Protein Isoforms/genetics | 2 | 0.0 |
Gene Expression Regulation, Enzymologic/*drug effects | 7 | 4.0 |
Genes, ras | 10 | 4.0 |
Proto-Oncogene Proteins c-jun/*metabolism | 2 | 2.0 |
Luminescent Proteins/genetics/metabolism | 2 | 1.0 |
Proteins/genetics/*metabolism | 5 | 1.0 |
Proto-Oncogene Protein pp60(c-src)/*metabolism | 5 | 12.0 |
Oncogene Proteins v-erbB/*metabolism | 2 | 33.0 |
Kidney/cytology/*metabolism | 2 | 9.0 |
ras Proteins/genetics/*metabolism | 2 | 6.0 |
Nerve Growth Factors/*physiology | 4 | 9.0 |
*Nervous System Physiology | 2 | 8.0 |
Epidermal Growth Factor/*chemistry/genetics/pharmacology | 2 | 100.0 |
Neurons/drug effects/*physiology | 2 | 6.0 |
Peptide Fragments/chemistry | 6 | 3.0 |
Recombinant Proteins/chemistry/pharmacology | 5 | 21.0 |
1-Phosphatidylinositol 3-Kinase/*physiology | 4 | 7.0 |
Cell Transformation, Neoplastic/genetics | 7 | 2.0 |
DNA Damage | 5 | 0.0 |
Membrane Glycoproteins/genetics/*physiology | 2 | 2.0 |
Embryo/physiology | 2 | 5.0 |
Membrane Potentials/drug effects | 5 | 3.0 |
Proto-Oncogene Proteins c-bcl-2/metabolism | 7 | 1.0 |
Benzoates/pharmacology | 2 | 10.0 |
Imidazoles/pharmacology | 5 | 2.0 |
Mucins/*biosynthesis | 2 | 5.0 |
Nitric Oxide/physiology | 3 | 6.0 |
Nitric-Oxide Synthase/antagonists & inhibitors | 2 | 4.0 |
Receptor, Epidermal Growth Factor/biosynthesis/genetics | 7 | 30.0 |
*Pertussis Toxin | 4 | 13.0 |
Virulence Factors, Bordetella/*pharmacology | 4 | 20.0 |
Bromodeoxyuridine | 3 | 9.0 |
Glial Fibrillary Acidic Protein/metabolism | 3 | 1.0 |
Intermediate Filament Proteins/metabolism | 4 | 8.0 |
Growth Substances/pharmacology/*physiology | 9 | 64.0 |
Muscle, Smooth/*cytology | 2 | 20.0 |
S Phase | 5 | 1.0 |
Trachea/*cytology | 3 | 42.0 |
Breast Neoplasms/drug therapy/metabolism | 3 | 33.0 |
Cell Nucleus/metabolism | 21 | 1.0 |
Cytoplasm/metabolism | 15 | 1.0 |
Somatostatin/analogs & derivatives/pharmacology | 2 | 50.0 |
Epidermal Growth Factor/*chemistry/genetics | 5 | 83.0 |
*Protein Folding | 4 | 3.0 |
Cell Movement/*genetics/physiology | 2 | 40.0 |
Staining and Labeling | 18 | 2.0 |
Electric Conductivity | 3 | 1.0 |
Exocytosis | 2 | 2.0 |
Luminescent Proteins/metabolism | 5 | 1.0 |
Neurons/metabolism | 4 | 1.0 |
Phosphotransferases (Alcohol Group Acceptor)/metabolism | 5 | 7.0 |
Chemotaxis | 6 | 3.0 |
Epidermal Growth Factor/metabolism/*physiology | 10 | 83.0 |
Mucins/physiology | 3 | 100.0 |
Ribosomal Protein S6 Kinases, 70-kDa/metabolism | 2 | 10.0 |
Cerebellum/metabolism | 2 | 4.0 |
Kidney/metabolism | 14 | 3.0 |
Laminin/metabolism | 5 | 4.0 |
Bladder Neoplasms/*metabolism/pathology | 4 | 12.0 |
Dextrans/*metabolism | 2 | 100.0 |
Dinoprostone/biosynthesis | 8 | 13.0 |
Enzyme Induction/drug effects | 18 | 4.0 |
Mink | 6 | 9.0 |
Prostaglandin-Endoperoxide Synthase/*biosynthesis | 2 | 4.0 |
Glioma | 3 | 4.0 |
Neuroblastoma | 4 | 2.0 |
Half-Life | 14 | 2.0 |
Morpholines/*pharmacology | 2 | 11.0 |
Cell Nucleus/drug effects/metabolism | 3 | 5.0 |
Luteal Phase | 2 | 3.0 |
Quinones/*pharmacology | 3 | 9.0 |
Hormone Antagonists/pharmacology | 4 | 6.0 |
Proto-Oncogene Proteins c-fos/biosynthesis | 5 | 16.0 |
Endometrium/cytology/*drug effects | 2 | 33.0 |
Haplotypes | 2 | 0.0 |
Skin/metabolism/pathology | 4 | 8.0 |
Breast Neoplasms/*metabolism/*pathology | 2 | 5.0 |
Estrogen Antagonists/*pharmacology | 11 | 15.0 |
Estrogens/*pharmacology | 6 | 7.0 |
Receptors, Progesterone/metabolism | 14 | 7.0 |
Genes, Viral | 4 | 1.0 |
Papillomavirus, Human/genetics | 4 | 10.0 |
*Adaptor Protein Complex 3 | 2 | 28.0 |
*Adaptor Protein Complex mu Subunits | 2 | 25.0 |
Evolution, Molecular | 8 | 1.0 |
*GTPase-Activating Proteins | 2 | 2.0 |
Indicators and Reagents/metabolism | 3 | 8.0 |
Luminescent Proteins/genetics | 5 | 2.0 |
Mutagenesis/physiology | 2 | 2.0 |
ral GTP-Binding Proteins/*metabolism | 2 | 50.0 |
1-Phosphatidylinositol 3-Kinase/antagonists & inhibitors/metabolism | 4 | 4.0 |
Glycogen Synthase Kinases | 2 | 3.0 |
Receptor, erbB-2/chemistry/metabolism | 2 | 66.0 |
Aorta | 5 | 3.0 |
Heparin/*pharmacology | 7 | 4.0 |
Muscle, Smooth, Vascular/cytology/drug effects/*physiology | 2 | 22.0 |
Papio | 3 | 1.0 |
Phenylalanine/analogs & derivatives/pharmacology | 2 | 28.0 |
Thrombin/*pharmacology/physiology | 2 | 66.0 |
Membrane Proteins/*genetics | 5 | 0.0 |
Doxorubicin/pharmacology | 4 | 1.0 |
Mitogen-Activated Protein Kinase 9 | 2 | 6.0 |
Paclitaxel/pharmacology | 2 | 2.0 |
Proto-Oncogene Proteins c-fos/genetics | 6 | 11.0 |
Receptor, Epidermal Growth Factor/drug effects/*metabolism | 43 | 79.0 |
Carbazoles/pharmacology | 4 | 8.0 |
Biopsy | 20 | 1.0 |
*Cryopreservation | 2 | 3.0 |
Fertilization in Vitro | 13 | 9.0 |
Ovarian Follicle/*metabolism | 5 | 19.0 |
Transforming Growth Factor alpha/*biosynthesis | 7 | 33.0 |
Antibodies, Monoclonal/immunology/*pharmacology | 3 | 6.0 |
Antimetabolites, Antineoplastic/pharmacology | 2 | 2.0 |
Fluorouracil/pharmacology | 4 | 7.0 |
Hydrogen Peroxide/metabolism | 3 | 2.0 |
Brain/*metabolism | 4 | 0.0 |
Organ Specificity | 20 | 1.0 |
Protein Kinases/genetics/*metabolism | 2 | 2.0 |
Pancreatic Neoplasms/*genetics/pathology | 3 | 7.0 |
Fibroblasts/*drug effects/metabolism | 10 | 22.0 |
Conserved Sequence | 15 | 1.0 |
Cysteine | 5 | 4.0 |
DNA Footprinting | 2 | 0.0 |
Keratin/*biosynthesis/genetics | 2 | 40.0 |
Cytokines/*immunology | 2 | 2.0 |
Antigens, CD/analysis | 4 | 0.0 |
Antigens, Differentiation, Myelomonocytic/analysis | 3 | 0.0 |
Colonic Neoplasms/*drug therapy | 2 | 11.0 |
Genes, myc/*genetics | 3 | 3.0 |
Microtubules/*drug effects | 2 | 10.0 |
Polymerase Chain Reaction/methods | 15 | 1.0 |
Proto-Oncogene Proteins c-myc/*metabolism | 6 | 6.0 |
Breast Neoplasms/immunology/*metabolism | 2 | 28.0 |
Cytokines/*metabolism/pharmacology | 3 | 23.0 |
Peptides/*metabolism/pharmacology | 2 | 20.0 |
Receptor, Epidermal Growth Factor/biosynthesis/metabolism | 4 | 66.0 |
Colon/*cytology | 3 | 25.0 |
Ornithine Decarboxylase/metabolism | 8 | 42.0 |
Putrescine/metabolism | 3 | 18.0 |
Wound Healing/physiology | 12 | 20.0 |
*Genes, ras | 12 | 5.0 |
Biological Markers/blood | 2 | 0.0 |
Epidermal Growth Factor/*analysis/metabolism | 4 | 100.0 |
Carcinoma, Hepatocellular/*metabolism/pathology | 5 | 7.0 |
Liver Neoplasms/*metabolism/pathology | 6 | 8.0 |
Bladder Neoplasms/*metabolism | 5 | 29.0 |
Receptor, Epidermal Growth Factor/*drug effects/*metabolism | 3 | 75.0 |
Calmodulin/*metabolism | 3 | 6.0 |
Chelating Agents/pharmacology | 3 | 3.0 |
Egtazic Acid/*analogs & derivatives/pharmacology | 3 | 12.0 |
Phosphodiesterase Inhibitors/pharmacology | 3 | 2.0 |
Sulfonamides/pharmacology | 5 | 4.0 |
Chemiluminescent Measurements | 2 | 1.0 |
Digestive System/*metabolism | 4 | 10.0 |
Protein Precursors/biosynthesis | 3 | 14.0 |
Proto-Oncogene Protein pp60(c-src)/metabolism | 2 | 5.0 |
Radioimmunoassay | 115 | 6.0 |
Antibodies/metabolism | 3 | 3.0 |
Epitope Mapping | 6 | 2.0 |
Recombinant Fusion Proteins/chemistry/metabolism | 6 | 3.0 |
Genetic Vectors/metabolism | 2 | 8.0 |
Forskolin/pharmacology | 26 | 7.0 |
Gelatinase B/*biosynthesis | 2 | 14.0 |
Hepatocyte Growth Factor/*metabolism | 2 | 1.0 |
Keratinocytes/drug effects/*physiology | 4 | 57.0 |
Helicobacter pylori/*physiology | 2 | 13.0 |
Intracellular Membranes/metabolism | 12 | 6.0 |
Stomach/*enzymology | 2 | 22.0 |
Breast Neoplasms/drug therapy/*enzymology/*pathology | 2 | 100.0 |
Cyclin E/metabolism | 4 | 3.0 |
Cyclins/metabolism | 8 | 1.0 |
G1 Phase/drug effects | 3 | 2.0 |
S Phase/drug effects | 6 | 10.0 |
*Transforming Growth Factor beta | 4 | 2.0 |
Growth Substances/chemistry/*genetics/metabolism | 2 | 50.0 |
*Multigene Family | 8 | 1.0 |
Liver/cytology/metabolism | 3 | 6.0 |
Severity of Illness Index | 5 | 0.0 |
Carcinoma, Squamous Cell/enzymology/*pathology | 3 | 60.0 |
Neoplasm Proteins/genetics/*metabolism | 2 | 1.0 |
Neuregulin-1/*pharmacology | 3 | 17.0 |
Receptor, erbB-2/immunology/*metabolism | 3 | 33.0 |
Chimeric Proteins/metabolism | 9 | 4.0 |
Neoplasm Proteins/analysis | 10 | 3.0 |
Tumor Markers, Biological/analysis | 13 | 1.0 |
World Health Organization | 2 | 2.0 |
Gene Expression Regulation, Developmental/physiology | 2 | 2.0 |
L-Lactate Dehydrogenase/metabolism | 4 | 2.0 |
Pulmonary Surfactant-Associated Protein A | 4 | 12.0 |
Pulmonary Surfactant-Associated Proteins | 6 | 16.0 |
Bone Marrow/drug effects | 4 | 5.0 |
Drug Administration Schedule | 5 | 0.0 |
Cell Survival/*drug effects | 8 | 10.0 |
Receptor, Epidermal Growth Factor/analysis/*genetics | 11 | 52.0 |
*src Homology Domains | 8 | 4.0 |
Autocrine Communication | 6 | 8.0 |
Chromatography, Gel | 48 | 5.0 |
Colonic Neoplasms/metabolism/*pathology | 8 | 32.0 |
Integrins/metabolism | 7 | 4.0 |
DNA/*metabolism | 4 | 0.0 |
*Promoter Regions (Genetics) | 18 | 0.0 |
Receptors, Estrogen/genetics/*metabolism | 2 | 5.0 |
RNA, Messenger/analysis/metabolism | 6 | 4.0 |
Receptors, Estrogen/*genetics/metabolism | 2 | 8.0 |
Cell Death/physiology | 2 | 2.0 |
Glucocorticoids/*pharmacology | 5 | 3.0 |
Phospholipases A/metabolism | 3 | 5.0 |
Proteins/chemistry/metabolism | 2 | 6.0 |
Receptors, Glucocorticoid/metabolism | 2 | 3.0 |
Follicular Fluid/physiology | 2 | 40.0 |
Menotropins/pharmacology | 2 | 15.0 |
Ovarian Follicle/*physiology | 7 | 28.0 |
Amniotic Fluid/metabolism | 3 | 9.0 |
Pregnancy/*metabolism | 4 | 6.0 |
Cyclins/*metabolism | 6 | 2.0 |
Enzyme Induction | 19 | 3.0 |
Retinoblastoma Protein/metabolism | 8 | 2.0 |
Asparagine | 3 | 9.0 |
Receptor, Epidermal Growth Factor/*chemistry/genetics/metabolism | 4 | 80.0 |
Calcium/*pharmacology | 10 | 12.0 |
Chlorides/*metabolism | 3 | 4.0 |
Colon | 2 | 7.0 |
Intestinal Mucosa/cytology/drug effects/*physiology | 2 | 66.0 |
Oligodeoxyribonucleotides, Antisense/pharmacology | 3 | 6.0 |
Forskolin/metabolism | 2 | 25.0 |
Epithelial Cells/cytology/drug effects/*physiology | 2 | 25.0 |
Receptor, Epidermal Growth Factor/genetics/physiology | 4 | 36.0 |
Ovarian Neoplasms/metabolism/*pathology | 2 | 12.0 |
Proto-Oncogene Proteins c-fos/metabolism | 4 | 3.0 |
Cell Count/drug effects | 11 | 15.0 |
Astrocytes/*physiology | 2 | 11.0 |
Dermis/*cytology | 2 | 22.0 |
Protein Binding/genetics | 5 | 2.0 |
Cyclins/genetics/*metabolism | 2 | 2.0 |
RNA Interference | 6 | 2.0 |
RNA, Small Interfering/genetics | 2 | 1.0 |
Saccharomyces cerevisiae/genetics | 2 | 0.0 |
Apolipoproteins/genetics/*metabolism | 2 | 20.0 |
Apolipoproteins B/genetics/metabolism | 2 | 28.0 |
Hepatoblastoma/*metabolism/pathology | 2 | 40.0 |
Liver Neoplasms/metabolism/pathology | 2 | 12.0 |
*Cell Hypoxia | 2 | 2.0 |
Protein p53/metabolism | 7 | 1.0 |
GTP Phosphohydrolases/genetics/metabolism | 2 | 18.0 |
Ubiquitins | 2 | 28.0 |
Intestinal Mucosa/physiology | 5 | 45.0 |
*Postoperative Care | 2 | 12.0 |
Breast/cytology/*drug effects | 4 | 44.0 |
Retroviridae Proteins, Oncogenic/metabolism | 4 | 11.0 |
*Caveolins | 3 | 8.0 |
Choriocarcinoma/metabolism | 4 | 28.0 |
Forskolin/*pharmacology | 3 | 10.0 |
*Response Elements | 3 | 4.0 |
Insulin-Like Growth Factor I/genetics | 4 | 19.0 |
Fetus/metabolism | 10 | 6.0 |
*Glycoproteins | 12 | 1.0 |
Growth Disorders/*genetics | 2 | 3.0 |
*Growth Substances | 3 | 16.0 |
*Neoplasm Proteins | 6 | 0.0 |
*Peptides | 3 | 4.0 |
Stromal Cells/drug effects | 3 | 30.0 |
*Apoptosis/drug effects | 3 | 2.0 |
Cyclin D1/biosynthesis | 2 | 4.0 |
Cyclins/biosynthesis | 5 | 5.0 |
Adenocarcinoma/metabolism/*pathology | 5 | 9.0 |
Breast Neoplasms/metabolism/*pathology | 9 | 10.0 |
CDC2 Protein Kinase/metabolism | 5 | 3.0 |
Adenocarcinoma/genetics/*metabolism/pathology | 3 | 11.0 |
Glycoproteins/*biosynthesis/genetics | 3 | 20.0 |
Growth Substances/*biosynthesis/genetics | 4 | 15.0 |
Fibroblasts/cytology/metabolism | 8 | 4.0 |
Apoptosis/*drug effects/genetics | 2 | 6.0 |
Cysteine Proteinase Inhibitors/*pharmacology | 2 | 6.0 |
DNA, Antisense/genetics | 2 | 4.0 |
Protein-Serine-Threonine Kinases/physiology | 2 | 2.0 |
*Proto-Oncogene Proteins c-bcl-2 | 2 | 0.0 |
Microcirculation | 4 | 1.0 |
Octreotide/*pharmacology | 4 | 18.0 |
Protein Isoforms/metabolism | 3 | 1.0 |
Receptor, Cholecystokinin B | 2 | 5.0 |
Receptors, Cholecystokinin/metabolism | 2 | 28.0 |
Tumor Cells, Cultured/pathology | 6 | 11.0 |
Alternative Splicing/*genetics | 2 | 1.0 |
Amino Acid Sequence/genetics | 3 | 1.0 |
Intestinal Mucosa/metabolism | 8 | 7.0 |
Membrane Glycoproteins/chemistry/*genetics | 3 | 8.0 |
Bradykinin/pharmacology | 7 | 14.0 |
Calcium Channels/*metabolism | 4 | 8.0 |
Cell Aging/physiology | 2 | 6.0 |
Receptors, Cytoplasmic and Nuclear/*metabolism | 3 | 2.0 |
Cathepsin D/*genetics | 3 | 18.0 |
*Gene Expression Regulation, Enzymologic | 4 | 0.0 |
Receptors, Estrogen/*genetics | 3 | 3.0 |
Heparin/*metabolism | 7 | 8.0 |
L Cells (Cell Line) | 7 | 3.0 |
Receptors, Cell Surface/chemistry | 2 | 25.0 |
Vero Cells | 4 | 1.0 |
Bradykinin/*pharmacology | 10 | 28.0 |
Pyrazoles/pharmacology | 3 | 6.0 |
Pyrimidines/pharmacology | 6 | 5.0 |
Adenocarcinoma | 17 | 14.0 |
Mammary Neoplasms, Animal | 2 | 33.0 |
Spermatogenesis/*physiology | 2 | 5.0 |
Submandibular Gland/chemistry | 3 | 75.0 |
Binding Sites/genetics | 13 | 1.0 |
Guinea Pigs | 13 | 1.0 |
*Intracellular Signaling Peptides and Proteins | 8 | 1.0 |
Microfilament Proteins/genetics/metabolism | 2 | 22.0 |
Gangliosides/*metabolism | 2 | 10.0 |
Chromatography, Ion Exchange | 11 | 3.0 |
Fucose/chemistry/*metabolism | 2 | 100.0 |
Membrane Proteins/chemistry/*metabolism | 5 | 8.0 |
Interleukin-1/*physiology | 3 | 3.0 |
Cell Cycle/genetics | 3 | 2.0 |
Transcription Factors/physiology | 5 | 2.0 |
*Bacterial Toxins | 9 | 6.0 |
Guanosine Diphosphate/metabolism | 4 | 3.0 |
Connective Tissue/drug effects/metabolism | 2 | 66.0 |
Epidermal Growth Factor/drug effects | 2 | 100.0 |
Drug Compounding | 2 | 13.0 |
Bone and Bones/*metabolism | 2 | 2.0 |
Membrane Glycoproteins/chemistry/genetics/*metabolism | 2 | 8.0 |
Osteoblasts/*metabolism | 3 | 5.0 |
Fibroblast Growth Factor 1/*pharmacology | 4 | 21.0 |
Nitriles/*pharmacology | 7 | 30.0 |
Ribosomal Protein S6 Kinases, 90-kDa/metabolism | 2 | 18.0 |
Endothelium, Vascular/*cytology/metabolism | 2 | 3.0 |
Microscopy, Phase-Contrast | 9 | 10.0 |
RNA, Messenger/drug effects | 4 | 6.0 |
Receptor, Epidermal Growth Factor/drug effects/genetics | 3 | 100.0 |
Remission Induction | 3 | 0.0 |
Epidermal Growth Factor/*chemistry/physiology | 3 | 100.0 |
Receptor, erbB-2/*physiology | 4 | 16.0 |
Mitogen-Activated Protein Kinases/metabolism/*physiology | 2 | 10.0 |
Bromodeoxyuridine/metabolism | 5 | 6.0 |
Ki-67 Antigen/metabolism | 6 | 2.0 |
Epidermal Growth Factor/chemistry/*immunology | 2 | 100.0 |
Quality Control | 2 | 1.0 |
Submandibular Gland/metabolism | 6 | 42.0 |
Epidermal Growth Factor/blood/*pharmacology | 2 | 100.0 |
Mucus/metabolism | 3 | 42.0 |
Ornithine Decarboxylase/*metabolism | 2 | 28.0 |
*Plants, Toxic | 2 | 5.0 |
Stomach Neoplasms | 4 | 12.0 |
*Tobacco | 2 | 8.0 |
Antibodies, Monoclonal/*therapeutic use | 9 | 2.0 |
Receptor, erbB-2/*antagonists & inhibitors/immunology | 2 | 66.0 |
Keratin/metabolism | 8 | 5.0 |
Muscle, Smooth/metabolism/pathology | 2 | 28.0 |
*Genes, Bacterial | 2 | 2.0 |
Genomic Library | 5 | 1.0 |
Recombinant Proteins/genetics | 3 | 2.0 |
Sequence Analysis | 5 | 1.0 |
Hydrogen Peroxide/*metabolism | 3 | 7.0 |
Lipoxygenase/*metabolism | 2 | 25.0 |
Lysophospholipids/*pharmacology | 4 | 11.0 |
*Sperm Injections, Intracytoplasmic | 2 | 12.0 |
Antigens, CD/*physiology | 2 | 0.0 |
Calcium/physiology | 8 | 3.0 |
GTP-Binding Proteins/physiology | 4 | 6.0 |
Amnion/*metabolism | 4 | 30.0 |
Cryopreservation | 2 | 1.0 |
Epidermal Growth Factor/genetics/metabolism | 10 | 71.0 |
Fibroblast Growth Factor 2/genetics/metabolism | 2 | 15.0 |
Growth Substances/genetics/*metabolism | 7 | 16.0 |
Receptors, Growth Factor/genetics/metabolism | 2 | 9.0 |
Transforming Growth Factor alpha/genetics/metabolism | 9 | 75.0 |
Transforming Growth Factor beta/genetics/metabolism | 3 | 8.0 |
Epidermal Growth Factor/blood/*metabolism/urine | 5 | 100.0 |
Saliva/chemistry | 5 | 12.0 |
Amniotic Fluid | 2 | 25.0 |
Phosphatidylcholines/analysis | 3 | 21.0 |
Breast Neoplasms/genetics/metabolism | 2 | 4.0 |
Estradiol/analogs & derivatives/*pharmacology | 2 | 12.0 |
Connective Tissue/chemistry | 2 | 28.0 |
Motion | 4 | 21.0 |
Estradiol/metabolism | 8 | 8.0 |
Progesterone/metabolism | 6 | 7.0 |
Collagen/pharmacology | 2 | 1.0 |
*Receptor Protein-Tyrosine Kinases | 2 | 3.0 |
Glycoproteins/pharmacology | 8 | 21.0 |
Keratinocytes/*chemistry | 3 | 33.0 |
Image Processing, Computer-Assisted | 9 | 2.0 |
Proliferating Cell Nuclear Antigen/*metabolism | 5 | 2.0 |
Cisplatin/*therapeutic use | 3 | 9.0 |
Infusions, Intravenous | 8 | 1.0 |
Receptor, Epidermal Growth Factor/*antagonists & inhibitors/genetics | 3 | 30.0 |
Cell Adhesion Molecules/metabolism | 6 | 2.0 |
Mitogens/*physiology | 2 | 12.0 |
Neovascularization, Physiologic | 3 | 1.0 |
Phospholipase C/metabolism | 26 | 9.0 |
Monophenol Monooxygenase/*genetics | 2 | 8.0 |
Enzyme Inhibitors/*pharmacology/therapeutic use | 2 | 6.0 |
*Nuclear Proteins | 4 | 0.0 |
Protein p53/genetics/metabolism | 2 | 2.0 |
Antihypertensive Agents/pharmacology | 4 | 8.0 |
Extracellular Matrix/pathology | 2 | 18.0 |
Antibodies, Blocking/pharmacology | 3 | 3.0 |
DNA/biosynthesis/drug effects | 4 | 15.0 |
Depression, Chemical | 4 | 2.0 |
Molecular Biology | 2 | 0.0 |
Receptors, Growth Factor/*genetics | 3 | 6.0 |
Epidermal Growth Factor/*secretion | 13 | 92.0 |
Transforming Growth Factor beta/*secretion | 3 | 33.0 |
Cyclin-Dependent Kinases/*metabolism | 4 | 1.0 |
Receptor, Epidermal Growth Factor/drug effects/genetics/*metabolism | 9 | 75.0 |
beta-Galactosidase/genetics/metabolism | 4 | 6.0 |
3T3 Cells/drug effects/metabolism | 3 | 25.0 |
Protein Processing, Post-Translational/drug effects | 5 | 4.0 |
Receptor, Epidermal Growth Factor/*drug effects/genetics/metabolism | 2 | 100.0 |
Cell Compartmentation | 13 | 3.0 |
Endosomes/*ultrastructure | 2 | 100.0 |
Microscopy, Immunoelectron | 14 | 2.0 |
Receptor, Epidermal Growth Factor/antagonists & inhibitors/*physiology | 6 | 37.0 |
*Skin Physiology | 5 | 14.0 |
Angiotensin II/physiology | 2 | 8.0 |
Calcium/metabolism/physiology | 2 | 16.0 |
Hormones/*physiology | 6 | 14.0 |
Manganese/metabolism | 3 | 9.0 |
MAP Kinase Kinase Kinase 2 | 2 | 28.0 |
Biological Transport, Active | 7 | 3.0 |
Phosphoproteins/chemistry/genetics/*metabolism | 4 | 9.0 |
Recombinant Fusion Proteins/chemistry/genetics/metabolism | 3 | 1.0 |
Breast Neoplasms/*physiopathology | 6 | 27.0 |
Peptide Fragments/metabolism | 14 | 3.0 |
Fibronectins/metabolism | 4 | 2.0 |
*Cytoprotection | 2 | 18.0 |
Glycoproteins/genetics/metabolism | 3 | 12.0 |
Cell Proliferation | 3 | 1.0 |
Microscopy, Electron, Transmission | 2 | 4.0 |
Diploidy | 4 | 3.0 |
Polyploidy | 3 | 7.0 |
Proliferating Cell Nuclear Antigen/metabolism | 5 | 2.0 |
*Cell Division/drug effects | 6 | 54.0 |
Cervix Neoplasms/pathology | 3 | 27.0 |
Endometrial Neoplasms/pathology | 2 | 25.0 |
Epithelium/pathology | 15 | 10.0 |
Fibroblasts/pathology | 4 | 5.0 |
Keratin/analysis | 16 | 6.0 |
Ovarian Neoplasms/*pathology | 7 | 13.0 |
Vimentin/analysis | 2 | 0.0 |
Growth Substances/genetics/*pharmacology/physiology | 2 | 100.0 |
RNA/genetics/metabolism | 3 | 1.0 |
Gelatinase B/*metabolism | 2 | 6.0 |
*Aging | 3 | 1.0 |
*Glomerular Filtration Rate | 2 | 8.0 |
Nephrectomy | 8 | 9.0 |
Cysteine/metabolism | 3 | 3.0 |
Epidermal Growth Factor/chemistry/genetics/*metabolism | 4 | 66.0 |
Logistic Models | 2 | 0.0 |
Stromal Cells/*physiology | 2 | 8.0 |
Thromboplastin/*biosynthesis | 2 | 2.0 |
Electric Impedance | 2 | 3.0 |
Gene Expression Regulation, Neoplastic/*genetics | 5 | 2.0 |
Angiotensin II/metabolism | 3 | 7.0 |
Carcinoma, Squamous Cell/*pathology | 22 | 26.0 |
Inhibitory Concentration 50 | 4 | 1.0 |
Receptors, Platelet-Derived Growth Factor/metabolism | 6 | 13.0 |
*Blood-Brain Barrier | 3 | 12.0 |
Anticarcinogenic Agents/*pharmacology | 5 | 5.0 |
Cell Transformation, Neoplastic/*drug effects | 8 | 22.0 |
Keratinocytes/cytology/drug effects/metabolism | 2 | 33.0 |
RNA, Messenger | 12 | 2.0 |
Transforming Growth Factor beta/metabolism/*pharmacology | 3 | 27.0 |
Endometrial Neoplasms | 3 | 21.0 |
Medroxyprogesterone 17-Acetate/pharmacology | 6 | 18.0 |
Enzyme Inhibitors/*therapeutic use | 4 | 4.0 |
Glycoproteins/*pharmacology | 14 | 14.0 |
*Linkage (Genetics) | 3 | 0.0 |
Lod Score | 2 | 0.0 |
Microsatellite Repeats | 2 | 0.0 |
Thrombin/metabolism | 10 | 6.0 |
Hyaluronic Acid/*biosynthesis | 3 | 15.0 |
Calcimycin/pharmacology | 20 | 8.0 |
Hydroxamic Acids/pharmacology | 3 | 1.0 |
Metalloendopeptidases/antagonists & inhibitors | 5 | 22.0 |
Protein Engineering | 7 | 7.0 |
Enzyme Precursors/*metabolism | 2 | 1.0 |
Serine Endopeptidases/*metabolism | 2 | 2.0 |
Adsorption | 4 | 2.0 |
*Cell Movement | 4 | 3.0 |
Collagen/*metabolism | 3 | 1.0 |
Fibronectins/*metabolism | 2 | 2.0 |
Keratinocytes/cytology/metabolism | 4 | 14.0 |
Fibrinolysis | 2 | 1.0 |
Carcinoma/*metabolism | 10 | 12.0 |
Neoplasms/*genetics | 2 | 0.0 |
Nucleic Acid Hybridization | 46 | 2.0 |
Breast Neoplasms/*genetics/pathology | 8 | 3.0 |
*Chromosomes, Human, Pair 17 | 2 | 0.0 |
Genetic Markers | 10 | 0.0 |
Growth Substances/biosynthesis/*physiology | 2 | 33.0 |
Membrane Proteins/*chemistry/genetics | 2 | 15.0 |
Phosphotyrosine/analysis | 15 | 26.0 |
Stomach/metabolism | 2 | 5.0 |
Recombinant Proteins/chemistry/genetics/metabolism | 7 | 2.0 |
Gene Expression Regulation, Enzymologic/*physiology | 3 | 3.0 |
Chemotaxis/drug effects | 10 | 10.0 |
Phospholipase C/*metabolism | 19 | 17.0 |
Intestinal Mucosa/*metabolism | 8 | 10.0 |
Cell Adhesion/immunology | 3 | 1.0 |
Cell Membrane/immunology | 3 | 1.0 |
Membrane Glycoproteins/*genetics/metabolism | 3 | 4.0 |
Alkaline Phosphatase/metabolism | 4 | 2.0 |
Human Growth Hormone/*pharmacology | 8 | 21.0 |
Phosphoprotein Phosphatase/metabolism | 6 | 8.0 |
Cell Membrane/physiology | 8 | 5.0 |
Spodoptera | 5 | 1.0 |
Body Fluids/*chemistry | 4 | 14.0 |
Mastectomy | 2 | 2.0 |
Suction | 2 | 11.0 |
*Tumor Markers, Biological | 2 | 1.0 |
Mitogen-Activated Protein Kinases/*antagonists & inhibitors | 2 | 11.0 |
Cations, Divalent | 5 | 7.0 |
Cell Extracts | 2 | 1.0 |
Fibronectins/pharmacology | 8 | 16.0 |
Magnesium/pharmacology | 9 | 7.0 |
Receptor Protein-Tyrosine Kinases/physiology | 2 | 4.0 |
Glycoproteins/genetics/*metabolism | 3 | 7.0 |
Stomach Neoplasms/*metabolism/pathology | 4 | 7.0 |
Protein Kinase Inhibitors/pharmacology | 2 | 10.0 |
Transcription Factor AP-1/genetics/metabolism | 4 | 19.0 |
Endometrial Neoplasms/*metabolism | 3 | 9.0 |
Proteins/*genetics | 11 | 0.0 |
Radiation Dosage | 4 | 4.0 |
Electrophoresis, Gel, Two-Dimensional | 6 | 1.0 |
*Genetic Techniques | 2 | 3.0 |
Proteomics/*methods | 2 | 9.0 |
Biological Transport/genetics | 2 | 4.0 |
Lectins/metabolism | 4 | 4.0 |
Receptors, Cell Surface/*chemistry | 3 | 30.0 |
Brain Neoplasms/*genetics/pathology | 2 | 2.0 |
DNA, Antisense/*genetics | 2 | 15.0 |
DNA, Neoplasm/genetics | 14 | 1.0 |
Glioblastoma/*genetics/pathology | 2 | 8.0 |
Leukemia, Promyelocytic, Acute/genetics | 2 | 16.0 |
Oncogene Proteins/biosynthesis/*genetics | 2 | 18.0 |
Protein p53/*genetics | 3 | 1.0 |
Porifera/*genetics | 2 | 50.0 |
Receptor, Insulin/classification/*genetics | 2 | 100.0 |
Breast Neoplasms/*secretion | 2 | 50.0 |
Brain Neoplasms/*therapy | 2 | 28.0 |
*Gene Therapy | 6 | 1.0 |
Glioma/*therapy | 3 | 60.0 |
*Lac Operon | 2 | 25.0 |
Retroviridae/*genetics | 5 | 3.0 |
Spheroids, Cellular | 4 | 33.0 |
DNA Fragmentation/drug effects | 5 | 5.0 |
Mannitol/pharmacology | 2 | 15.0 |
Neuroblastoma/*pathology | 4 | 7.0 |
Biological Transport, Active/drug effects | 5 | 8.0 |
Sodium/*physiology | 3 | 30.0 |
Antioxidants/pharmacology | 4 | 2.0 |
Nitrates/metabolism | 4 | 21.0 |
Nitric-Oxide Synthase/metabolism | 2 | 1.0 |
Tubulin/metabolism | 3 | 3.0 |
Endothelium, Vascular/cytology/metabolism | 3 | 2.0 |
Oleic Acid/pharmacology | 2 | 6.0 |
DNA, Neoplasm/metabolism | 7 | 4.0 |
Myometrium/metabolism | 5 | 21.0 |
Progesterone/*metabolism | 3 | 8.0 |
Uterine Neoplasms/*metabolism/pathology | 2 | 13.0 |
Adenocarcinoma/pathology | 5 | 6.0 |
Carcinoma, Squamous Cell/pathology | 15 | 32.0 |
Ovarian Neoplasms/pathology | 3 | 9.0 |
Urinary Plasminogen Activator/metabolism | 3 | 6.0 |
Bacteriophages/*genetics | 2 | 18.0 |
Cell Differentiation/*drug effects | 8 | 5.0 |
Gelatin/metabolism | 2 | 14.0 |
Chloroquine/pharmacology | 9 | 11.0 |
Simian virus 40 | 6 | 12.0 |
Transforming Growth Factor alpha/genetics/*pharmacology | 4 | 100.0 |
*Mitogen-Activated Protein Kinases | 37 | 10.0 |
Neoplasms, Experimental/*drug therapy | 2 | 10.0 |
Piperidines/*pharmacology | 2 | 3.0 |
Chemotactic Factors/*pharmacology | 2 | 5.0 |
Cytoskeleton/drug effects/ultrastructure | 2 | 28.0 |
Prolactin/*pharmacology | 5 | 6.0 |
Body Weight/drug effects | 7 | 3.0 |
Head and Neck Neoplasms/pathology | 2 | 12.0 |
Acetophenones/pharmacology | 2 | 9.0 |
Benzopyrans/pharmacology | 2 | 8.0 |
Crosses, Genetic | 4 | 0.0 |
Phospholipase D/*metabolism | 4 | 5.0 |
Genes, fos | 14 | 11.0 |
Proto-Oncogene Proteins c-jun/metabolism | 2 | 1.0 |
Cell Fractionation | 10 | 3.0 |
Cell Membrane/*physiology | 2 | 10.0 |
Anti-Ulcer Agents/therapeutic use | 2 | 16.0 |
*Helicobacter pylori/isolation & purification | 2 | 20.0 |
Omeprazole/therapeutic use | 2 | 28.0 |
*Blood | 5 | 11.0 |
Transforming Growth Factor beta/blood | 2 | 7.0 |
Skin Transplantation | 2 | 7.0 |
Epithelial Cells/*physiology | 3 | 10.0 |
3' Untranslated Regions/*genetics | 2 | 5.0 |
*Alternative Splicing | 5 | 0.0 |
Ovary/cytology/*metabolism | 2 | 22.0 |
Tumor Markers, Biological/*metabolism | 3 | 0.0 |
Cysteine Endopeptidases/metabolism | 3 | 1.0 |
Isoproterenol/pharmacology | 10 | 9.0 |
Multienzyme Complexes/metabolism | 3 | 1.0 |
Proteasome Endopeptidase Complex | 7 | 1.0 |
Serine Proteinase Inhibitors/pharmacology | 2 | 4.0 |
Growth Substances/genetics/pharmacology | 2 | 66.0 |
Pancreatic Neoplasms/genetics/*metabolism/pathology | 2 | 16.0 |
Uterus/metabolism | 4 | 10.0 |
Cell Transformation, Neoplastic/genetics/*pathology | 2 | 18.0 |
Epithelial Cells/metabolism/*pathology | 2 | 25.0 |
Allosteric Regulation | 5 | 8.0 |
Iodine Radioisotopes/diagnostic use | 50 | 16.0 |
Transferrin/analysis | 2 | 2.0 |
Progesterone/pharmacology | 15 | 13.0 |
Cell Polarity/*physiology | 2 | 8.0 |
Kidney | 16 | 4.0 |
Receptor, Epidermal Growth Factor/genetics/*physiology | 17 | 51.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/*metabolism | 40 | 13.0 |
Endoplasmic Reticulum/*enzymology | 2 | 7.0 |
Subcellular Fractions/enzymology | 2 | 2.0 |
Antibodies, Monoclonal/chemistry | 3 | 3.0 |
*Drug Design | 2 | 2.0 |
Bone Morphogenetic Proteins/pharmacology | 2 | 6.0 |
Ploidies | 8 | 3.0 |
Oncogene Protein pp60(v-src)/*metabolism | 2 | 16.0 |
Phosphoproteins/genetics/*metabolism | 4 | 2.0 |
Oligodeoxyribonucleotides | 18 | 2.0 |
Caco-2 Cells/drug effects | 4 | 80.0 |
Calcitriol/*pharmacology | 7 | 3.0 |
Calcium Channel Agonists/pharmacology | 2 | 9.0 |
Interleukins/metabolism | 2 | 6.0 |
Tears/*metabolism | 6 | 40.0 |
Age of Onset | 2 | 0.0 |
Microfilament Proteins/chemistry/*genetics | 2 | 28.0 |
Sex Factors | 16 | 1.0 |
*DNA Replication/drug effects | 2 | 16.0 |
Leydig Cells/drug effects/*metabolism | 3 | 42.0 |
Luteinizing Hormone/physiology | 2 | 28.0 |
Swine/*metabolism | 2 | 18.0 |
Adaptation, Physiological/*drug effects | 2 | 100.0 |
Digestive System/*growth & development | 3 | 100.0 |
*Immunoenzyme Techniques | 3 | 2.0 |
Neoplasm Proteins/*analysis | 10 | 3.0 |
Prostate/*chemistry | 2 | 20.0 |
Prostatic Hyperplasia/*metabolism | 10 | 21.0 |
Prostatic Neoplasms/*chemistry | 2 | 14.0 |
Stromal Cells/chemistry | 2 | 8.0 |
Transforming Growth Factor alpha/*analysis | 29 | 56.0 |
Enzyme Inhibitors/*metabolism | 4 | 5.0 |
Flutamide/analogs & derivatives/pharmacology | 3 | 25.0 |
Metribolone/pharmacology | 3 | 13.0 |
Microtubule-Associated Proteins/*metabolism | 2 | 1.0 |
Prostatic Neoplasms/*metabolism/pathology | 7 | 9.0 |
Receptors, Androgen/biosynthesis | 2 | 22.0 |
Neovascularization, Pathologic/metabolism | 2 | 2.0 |
Proteins/analysis | 5 | 3.0 |
Nerve Tissue Proteins/analysis | 4 | 5.0 |
Neurons/*cytology/drug effects | 3 | 37.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/physiology | 2 | 5.0 |
Mitogen-Activated Protein Kinase 1 | 21 | 15.0 |
src-Family Kinases/*physiology | 3 | 7.0 |
Epitopes, B-Lymphocyte/immunology | 2 | 12.0 |
Peptide Fragments/genetics/immunology | 2 | 5.0 |
Quercetin/*pharmacology | 4 | 16.0 |
Tumor Cells, Cultured/cytology/drug effects | 6 | 17.0 |
Gonadal Steroid Hormones/*physiology | 4 | 23.0 |
Sexual Maturation/*physiology | 2 | 33.0 |
Cross-Linking Reagents/metabolism | 4 | 7.0 |
Retroviridae | 2 | 2.0 |
Amiloride/pharmacology | 5 | 14.0 |
Cell Membrane/chemistry/ultrastructure | 2 | 25.0 |
Immunosorbent Techniques | 14 | 4.0 |
Neovascularization, Physiologic/drug effects | 2 | 2.0 |
Regeneration/*physiology | 4 | 15.0 |
Collagen/genetics | 2 | 2.0 |
Fibronectins/genetics | 3 | 10.0 |
Fibrosis | 7 | 4.0 |
Transforming Growth Factor beta/pharmacology/*physiology | 2 | 8.0 |
Keratinocytes/*cytology/drug effects | 5 | 62.0 |
Wound Healing/drug effects | 16 | 48.0 |
Antigens, Tumor-Associated, Carbohydrate/analysis | 3 | 15.0 |
Carcinoembryonic Antigen/analysis | 2 | 1.0 |
*Chromosome Aberrations | 4 | 0.0 |
Tumor Markers, Biological/*analysis | 26 | 2.0 |
Gene Targeting | 10 | 3.0 |
Histones/*metabolism | 2 | 1.0 |
Chemotherapy, Adjuvant | 3 | 1.0 |
Epidermal Growth Factor/antagonists & inhibitors | 6 | 28.0 |
Receptors, Estrogen/drug effects/*metabolism | 2 | 28.0 |
Fibroblast Growth Factor 1/pharmacology | 10 | 43.0 |
Vascular Endothelial Growth Factor A/pharmacology | 2 | 7.0 |
Arginine/genetics | 4 | 2.0 |
Serine/genetics | 2 | 2.0 |
Arteriosclerosis/*metabolism | 2 | 3.0 |
Chromosomes, Human, Pair 14 | 2 | 1.0 |
Cloning, Molecular/methods | 3 | 1.0 |
RNA, Messenger/isolation & purification | 2 | 2.0 |
Autoradiography | 53 | 10.0 |
Glioblastoma/*metabolism | 3 | 9.0 |
Blood Glucose/metabolism | 2 | 0.0 |
Calcium-Binding Proteins/genetics | 2 | 5.0 |
Marfan Syndrome/*genetics | 7 | 12.0 |
Lung Neoplasms/genetics/*metabolism/pathology | 2 | 7.0 |
Receptor, erbB-2/*biosynthesis/genetics | 2 | 25.0 |
Digestive System/*drug effects | 2 | 33.0 |
Asthma/metabolism/*pathology | 2 | 50.0 |
Bronchi/metabolism/*pathology | 2 | 28.0 |
Bronchitis/metabolism/*pathology | 2 | 100.0 |
Endopeptidases/metabolism | 5 | 3.0 |
Epithelium/metabolism/pathology | 6 | 9.0 |
Transforming Growth Factor beta/analysis | 3 | 6.0 |
Gene Expression Regulation, Developmental/*physiology | 2 | 1.0 |
Evaluation Studies | 3 | 0.0 |
Tomography, Emission-Computed | 3 | 2.0 |
Transforming Growth Factor alpha/genetics/*metabolism | 3 | 20.0 |
Membrane Proteins/*genetics/metabolism | 2 | 1.0 |
Cell Division/*drug effects/physiology | 6 | 31.0 |
Protein-Tyrosine Kinase/metabolism/*physiology | 2 | 7.0 |
Protein Kinase C/antagonists & inhibitors/*physiology | 3 | 10.0 |
*Trans-Activation (Genetics)/drug effects | 3 | 7.0 |
Enzyme Activation/drug effects/physiology | 4 | 6.0 |
Phosphatidylinositols/metabolism | 12 | 10.0 |
Breast Neoplasms/*enzymology | 6 | 9.0 |
Life Cycle Stages | 2 | 25.0 |
Neoplasms/therapy | 3 | 6.0 |
Neoplasm Proteins/*biosynthesis | 4 | 4.0 |
Androgens/*pharmacology | 7 | 13.0 |
Orchiectomy | 2 | 1.0 |
Recombinant Proteins/metabolism/pharmacology | 5 | 4.0 |
Metalloendopeptidases/*genetics | 5 | 5.0 |
Mucins/metabolism | 2 | 4.0 |
Parietal Cells, Gastric/metabolism | 2 | 40.0 |
Ethanol/*pharmacology | 6 | 5.0 |
Mucous Membrane/cytology | 3 | 27.0 |
Epidermis/cytology | 4 | 10.0 |
Gelatinase B | 12 | 15.0 |
Keratinocytes/cytology/drug effects/*enzymology | 2 | 66.0 |
*Mitogen-Activated Protein Kinase Kinases | 10 | 10.0 |
Ceramides/*metabolism | 2 | 8.0 |
Collagenases/*genetics | 4 | 22.0 |
Gelatinase A | 4 | 5.0 |
Gene Expression Regulation, Enzymologic/drug effects/physiology | 2 | 6.0 |
Interstitial Collagenase | 6 | 14.0 |
Metalloendopeptidases/genetics | 5 | 18.0 |
Membrane Proteins/analysis | 5 | 4.0 |
Proto-Oncogene Proteins c-bcl-2/analysis | 3 | 1.0 |
Cross-Linking Reagents | 13 | 3.0 |
Organometallic Compounds/*pharmacology | 2 | 22.0 |
Creatinine/urine | 15 | 13.0 |
Kidney Failure, Chronic/*urine | 2 | 50.0 |
Carrier Proteins/chemistry/genetics/*metabolism | 3 | 2.0 |
Receptor, Insulin/metabolism | 12 | 15.0 |
ral GTP-Binding Proteins | 2 | 18.0 |
Fibroblasts/*physiology | 8 | 14.0 |
Insulin-Like Growth Factor I/*metabolism/pharmacology | 3 | 30.0 |
Prostatic Neoplasms/prevention & control | 2 | 66.0 |
Epithelium/physiology | 13 | 15.0 |
Gastric Mucosa/cytology/*physiology | 2 | 66.0 |
Factor VIIa/*metabolism | 2 | 5.0 |
Factor XIa/*metabolism | 2 | 50.0 |
*Cell Communication | 3 | 3.0 |
Amino Acids/analysis | 21 | 7.0 |
Liver/*cytology | 3 | 9.0 |
Caffeic Acids/pharmacology | 2 | 40.0 |
Nordihydroguaiaretic Acid/pharmacology | 3 | 13.0 |
Neuregulins | 27 | 47.0 |
Receptor, erbB-3 | 30 | 34.0 |
Receptor, Epidermal Growth Factor/genetics/immunology/*metabolism | 4 | 44.0 |
Receptors, Cell Surface/genetics/*metabolism | 5 | 3.0 |
Immunoglobulins, Fab/*genetics | 2 | 33.0 |
beta-Galactosidase/genetics | 4 | 3.0 |
Estradiol/therapeutic use | 2 | 16.0 |
Vanadates/*pharmacology | 2 | 8.0 |
Carrier Proteins/genetics | 4 | 1.0 |
Epidermal Growth Factor/metabolism/physiology | 5 | 83.0 |
src Homology Domains/physiology | 3 | 6.0 |
Wound Healing/drug effects/*physiology | 4 | 26.0 |
Androgens/physiology | 5 | 11.0 |
Anti-Inflammatory Agents, Non-Steroidal/*pharmacology | 3 | 2.0 |
Carcinoma/metabolism/*pathology | 2 | 9.0 |
Epidermal Growth Factor/chemistry/*genetics/metabolism | 2 | 100.0 |
Phosphotransferases (Alcohol Group Acceptor)/*metabolism | 5 | 6.0 |
Cytoplasm/enzymology | 4 | 5.0 |
Receptor Protein-Tyrosine Kinases/antagonists & inhibitors/*metabolism | 2 | 20.0 |
Stereoisomerism | 6 | 1.0 |
Protein-Tyrosine Kinase/*drug effects/metabolism | 2 | 50.0 |
Receptor, Muscarinic M3 | 2 | 13.0 |
Biotin/chemistry | 3 | 21.0 |
*Electromagnetic Fields | 2 | 6.0 |
Keratinocytes/*cytology | 9 | 28.0 |
Mesoderm/*cytology | 2 | 7.0 |
Skin/pathology | 3 | 1.0 |
Epidermal Growth Factor/genetics/pharmacology/*physiology | 2 | 66.0 |
Disulfides/analysis | 2 | 11.0 |
Hydrogen Bonding | 4 | 2.0 |
Affinity Labels/metabolism | 3 | 25.0 |
Cytochrome c Group/metabolism | 2 | 1.0 |
Growth | 2 | 4.0 |
Hormones/physiology | 2 | 6.0 |
Liver/physiology | 2 | 3.0 |
Pregnancy/*urine | 2 | 50.0 |
Probability | 5 | 0.0 |
Psoriasis/pathology | 2 | 25.0 |
Ovariectomy | 2 | 1.0 |
Epidermal Growth Factor/*analysis/immunology | 6 | 100.0 |
*Fertilization in Vitro | 3 | 2.0 |
Predictive Value of Tests | 9 | 0.0 |
*Breast Neoplasms | 2 | 10.0 |
Tumor Cells, Cultured/cytology/drug effects/metabolism | 3 | 11.0 |
Coated Pits, Cell-Membrane/metabolism | 3 | 25.0 |
Age Distribution | 2 | 0.0 |
Tumor Markers, Biological/*blood | 3 | 0.0 |
Recombinant Fusion Proteins/genetics/immunology | 2 | 4.0 |
*Protein Conformation | 10 | 4.0 |
Thrombomodulin/chemistry/*metabolism | 2 | 100.0 |
3T3 Cells/drug effects | 5 | 45.0 |
Platelet-Derived Growth Factor/metabolism/pharmacology | 2 | 18.0 |
Protein Processing, Post-Translational/*drug effects | 4 | 7.0 |
Fibroblasts/cytology/drug effects | 11 | 27.0 |
Glycoproteins/*metabolism | 13 | 6.0 |
Ovarian Neoplasms/*genetics/*metabolism/pathology | 2 | 40.0 |
Tumor Stem Cell Assay | 12 | 6.0 |
Epidermal Growth Factor/*immunology/metabolism | 3 | 100.0 |
Receptor, Epidermal Growth Factor/*immunology/metabolism | 5 | 62.0 |
Cell Adhesion Molecules/physiology | 2 | 2.0 |
Protein Hybridization | 3 | 5.0 |
Cornea/*cytology/drug effects | 3 | 75.0 |
Fibroblasts/*cytology/drug effects | 8 | 66.0 |
Pigment Epithelium of Eye/*metabolism | 3 | 9.0 |
Antineoplastic Agents/*adverse effects | 2 | 3.0 |
Breast Neoplasms/*drug therapy | 5 | 7.0 |
Calcimycin/*pharmacology | 3 | 10.0 |
Cell Nucleus/enzymology | 2 | 2.0 |
Egtazic Acid/pharmacology | 8 | 7.0 |
Skin/drug effects | 6 | 28.0 |
Arachidonic Acid/*metabolism | 6 | 16.0 |
Mitosis/*physiology | 4 | 4.0 |
Dinoprostone/*biosynthesis | 14 | 32.0 |
Fibroblasts/drug effects/metabolism | 20 | 13.0 |
Quinones/pharmacology | 4 | 2.0 |
Carcinoma/drug therapy | 2 | 33.0 |
Caenorhabditis elegans/genetics | 4 | 5.0 |
Drosophila melanogaster/genetics | 3 | 3.0 |
*Evolution, Molecular | 2 | 0.0 |
*Phylogeny | 3 | 1.0 |
Wounds and Injuries/*metabolism | 3 | 37.0 |
Administration, Cutaneous | 2 | 2.0 |
Administration, Topical | 8 | 7.0 |
Receptor, erbB-2/drug effects/metabolism | 3 | 37.0 |
Adenoviridae | 3 | 3.0 |
Cathepsin D/metabolism | 2 | 5.0 |
Cell Polarity | 8 | 6.0 |
Golgi Apparatus/*metabolism | 2 | 2.0 |
Lysosomes/*metabolism | 6 | 7.0 |
Pichia | 2 | 16.0 |
*Autocrine Communication | 2 | 8.0 |
Gene Dosage | 2 | 0.0 |
Liver/cytology/drug effects/*metabolism | 4 | 20.0 |
Epithelial Cells/cytology/drug effects/enzymology | 2 | 28.0 |
Luciferases/biosynthesis | 3 | 3.0 |
Plastics | 3 | 9.0 |
Proteoglycans | 7 | 8.0 |
Recombinant Fusion Proteins/biosynthesis | 11 | 2.0 |
Blood Platelets/*metabolism | 7 | 2.0 |
Clathrin/*metabolism | 3 | 7.0 |
Cell Division/drug effects/radiation effects | 4 | 16.0 |
Rats, Inbred BUF | 2 | 9.0 |
Keratinocytes/*drug effects/enzymology | 3 | 75.0 |
Neoplasms, Hormone-Dependent/*pathology | 3 | 16.0 |
Mitogens/metabolism | 2 | 8.0 |
Trans-Activation (Genetics)/genetics | 2 | 2.0 |
Connexin 43/*metabolism | 3 | 37.0 |
Fluorescent Dyes/metabolism | 2 | 2.0 |
Liver/cytology | 3 | 4.0 |
Platelet-Derived Growth Factor/antagonists & inhibitors/*pharmacology | 2 | 100.0 |
Recombinant Fusion Proteins/pharmacology | 2 | 2.0 |
Dihydrotestosterone/metabolism | 5 | 9.0 |
Tumor Cells, Cultured/*drug effects | 8 | 18.0 |
Cysteine Endopeptidases/*metabolism | 5 | 2.0 |
Multienzyme Complexes/*metabolism | 4 | 2.0 |
Particle Size | 5 | 1.0 |
Helicobacter Infections/physiopathology | 2 | 40.0 |
Helicobacter pylori | 3 | 7.0 |
*Regeneration | 4 | 14.0 |
*Genes, Tumor Suppressor | 4 | 0.0 |
Neuronal Plasticity | 2 | 7.0 |
Rats/embryology/*genetics | 2 | 66.0 |
Interphase/drug effects | 4 | 14.0 |
RNA, Neoplasm/analysis | 15 | 5.0 |
Fatty Acids/*metabolism | 2 | 2.0 |
3T3 Cells/metabolism | 3 | 10.0 |
Recombinant Proteins/genetics/immunology/metabolism | 2 | 8.0 |
Laparotomy | 2 | 11.0 |
Cytosol/enzymology | 10 | 5.0 |
Protein-Tyrosine Kinase/genetics/metabolism | 3 | 4.0 |
Protein-Tyrosine-Phosphatase/genetics/*metabolism | 5 | 10.0 |
Granulosa Cells/drug effects/*metabolism | 7 | 30.0 |
Receptors, LH/metabolism | 2 | 16.0 |
Transforming Growth Factor alpha/*metabolism/pharmacology | 3 | 75.0 |
Somatomedins/metabolism | 5 | 17.0 |
Chromosome Banding | 4 | 0.0 |
Creatinine/blood | 6 | 1.0 |
Linear Models | 5 | 1.0 |
Neuroblastoma/*metabolism | 2 | 3.0 |
Mannitol/metabolism | 2 | 40.0 |
Transforming Growth Factor alpha/immunology | 4 | 80.0 |
Phenanthridines/pharmacology | 4 | 20.0 |
Ceramides/metabolism | 2 | 5.0 |
Chromatography, Thin Layer | 6 | 3.0 |
Oxidoreductases/metabolism | 3 | 4.0 |
Pertussis Toxin/pharmacology | 3 | 5.0 |
Phosphoric Monoester Hydrolases/*physiology | 2 | 6.0 |
RNA, Small Interfering/metabolism | 3 | 1.0 |
Colon/*pathology | 2 | 12.0 |
Glucose/*metabolism | 10 | 6.0 |
Glycolysis | 2 | 3.0 |
Luteinizing Hormone/pharmacology | 8 | 24.0 |
Phosphofructokinase-1/metabolism | 2 | 8.0 |
Antibodies/immunology | 12 | 3.0 |
Culture Media/chemistry | 5 | 13.0 |
Epidermal Growth Factor/*biosynthesis/immunology/physiology | 2 | 100.0 |
Colonic Neoplasms/*metabolism/pathology | 3 | 7.0 |
Glycoproteins/*biosynthesis | 8 | 16.0 |
Tumor Markers, Biological/biosynthesis | 2 | 5.0 |
Phosphoprotein Phosphatase/antagonists & inhibitors/metabolism | 2 | 22.0 |
Transfection/genetics | 4 | 2.0 |
Angiotensin II/*pharmacology | 3 | 2.0 |
Chimeric Proteins | 3 | 3.0 |
Cyclin-Dependent Kinases/antagonists & inhibitors | 3 | 3.0 |
G1 Phase | 7 | 2.0 |
Interphase | 6 | 3.0 |
Metaphase | 2 | 1.0 |
Interferons/pharmacology | 2 | 2.0 |
Trophoblasts/cytology/*physiology | 4 | 22.0 |
Glycoproteins/*physiology | 4 | 6.0 |
Genes, Immediate-Early | 4 | 7.0 |
Proto-Oncogene Proteins c-jun/genetics | 4 | 10.0 |
Hexosaminidases/metabolism | 2 | 13.0 |
Actins/*physiology | 2 | 5.0 |
Cytoskeleton/drug effects/*physiology | 2 | 22.0 |
DNA Replication | 18 | 4.0 |
Epidermal Growth Factor/administration & dosage/pharmacology | 3 | 75.0 |
Protein Kinases/*physiology | 3 | 5.0 |
Gels | 9 | 9.0 |
Mammary Neoplasms, Experimental/*pathology | 5 | 31.0 |
Collagenases/biosynthesis | 4 | 36.0 |
Endometrium/cytology/drug effects/*metabolism | 4 | 30.0 |
Protease Inhibitors/*metabolism | 2 | 11.0 |
Cyclin-Dependent Kinases/*antagonists & inhibitors | 2 | 1.0 |
Drug Delivery Systems | 4 | 4.0 |
Polyethylene Glycols/*chemistry | 2 | 15.0 |
Gene Transfer Techniques | 7 | 1.0 |
*Cytokines | 2 | 5.0 |
Skin/cytology/*enzymology | 2 | 28.0 |
Gene Expression Regulation, Developmental/*drug effects | 2 | 10.0 |
Homozygote | 4 | 0.0 |
Morphogenesis/drug effects | 4 | 17.0 |
Receptor, Epidermal Growth Factor/deficiency/genetics/*physiology | 2 | 50.0 |
Tetrachlorodibenzodioxin/*toxicity | 3 | 6.0 |
Colonic Neoplasms/*pathology | 13 | 16.0 |
Spermidine/metabolism | 3 | 37.0 |
Embryo/*cytology | 2 | 6.0 |
Gene Expression Regulation/physiology | 2 | 0.0 |
RNA, Messenger/biosynthesis/drug effects | 2 | 3.0 |
Intestinal Absorption/*drug effects | 2 | 12.0 |
Monosaccharide Transport Proteins/metabolism | 2 | 5.0 |
Rats, Inbred Lew | 2 | 0.0 |
Sodium/metabolism | 6 | 4.0 |
Actins/analysis | 4 | 2.0 |
Fluorescent Dyes/diagnostic use | 2 | 5.0 |
Rhodamines/diagnostic use | 2 | 28.0 |
Stress, Mechanical | 2 | 0.0 |
Carcinoma, Squamous Cell/*therapy | 2 | 22.0 |
Chloramphenicol O-Acetyltransferase/genetics/metabolism | 4 | 2.0 |
Thymidine Kinase/genetics | 5 | 6.0 |
Pancreatic Neoplasms/metabolism | 2 | 10.0 |
Stomach Ulcer/*physiopathology | 3 | 75.0 |
Gastrins/*pharmacology | 2 | 12.0 |
Bombesin/pharmacology | 4 | 26.0 |
Gastrins/pharmacology | 4 | 33.0 |
Hormones/*pharmacology | 14 | 30.0 |
Phospholipase D/metabolism | 3 | 11.0 |
Escherichia coli/*genetics | 2 | 2.0 |
Receptors, Cell Surface/drug effects | 5 | 27.0 |
Adenocarcinoma/*pathology | 9 | 11.0 |
Integrin alpha2beta1/*physiology | 2 | 100.0 |
Reactive Oxygen Species/*metabolism | 8 | 5.0 |
Cell Transformation, Neoplastic/pathology | 2 | 4.0 |
Precancerous Conditions/*pathology | 2 | 7.0 |
Endothelium, Vascular/metabolism | 4 | 1.0 |
*Down-Regulation/drug effects | 2 | 20.0 |
Endothelium, Vascular/*cytology/drug effects/metabolism | 3 | 15.0 |
Glycosaminoglycans/metabolism | 2 | 4.0 |
Growth Inhibitors/*physiology | 2 | 5.0 |
*Apoptosis/genetics | 2 | 5.0 |
Protein Kinase C/*antagonists & inhibitors | 2 | 6.0 |
Skin | 5 | 6.0 |
Up-Regulation/physiology | 2 | 1.0 |
Neoplasms, Hormone-Dependent/*metabolism | 3 | 23.0 |
Glial Fibrillary Acidic Protein/biosynthesis | 2 | 10.0 |
Carcinoma, Squamous Cell/drug therapy/metabolism | 2 | 22.0 |
Restriction Mapping | 22 | 1.0 |
Keratinocytes/*drug effects | 6 | 33.0 |
Thionucleotides/pharmacology | 4 | 6.0 |
Immunoglobulins, Fab/immunology | 3 | 2.0 |
Phospholipids/metabolism | 10 | 5.0 |
Choriocarcinoma/*metabolism | 2 | 22.0 |
Placenta/*metabolism | 19 | 12.0 |
Trophoblasts/*physiology | 4 | 22.0 |
Mitogen-Activated Protein Kinase Kinases | 4 | 10.0 |
Epithelial Cells/cytology | 2 | 2.0 |
Membranes/metabolism | 6 | 13.0 |
Cell Line/cytology | 2 | 50.0 |
*Neuregulin-1 | 7 | 26.0 |
Chromatography, Liquid | 4 | 3.0 |
Lung Neoplasms/metabolism/*radionuclide imaging | 2 | 66.0 |
Receptor, Epidermal Growth Factor/*biosynthesis/metabolism | 6 | 60.0 |
Subcellular Fractions | 4 | 2.0 |
Urinary Plasminogen Activator/*metabolism | 5 | 13.0 |
*Cell Survival | 3 | 8.0 |
Fibroblasts/cytology/enzymology/metabolism | 2 | 66.0 |
Anti-Bacterial Agents/*pharmacology | 2 | 1.0 |
Receptor, Insulin/drug effects/metabolism | 2 | 66.0 |
Antineoplastic Agents/therapeutic use | 2 | 0.0 |
Interleukin-6/*biosynthesis | 2 | 1.0 |
Cell Division/drug effects/*genetics | 2 | 22.0 |
Antibodies/*pharmacology | 2 | 6.0 |
Carcinoma, Squamous Cell/*radionuclide imaging | 3 | 60.0 |
Iodine Radioisotopes/*diagnostic use | 4 | 6.0 |
Bladder Neoplasms/*drug therapy | 3 | 30.0 |
Carcinoma, Squamous Cell/*drug therapy | 4 | 14.0 |
Liver/*metabolism | 10 | 2.0 |
Rats, Inbred Strains | 57 | 7.0 |
Carcinoma, Squamous Cell/*pathology/radiotherapy | 2 | 50.0 |
Dose-Response Relationship, Radiation | 12 | 3.0 |
Tumor Cells, Cultured/drug effects/radiation effects | 2 | 11.0 |
Adenocarcinoma/*metabolism/pathology | 8 | 6.0 |
Pancreas/metabolism | 6 | 6.0 |
Receptor, Platelet-Derived Growth Factor beta | 3 | 16.0 |
Cervix Neoplasms | 7 | 29.0 |
Colonic Neoplasms | 9 | 6.0 |
Receptor Protein-Tyrosine Kinases/*antagonists & inhibitors | 5 | 11.0 |
Recombinant Proteins/biosynthesis | 10 | 2.0 |
Vulvar Neoplasms | 4 | 57.0 |
Promegestone/pharmacology | 4 | 25.0 |
Adenocarcinoma/*genetics/pathology | 2 | 2.0 |
Epithelium/metabolism | 39 | 9.0 |
Proto-Oncogene Proteins/genetics/*metabolism | 7 | 1.0 |
Transcription Factors/genetics/*metabolism | 3 | 0.0 |
Carcinoma, Squamous Cell/*metabolism | 22 | 21.0 |
Laryngeal Neoplasms/*metabolism | 2 | 15.0 |
Sialoglycoproteins/*metabolism | 2 | 7.0 |
Granulosa Cells/*chemistry | 2 | 50.0 |
Hormones/metabolism | 2 | 6.0 |
Glioblastoma/metabolism/pathology | 2 | 20.0 |
Glioma/*metabolism/pathology | 4 | 14.0 |
Aging/physiology | 6 | 3.0 |
Mesoderm/metabolism | 2 | 2.0 |
Lipase/*metabolism | 2 | 3.0 |
Gene Expression Regulation, Neoplastic/genetics | 3 | 1.0 |
Recombinant Proteins/analysis | 4 | 8.0 |
Mice, Inbred CBA | 2 | 0.0 |
Stem Cells/metabolism | 2 | 2.0 |
Fibroblast Growth Factor 1 | 2 | 7.0 |
Lung/cytology | 3 | 5.0 |
Gap Junctions/*metabolism | 2 | 28.0 |
Phosphoserine/analysis | 4 | 22.0 |
Receptor, erbB-2 | 36 | 21.0 |
Receptors, Nerve Growth Factor/*metabolism | 3 | 6.0 |
*Sequence Homology, Amino Acid | 2 | 2.0 |
Gene Expression Regulation, Developmental/drug effects | 2 | 7.0 |
Palate/drug effects/*embryology/metabolism | 2 | 100.0 |
Transforming Growth Factors/genetics | 3 | 42.0 |
Dyes | 6 | 5.0 |
DNA, Neoplasm/analysis | 14 | 1.0 |
Tumor Cells, Cultured/drug effects/metabolism/pathology | 3 | 7.0 |
Tumor Markers, Biological/metabolism | 8 | 2.0 |
Gastroesophageal Reflux/*complications | 2 | 40.0 |
Mucous Membrane/physiology | 2 | 25.0 |
Phorbol 12,13-Dibutyrate/*pharmacology | 3 | 17.0 |
Bronchi/*physiology | 2 | 25.0 |
Extracellular Matrix/*physiology | 4 | 9.0 |
Mucins/secretion | 2 | 50.0 |
Receptor, Epidermal Growth Factor/metabolism/physiology | 5 | 50.0 |
Urinary Plasminogen Activator/*biosynthesis/genetics | 3 | 37.0 |
Antineoplastic Agents/metabolism | 2 | 11.0 |
Epidermal Growth Factor/genetics/*pharmacology | 4 | 80.0 |
Heparin/genetics | 2 | 100.0 |
Fibroblasts/*cytology | 9 | 31.0 |
Glycoproteins/chemistry/*metabolism | 4 | 33.0 |
Keratinocytes/*enzymology/*pathology | 2 | 100.0 |
Granulosa Cells/*drug effects/metabolism | 2 | 28.0 |
Immunoradiometric Assay | 2 | 1.0 |
Follicular Fluid/*metabolism | 5 | 19.0 |
Granulosa Cells/metabolism | 3 | 8.0 |
Ovarian Follicle/physiology | 2 | 25.0 |
Theca Cells/metabolism | 2 | 40.0 |
Anti-Inflammatory Agents, Non-Steroidal/*adverse effects | 2 | 18.0 |
Gastroscopy | 5 | 11.0 |
Histamine H2 Antagonists/pharmacology | 4 | 33.0 |
Ranitidine/pharmacology | 2 | 40.0 |
Saliva/drug effects/*metabolism | 2 | 100.0 |
*Oncogenes | 23 | 5.0 |
Proto-Oncogenes | 18 | 10.0 |
Synapses/physiology | 2 | 5.0 |
Cholera Toxin/pharmacology | 16 | 21.0 |
Biopolymers | 3 | 2.0 |
DNA, Complementary/chemistry | 3 | 1.0 |
Arginine/*metabolism | 3 | 6.0 |
Ileum/*surgery | 2 | 18.0 |
Jejunum/*surgery | 2 | 20.0 |
Sodium/*pharmacology | 3 | 18.0 |
Tritium | 19 | 8.0 |
Losartan/pharmacology | 2 | 6.0 |
Receptors, Platelet-Derived Growth Factor/genetics | 2 | 13.0 |
Blood Coagulation Factors/*chemistry | 2 | 40.0 |
*Conserved Sequence | 2 | 1.0 |
Animals, Newborn/*metabolism | 2 | 15.0 |
Intestinal Absorption | 4 | 2.0 |
Receptors, Cytokine/genetics/*metabolism | 2 | 6.0 |
Muscle Contraction/*drug effects | 2 | 8.0 |
Muscle, Smooth, Vascular/*drug effects | 2 | 10.0 |
T-Lymphocytes/immunology | 4 | 0.0 |
*Organ Culture Techniques | 2 | 100.0 |
Receptors, Cell Surface/genetics | 4 | 3.0 |
Cell Adhesion Molecules/analysis | 3 | 1.0 |
Keratinocytes | 5 | 14.0 |
Oncogene Proteins, Viral/genetics | 4 | 11.0 |
Stromal Cells/*cytology/drug effects | 2 | 66.0 |
Trichloroacetic Acid | 2 | 50.0 |
Oligonucleotides, Antisense/metabolism | 2 | 6.0 |
Monensin/pharmacology | 5 | 9.0 |
Gene Expression/genetics | 6 | 2.0 |
Membrane Proteins/genetics | 4 | 1.0 |
Apoptosis/genetics | 3 | 1.0 |
Hydroquinones/pharmacology | 4 | 12.0 |
Receptors, Bombesin | 2 | 25.0 |
Activins | 8 | 10.0 |
Inhibins/pharmacology | 3 | 16.0 |
Lung | 5 | 5.0 |
Lung Neoplasms/metabolism | 5 | 14.0 |
RNA, Messenger/*biosynthesis | 10 | 4.0 |
Epithelial Cells/*cytology | 2 | 8.0 |
Mitotic Index | 7 | 4.0 |
Blood Proteins/pharmacology | 4 | 9.0 |
Butyric Acid | 4 | 8.0 |
Butyric Acids/*pharmacology | 3 | 13.0 |
Receptor, Epidermal Growth Factor/analysis/physiology | 2 | 50.0 |
Papillomavirus, Human/*physiology | 3 | 15.0 |
Peptides, Cyclic/pharmacology | 2 | 5.0 |
Receptor, Endothelin A | 2 | 7.0 |
*RNA, Antisense | 2 | 22.0 |
Receptor, Epidermal Growth Factor/biosynthesis/*genetics | 6 | 24.0 |
Endothelial Growth Factors/genetics/*metabolism | 2 | 2.0 |
Lymphokines/genetics/*metabolism | 2 | 2.0 |
RNA/biosynthesis | 6 | 6.0 |
Injections, Intraperitoneal | 2 | 1.0 |
Androgens/*metabolism | 2 | 3.0 |
Chromosomes, Human, Pair 4 | 3 | 2.0 |
Glucuronosyltransferase/genetics/*metabolism | 2 | 5.0 |
Receptors, Growth Factor/genetics/*metabolism | 2 | 6.0 |
Mesoderm/*physiology | 3 | 12.0 |
Chick Embryo | 11 | 2.0 |
Genome, Human | 2 | 0.0 |
Crystallography, X-Ray | 10 | 1.0 |
*Protein Structure, Tertiary | 11 | 9.0 |
Interferon Type II/metabolism/pharmacology | 2 | 14.0 |
rac GTP-Binding Proteins | 2 | 1.0 |
Homeostasis | 8 | 2.0 |
Recombinant Proteins/administration & dosage/pharmacology | 4 | 6.0 |
Fertilization in Vitro/*methods | 2 | 7.0 |
Gonadotropins/*pharmacology | 4 | 23.0 |
Cell Communication/*physiology | 3 | 4.0 |
Interleukin-6/physiology | 2 | 3.0 |
*DNA, Antisense | 2 | 20.0 |
Ovarian Neoplasms | 5 | 13.0 |
Bladder Neoplasms/*enzymology/urine | 2 | 100.0 |
Keratinocytes/*metabolism | 10 | 10.0 |
Fatal Outcome | 3 | 0.0 |
Introns/genetics | 2 | 0.0 |
RNA Splicing | 2 | 0.0 |
Colorectal Neoplasms/*metabolism | 6 | 14.0 |
Breast/cytology/metabolism | 2 | 9.0 |
Mammary Glands, Animal/cytology/metabolism | 2 | 33.0 |
Bladder Neoplasms | 2 | 10.0 |
Epidermal Growth Factor/*biosynthesis/pharmacology | 2 | 100.0 |
Glycoproteins/*biosynthesis/pharmacology | 2 | 100.0 |
Growth Substances/*biosynthesis/pharmacology | 3 | 60.0 |
alpha 1-Antitrypsin/biosynthesis | 2 | 25.0 |
Culture Media/pharmacology | 9 | 10.0 |
Hepatocyte Growth Factor/*physiology | 2 | 3.0 |
Blood Platelets/*physiology | 3 | 1.0 |
Endothelium, Vascular/*physiology | 2 | 1.0 |
Epidermal Growth Factor/analysis/*secretion | 5 | 100.0 |
Cell Size | 4 | 1.0 |
Protein p16/genetics/metabolism | 2 | 7.0 |
*Flow Cytometry | 2 | 1.0 |
Transforming Growth Factor alpha/metabolism/pharmacology | 3 | 50.0 |
Lung Neoplasms/*metabolism/pathology | 3 | 4.0 |
Breast Neoplasms/pathology | 9 | 8.0 |
Endothelium, Vascular/drug effects | 3 | 5.0 |
*Signal Transduction/drug effects | 6 | 6.0 |
Cell Transformation, Viral | 16 | 5.0 |
Immunohistochemistry/methods | 17 | 2.0 |
*Gene Expression Profiling | 4 | 0.0 |
Organ Size | 3 | 1.0 |
Keratin/genetics | 2 | 4.0 |
Papillomavirus, Human/*genetics | 2 | 2.0 |
Neoplasm Proteins/genetics | 2 | 0.0 |
Neutralization Tests | 3 | 0.0 |
Receptor, erbB-2/*genetics | 3 | 8.0 |
Collagenases/genetics/*metabolism | 2 | 33.0 |
Keratin/biosynthesis | 5 | 19.0 |
Metalloendopeptidases/biosynthesis | 3 | 15.0 |
DNA/*biosynthesis | 28 | 28.0 |
Intestine, Small/cytology/*metabolism | 3 | 42.0 |
Peptides/metabolism/*pharmacology | 6 | 25.0 |
Diabetic Nephropathies/urine | 2 | 66.0 |
Glomerular Filtration Rate | 6 | 5.0 |
Paracrine Communication | 3 | 7.0 |
Genes, myc | 11 | 4.0 |
Proto-Oncogene Proteins c-fos/*biosynthesis | 2 | 14.0 |
Proto-Oncogene Proteins c-myc/*biosynthesis | 2 | 11.0 |
Pancreas/pathology | 2 | 5.0 |
Carcinoma/*metabolism/pathology | 5 | 8.0 |
Endometrial Neoplasms/*metabolism/pathology | 3 | 9.0 |
Epithelium, Corneal/cytology/*drug effects | 2 | 100.0 |
Urinary Plasminogen Activator/*genetics | 2 | 11.0 |
Epithelium/chemistry/pathology | 3 | 8.0 |
Receptor, Epidermal Growth Factor/*analysis/immunology | 8 | 53.0 |
Immunotherapy | 6 | 1.0 |
Interleukin-1/analysis | 5 | 5.0 |
Chimeric Proteins/*metabolism | 4 | 33.0 |
Receptors, Cell Surface/*genetics | 20 | 6.0 |
Pancreatic Neoplasms/pathology | 2 | 11.0 |
Plant Proteins/*pharmacology | 2 | 10.0 |
Protein C/*metabolism | 6 | 3.0 |
Thrombin/chemistry/metabolism | 2 | 40.0 |
Hypoglycemic Agents/pharmacology | 2 | 6.0 |
Thiazoles/pharmacology | 3 | 2.0 |
*Thiazolidinediones | 2 | 2.0 |
Thymidine/*metabolism | 4 | 22.0 |
Carcinoma, Squamous Cell/metabolism | 21 | 35.0 |
Cell Membrane/drug effects/metabolism/ultrastructure | 2 | 25.0 |
Flow Cytometry/methods | 2 | 0.0 |
Epidermal Growth Factor/*analysis/physiology | 3 | 100.0 |
Dextrans/metabolism | 2 | 9.0 |
Cross Reactions | 18 | 2.0 |
Hybridomas/immunology | 2 | 1.0 |
Phosphoproteins/*immunology | 2 | 16.0 |
Leiomyoma/*chemistry | 4 | 66.0 |
Proliferating Cell Nuclear Antigen/*analysis | 3 | 1.0 |
Uterine Neoplasms/*chemistry | 4 | 40.0 |
Hypothyroidism/blood | 2 | 15.0 |
Platelet Count | 5 | 1.0 |
Thyroid Diseases/*blood | 2 | 22.0 |
Thyroxine/blood | 5 | 1.0 |
Alanine | 4 | 4.0 |
Reactive Oxygen Species/metabolism | 4 | 1.0 |
Transcription, Genetic/genetics | 4 | 1.0 |
Antimetabolites/*pharmacology | 2 | 14.0 |
*Protein Biosynthesis | 11 | 2.0 |
Protein Synthesis Inhibitors/*pharmacology | 2 | 6.0 |
Cadherins/immunology | 2 | 15.0 |
Extracellular Matrix/chemistry | 2 | 11.0 |
Guanine Nucleotide Exchange Factors | 8 | 8.0 |
Proto-Oncogene Proteins c-abl/metabolism | 2 | 10.0 |
src Homology Domains/*genetics | 2 | 6.0 |
Arachidonic Acids/metabolism | 3 | 7.0 |
Cyclooxygenase Inhibitors/*pharmacology | 2 | 5.0 |
Prostaglandin-Endoperoxide Synthase/metabolism | 3 | 4.0 |
Chimera | 7 | 3.0 |
Calcium/*physiology | 4 | 3.0 |
Enzyme Activation/radiation effects | 2 | 8.0 |
Down-Regulation/physiology | 4 | 4.0 |
Estrogens/pharmacology | 9 | 10.0 |
Receptor, Epidermal Growth Factor/antagonists & inhibitors/immunology | 3 | 50.0 |
*Temperature | 2 | 6.0 |
Isomerism | 6 | 2.0 |
Receptors, Estrogen/chemistry/*drug effects/metabolism | 2 | 100.0 |
Breast Neoplasms/drug therapy/*metabolism | 2 | 9.0 |
Calcitonin/*pharmacology | 2 | 11.0 |
Androgens/*physiology | 3 | 6.0 |
Prostate/enzymology | 2 | 3.0 |
Embryo Transfer | 5 | 6.0 |
Ovulation Induction | 2 | 5.0 |
Tacrolimus Binding Proteins | 2 | 6.0 |
Variation (Genetics) | 5 | 0.0 |
Mouth Mucosa/*cytology | 3 | 23.0 |
Transforming Growth Factor beta/*physiology | 6 | 4.0 |
Breast/metabolism/*pathology | 2 | 20.0 |
Epithelium | 4 | 6.0 |
Glutamine/*metabolism | 3 | 37.0 |
Sodium/pharmacology | 2 | 10.0 |
Cell Membrane/metabolism/ultrastructure | 6 | 10.0 |
Ferritin/*metabolism | 2 | 7.0 |
Perfusion | 5 | 2.0 |
Electrophoretic Mobility Shift Assay | 3 | 0.0 |
Intestines/cytology | 2 | 28.0 |
Adaptor Proteins, Signal Transducing/metabolism | 2 | 14.0 |
Extracellular Signal-Regulated MAP Kinases/metabolism | 2 | 11.0 |
Liver/*drug effects/metabolism | 4 | 8.0 |
Peptides/genetics | 4 | 4.0 |
Carcinoma, Non-Small-Cell Lung/*pathology | 2 | 8.0 |
*Cell Cycle | 3 | 1.0 |
Proto-Oncogene Protein pp60(c-src)/*physiology | 4 | 66.0 |
Bone Neoplasms/*metabolism/pathology | 2 | 11.0 |
Breast | 4 | 12.0 |
Cadherins/*metabolism | 2 | 2.0 |
Cell Aggregation/drug effects | 3 | 6.0 |
Colony-Forming Units Assay | 13 | 2.0 |
Epidermal Growth Factor/chemistry/metabolism/*pharmacology | 2 | 100.0 |
Thyroidectomy | 2 | 1.0 |
Thyrotropin/blood | 3 | 0.0 |
Densitometry | 2 | 1.0 |
Lung/*embryology | 2 | 11.0 |
Platelet-Derived Growth Factor/*physiology | 9 | 39.0 |
*Tyrphostins | 25 | 48.0 |
Procollagen/genetics | 2 | 8.0 |
*Tumor Cells, Cultured | 4 | 5.0 |
Trophoblasts/*metabolism | 6 | 12.0 |
Gene Expression Regulation/*genetics | 2 | 1.0 |
Dinoprost/*biosynthesis | 2 | 33.0 |
Chorionic Gonadotropin/*pharmacology | 7 | 12.0 |
Granulosa Cells/physiology | 4 | 50.0 |
Oocytes/*cytology/metabolism | 2 | 50.0 |
Prophase | 2 | 14.0 |
*Flavonoids | 2 | 8.0 |
Molecular Structure | 16 | 2.0 |
Phenols/pharmacology | 3 | 11.0 |
Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology | 2 | 9.0 |
Cell Membrane/chemistry | 6 | 4.0 |
Cytoplasm/chemistry | 3 | 1.0 |
Follicle Stimulating Hormone/*pharmacology | 5 | 17.0 |
Granulosa Cells/chemistry | 2 | 10.0 |
Muscle, Smooth/*metabolism | 3 | 12.0 |
Androgens/metabolism | 4 | 6.0 |
RNA, Neoplasm/genetics/metabolism | 3 | 2.0 |
Drug Design | 2 | 0.0 |
Growth Substances/chemistry/metabolism | 2 | 66.0 |
Uridine/metabolism | 2 | 20.0 |
Drug Implants | 2 | 5.0 |
Models, Theoretical | 2 | 1.0 |
Arachidonic Acids/*metabolism | 2 | 6.0 |
Phospholipases A/*metabolism | 4 | 8.0 |
Isotretinoin/pharmacology | 3 | 50.0 |
Lipids/biosynthesis | 3 | 15.0 |
Phenolsulfonphthalein/pharmacology | 2 | 100.0 |
Terpenes/pharmacology | 2 | 7.0 |
Gastrins/*metabolism | 3 | 18.0 |
Anti-Bacterial Agents/therapeutic use | 2 | 1.0 |
Second Messenger Systems/physiology | 2 | 5.0 |
*Cloning, Molecular | 5 | 1.0 |
Sperm-Ovum Interactions | 2 | 7.0 |
Proto-Oncogene Proteins/chemistry/*metabolism | 2 | 3.0 |
Receptor, erbB-2/chemistry/*metabolism | 3 | 33.0 |
Choriocarcinoma | 4 | 10.0 |
Fibronectins/*biosynthesis | 4 | 36.0 |
Laminin/*biosynthesis | 3 | 42.0 |
Receptor, Epidermal Growth Factor/genetics/*metabolism/physiology | 3 | 100.0 |
src Homology Domains/genetics/*physiology | 2 | 15.0 |
Chi-Square Distribution | 2 | 0.0 |
Chorion/metabolism | 4 | 25.0 |
Pregnancy, Animal/*metabolism | 2 | 13.0 |
Dietary Proteins/pharmacology | 2 | 20.0 |
Stomach/*metabolism | 3 | 16.0 |
Insulin-Like Growth Factor II/pharmacology | 9 | 36.0 |
Insulinoma | 2 | 11.0 |
Pancreatic Neoplasms | 5 | 12.0 |
Prolactin/pharmacology | 8 | 21.0 |
Leukocytes/enzymology | 2 | 1.0 |
Myocardium/enzymology | 2 | 2.0 |
Receptors, Interferon/metabolism | 2 | 5.0 |
Serine/*metabolism | 4 | 4.0 |
Antibodies/immunology/pharmacology | 2 | 6.0 |
Clone Cells/cytology | 8 | 40.0 |
DNA Replication/physiology | 3 | 9.0 |
Oligopeptides | 2 | 6.0 |
Receptor, IGF Type 1/metabolism | 4 | 12.0 |
Antibodies, Neoplasm/metabolism/*therapeutic use | 2 | 100.0 |
Doxorubicin/therapeutic use | 2 | 3.0 |
Lymphocytes/immunology | 2 | 0.0 |
Confidence Intervals | 2 | 0.0 |
Odds Ratio | 2 | 0.0 |
Antibiotics, Antineoplastic/pharmacology | 2 | 2.0 |
*Avian Proteins | 2 | 2.0 |
Receptor, erbB-2/genetics | 2 | 10.0 |
Receptors, Estrogen/chemistry/genetics/*metabolism | 2 | 33.0 |
Calcium/metabolism/*pharmacology | 2 | 25.0 |
Dithiothreitol/pharmacology | 3 | 3.0 |
Lipoproteins, LDL/metabolism | 3 | 1.0 |
Trypsin/metabolism | 8 | 5.0 |
Amnion/cytology/drug effects/*metabolism | 4 | 80.0 |
Gene Expression Regulation, Developmental/*genetics | 2 | 2.0 |
Factor Xa/metabolism | 4 | 7.0 |
*Gene Targeting | 2 | 6.0 |
Neoplasms/metabolism | 4 | 4.0 |
Recombinant Fusion Proteins | 8 | 2.0 |
Gene Expression Regulation, Neoplastic/*physiology | 4 | 2.0 |
Blood Physiology | 5 | 7.0 |
Calcitriol/*analogs & derivatives/pharmacology | 2 | 10.0 |
Receptors, Growth Factor/physiology | 2 | 4.0 |
Dyes/diagnostic use | 4 | 5.0 |
Thyrotropin/metabolism | 4 | 7.0 |
Chemotaxis/*drug effects | 6 | 12.0 |
Ionophores/pharmacology | 2 | 1.0 |
Keratinocytes/cytology/*metabolism | 4 | 11.0 |
Asbestos/*pharmacology | 2 | 66.0 |
Lung Neoplasms/metabolism/pathology | 3 | 16.0 |
Cytokines/*blood | 2 | 0.0 |
Growth Substances/blood | 2 | 15.0 |
Alkaline Phosphatase/biosynthesis | 2 | 13.0 |
Extracellular Matrix Proteins/*physiology | 3 | 14.0 |
Fungal Proteins/*metabolism | 2 | 2.0 |
Neoplasm Metastasis/pathology | 2 | 9.0 |
Osteogenesis | 2 | 8.0 |
Keratinocytes/*drug effects/physiology | 4 | 50.0 |
Gene Targeting/*methods | 2 | 9.0 |
Gene Therapy/*methods | 7 | 1.0 |
Glutathione Transferase/biosynthesis | 2 | 6.0 |
*Phosphoproteins | 3 | 2.0 |
Furin | 2 | 4.0 |
Keratinocytes/pathology | 4 | 16.0 |
Mucous Membrane/pathology | 3 | 8.0 |
Serine/chemistry | 5 | 3.0 |
*Lectins | 2 | 1.0 |
Mannose-Binding Lectin/*metabolism | 2 | 66.0 |
Bombesin/*pharmacology | 6 | 33.0 |
Gastrin-Releasing Peptide/pharmacology | 2 | 33.0 |
Plasmin/metabolism | 3 | 3.0 |
Cyclin D1/*antagonists & inhibitors/genetics | 2 | 100.0 |
Factor VII Deficiency/*genetics | 2 | 20.0 |
Thromboplastin/metabolism | 4 | 5.0 |
Inositol Phosphates/*metabolism | 7 | 21.0 |
Proto-Oncogene Proteins c-jun/*genetics | 3 | 13.0 |
Protein Kinase Inhibitors | 8 | 6.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase | 8 | 21.0 |
*Photochemotherapy | 2 | 4.0 |
Peptide Fragments/chemistry/metabolism | 3 | 2.0 |
Insulin-Like Growth Factor I/physiology | 6 | 19.0 |
Ileum | 2 | 33.0 |
Jejunum | 2 | 18.0 |
Antibodies/isolation & purification | 2 | 11.0 |
Skin/*metabolism | 12 | 11.0 |
Skin Neoplasms/*metabolism | 2 | 5.0 |
Nitric Oxide/*pharmacology | 2 | 4.0 |
Transcription Factor AP-1/*metabolism | 3 | 1.0 |
Endothelium, Vascular/chemistry | 5 | 8.0 |
Steroids/pharmacology | 4 | 10.0 |
RNA, Antisense | 5 | 9.0 |
Polycystic Kidney, Autosomal Dominant/*pathology | 2 | 66.0 |
Psoriasis/*metabolism | 5 | 20.0 |
Cell Membrane/drug effects | 5 | 12.0 |
Horseradish Peroxidase/metabolism | 2 | 11.0 |
Lipoproteins/pharmacology | 2 | 9.0 |
Rhodamines/metabolism | 3 | 14.0 |
Cell-Free System | 4 | 1.0 |
Cholecystokinin/*pharmacology | 3 | 12.0 |
Glutathione Transferase | 2 | 4.0 |
Androgen Antagonists/*therapeutic use | 2 | 5.0 |
Epidermal Growth Factor/analysis/*metabolism | 10 | 90.0 |
Testosterone/metabolism | 6 | 4.0 |
Breast Neoplasms/*genetics | 9 | 1.0 |
Epidermal Growth Factor/administration & dosage/*pharmacology | 16 | 94.0 |
Infusion Pumps, Implantable | 2 | 11.0 |
Epidermal Growth Factor/*diagnostic use | 4 | 100.0 |
Epidermal Growth Factor/analysis/*physiology | 2 | 100.0 |
Kidney/*metabolism | 11 | 6.0 |
Chlorates/pharmacology | 2 | 12.0 |
Polysaccharide-Lyases/pharmacology | 2 | 12.0 |
Gastric Juice/chemistry | 2 | 33.0 |
Carcinoma, Hepatocellular/*pathology | 2 | 4.0 |
Liver Neoplasms/*pathology | 4 | 7.0 |
Vimentin/metabolism | 2 | 1.0 |
Insulin-Like Growth Factor I/*physiology | 8 | 23.0 |
Antineoplastic Agents, Hormonal/pharmacology | 3 | 6.0 |
Prostatic Neoplasms/*pathology | 15 | 12.0 |
Cell Division/drug effects/genetics | 2 | 2.0 |
Mitogen-Activated Protein Kinase 3/*metabolism | 2 | 14.0 |
Peptides/genetics/*metabolism | 2 | 6.0 |
Mitosis/physiology | 2 | 2.0 |
Antibiotics, Antineoplastic/*therapeutic use | 2 | 8.0 |
Doxorubicin/*analogs & derivatives/*therapeutic use | 2 | 66.0 |
Gonadorelin/*analogs & derivatives/*therapeutic use | 2 | 66.0 |
Mitotic Index/drug effects | 3 | 23.0 |
Ovarian Neoplasms/*drug therapy/metabolism | 2 | 15.0 |
*Tyrosine | 12 | 24.0 |
Genetic Screening | 2 | 0.0 |
DNA, Neoplasm/*biosynthesis | 3 | 30.0 |
Myelin Basic Proteins/metabolism | 6 | 10.0 |
Pyridines/pharmacology | 4 | 1.0 |
Transcription, Genetic/drug effects/genetics | 2 | 8.0 |
Receptor, Epidermal Growth Factor/*analysis/metabolism | 7 | 46.0 |
Anti-Ulcer Agents/*therapeutic use | 2 | 16.0 |
Prostaglandins F, Synthetic/*therapeutic use | 2 | 66.0 |
*Genes, Structural | 19 | 2.0 |
Promoter Regions (Genetics)/drug effects/genetics/physiology | 2 | 25.0 |
RNA, Messenger/drug effects/genetics/metabolism | 2 | 2.0 |
Inositol/metabolism | 5 | 20.0 |
Peptide Fragments | 2 | 2.0 |
Pyrimidines/*pharmacology | 4 | 6.0 |
Antigens, Polyomavirus Transforming/*genetics | 2 | 7.0 |
Antineoplastic Agents/metabolism/*pharmacology | 3 | 11.0 |
Tea/chemistry | 2 | 14.0 |
Receptor, Insulin/*metabolism | 16 | 28.0 |
Son of Sevenless Proteins | 9 | 16.0 |
Receptors, Cell Surface/*drug effects/metabolism | 10 | 58.0 |
Tumor Cells, Cultured/drug effects/enzymology | 2 | 6.0 |
Alanine/metabolism | 4 | 11.0 |
Glutamine/metabolism | 2 | 8.0 |
Proteins/chemistry/*metabolism | 6 | 6.0 |
Diglycerides/analysis | 2 | 50.0 |
Cyclins/*physiology | 2 | 3.0 |
Mifepristone/pharmacology | 5 | 6.0 |
Progesterone/antagonists & inhibitors/*pharmacology | 2 | 100.0 |
Lung/metabolism | 6 | 3.0 |
Spleen/metabolism | 4 | 3.0 |
GTPase-Activating Proteins | 13 | 8.0 |
Glioblastoma/metabolism | 2 | 8.0 |
Immunochemistry | 6 | 2.0 |
Diphtheria Toxin/*metabolism | 3 | 75.0 |
9,10-Dimethyl-1,2-benzanthracene | 2 | 13.0 |
Carcinogens | 3 | 3.0 |
Oncogene Proteins/biosynthesis | 2 | 20.0 |
Skin/drug effects/*metabolism | 3 | 25.0 |
Tetradecanoylphorbol Acetate | 3 | 4.0 |
Gastrins/blood | 3 | 4.0 |
Antineoplastic Agents/*toxicity | 2 | 3.0 |
Kidney Neoplasms | 2 | 11.0 |
Factor VIIa/metabolism | 4 | 8.0 |
Fluorouracil/*pharmacology | 2 | 5.0 |
Sjogren's Syndrome/*metabolism | 2 | 22.0 |
Cell Cycle/drug effects/physiology | 5 | 9.0 |
Leupeptins/pharmacology | 5 | 3.0 |
1-Phosphatidylinositol 3-Kinase | 11 | 7.0 |
Androstenedione/metabolism | 5 | 17.0 |
Fibronectins/analysis | 3 | 5.0 |
Granulocyte-Macrophage Colony-Stimulating Factor/analysis | 2 | 8.0 |
Insulin-Like Growth Factor I/analysis | 8 | 6.0 |
Insulin-Like Growth Factor II/analysis | 2 | 22.0 |
Interferon Type II/analysis | 2 | 2.0 |
Interleukins/analysis | 3 | 9.0 |
Nerve Growth Factors/analysis | 2 | 16.0 |
Peptides/analysis | 4 | 5.0 |
Periodontal Ligament/cytology/*drug effects/metabolism | 2 | 50.0 |
Tumor Necrosis Factor-alpha/analysis | 4 | 0.0 |
Neutrophils/*cytology | 2 | 10.0 |
Ultracentrifugation | 3 | 1.0 |
Peptide Fragments/chemistry/genetics/metabolism | 3 | 4.0 |
Extracellular Matrix | 2 | 8.0 |
Nerve Growth Factors/*pharmacology | 5 | 4.0 |
Receptors, Tumor Necrosis Factor | 2 | 0.0 |
Brain/*physiology | 2 | 1.0 |
Image Interpretation, Computer-Assisted | 2 | 20.0 |
Antioxidants/metabolism | 3 | 3.0 |
Calcium/chemistry/metabolism | 2 | 16.0 |
Arachidonic Acid/metabolism | 10 | 10.0 |
Cyclic GMP/metabolism | 4 | 4.0 |
Dinoprostone/metabolism | 5 | 6.0 |
*Neovascularization, Pathologic | 8 | 2.0 |
Nitric Oxide/*metabolism | 2 | 1.0 |
Nitrites/metabolism | 3 | 7.0 |
Vascular Endothelial Growth Factor A/metabolism | 4 | 3.0 |
Actins/biosynthesis | 4 | 9.0 |
Dimethyl Sulfoxide/*pharmacology | 3 | 12.0 |
Freeze Fracturing | 2 | 8.0 |
Mitosis/drug effects | 20 | 19.0 |
Electrophysiology | 2 | 0.0 |
Bladder Neoplasms/*pathology | 2 | 9.0 |
Endothelium, Corneal/*cytology/drug effects | 2 | 100.0 |
Somatomedins/*pharmacology | 15 | 53.0 |
Video Recording | 3 | 11.0 |
Inositol 1,4,5-Trisphosphate/metabolism | 6 | 11.0 |
Proto-Oncogene Proteins c-raf | 12 | 11.0 |
Radiation, Ionizing | 2 | 1.0 |
Binding Sites/drug effects | 4 | 6.0 |
Substrate Specificity/drug effects | 2 | 15.0 |
Lung Neoplasms/*metabolism | 8 | 10.0 |
Aminoquinolines | 3 | 42.0 |
Calcium-Binding Proteins/genetics/*metabolism | 2 | 8.0 |
Carrier Proteins/*genetics/metabolism | 3 | 1.0 |
Feasibility Studies | 2 | 0.0 |
Antineoplastic Agents, Hormonal/*therapeutic use | 2 | 2.0 |
Insulin-Like Growth Factor I/*analysis | 5 | 9.0 |
Cornea/cytology/*metabolism | 2 | 16.0 |
Interleukin-6/pharmacology | 9 | 3.0 |
ras Guanine Nucleotide Exchange Factors | 6 | 11.0 |
Kidney/cytology/metabolism | 4 | 4.0 |
Metalloendopeptidases/*antagonists & inhibitors | 2 | 7.0 |
Genistein | 21 | 28.0 |
Isoflavones/pharmacology | 16 | 24.0 |
Iodoacetamide/pharmacology | 2 | 12.0 |
Epithelium/drug effects | 22 | 53.0 |
Genes, ras/*physiology | 2 | 7.0 |
Transforming Growth Factor alpha/analysis/immunology | 2 | 66.0 |
Oncogene Proteins/physiology | 2 | 18.0 |
Thymidine/analysis/metabolism | 3 | 75.0 |
Fluoresceins | 5 | 7.0 |
Microscopy, Fluorescence/methods | 2 | 6.0 |
Oligonucleotides, Antisense/*pharmacology | 3 | 3.0 |
G0 Phase | 3 | 4.0 |
*Mitosis | 5 | 4.0 |
Receptors, Interleukin/metabolism | 2 | 3.0 |
Receptors, Interleukin-4 | 2 | 2.0 |
Breast Neoplasms/*chemistry/pathology | 7 | 11.0 |
Carcinoma/*chemistry/pathology | 4 | 25.0 |
Cell Adhesion/*physiology | 2 | 1.0 |
Oligopeptides/*metabolism | 2 | 6.0 |
Cholera Toxin/*pharmacology | 6 | 37.0 |
Na(+)-K(+)-Exchanging ATPase/metabolism | 4 | 9.0 |
Sodium/*metabolism | 4 | 6.0 |
Eye Proteins/analysis | 2 | 25.0 |
Tears/*chemistry | 3 | 16.0 |
Carcinoma, Hepatocellular/*metabolism | 4 | 3.0 |
Liver Neoplasms/*metabolism | 5 | 5.0 |
Proto-Oncogene Protein c-met | 8 | 6.0 |
Receptor Protein-Tyrosine Kinases/*genetics/metabolism | 2 | 3.0 |
Enzyme Stability | 3 | 1.0 |
Fibroblast Growth Factor 1/biosynthesis | 2 | 66.0 |
Fibroblast Growth Factor 2/biosynthesis | 2 | 7.0 |
Insulin-Like Growth Factor I/biosynthesis | 4 | 36.0 |
Interleukin-1/biosynthesis | 4 | 2.0 |
Interleukin-6/biosynthesis | 2 | 0.0 |
Platelet-Derived Growth Factor/biosynthesis | 3 | 30.0 |
Transforming Growth Factor beta/biosynthesis | 5 | 10.0 |
Exotoxins/pharmacology | 2 | 20.0 |
Lysine/*analogs & derivatives/biosynthesis | 2 | 100.0 |
Epidermal Growth Factor/biosynthesis/*pharmacology | 4 | 100.0 |
Inositol Phosphates/analysis | 2 | 50.0 |
Receptor Protein-Tyrosine Kinases/biosynthesis | 3 | 9.0 |
Thymidine Kinase/*metabolism | 2 | 13.0 |
Prostatic Hyperplasia/*pathology | 4 | 20.0 |
Peptides/*physiology | 4 | 9.0 |
Arteries/metabolism | 2 | 12.0 |
In Situ Hybridization/methods | 3 | 2.0 |
*Bone Marrow Cells | 7 | 2.0 |
Gastric Mucosa/*metabolism | 4 | 13.0 |
Stomach Ulcer/*metabolism/physiopathology | 2 | 100.0 |
Protein-Tyrosine Kinase/*drug effects | 2 | 50.0 |
Pyridines/*pharmacology | 3 | 4.0 |
*Menstrual Cycle | 7 | 11.0 |
1-Methyl-3-isobutylxanthine/pharmacology | 8 | 8.0 |
Point Mutation/genetics | 3 | 1.0 |
Receptors, Estrogen/drug effects/*genetics | 2 | 50.0 |
*Proto-Oncogenes | 31 | 4.0 |
Thyroid Gland/cytology/*metabolism | 4 | 22.0 |
Receptor, Epidermal Growth Factor/agonists/*metabolism | 2 | 66.0 |
*Promoter Regions (Genetics)/drug effects | 3 | 7.0 |
Serum Response Factor | 3 | 2.0 |
Tetradecanoylphorbol Acetate/toxicity | 3 | 25.0 |
Tissue Inhibitor of Metalloproteinase-2 | 4 | 14.0 |
Tissue Inhibitor of Metalloproteinases | 12 | 19.0 |
Uterine Neoplasms/metabolism | 2 | 25.0 |
Chloramphenicol O-Acetyltransferase/genetics | 6 | 2.0 |
Gene Expression Regulation, Viral | 2 | 0.0 |
Codon | 4 | 0.0 |
Pituitary Gland/chemistry | 3 | 13.0 |
Tissue Extracts/pharmacology | 5 | 21.0 |
Carrier Proteins/pharmacology | 2 | 3.0 |
Models, Structural | 6 | 3.0 |
1-Carboxyglutamic Acid/*chemistry | 2 | 18.0 |
X-Ray Diffraction | 5 | 5.0 |
Keratinocytes/cytology/*metabolism/radiation effects | 2 | 100.0 |
Keratin/biosynthesis/genetics | 2 | 50.0 |
Amniotic Fluid/chemistry | 3 | 8.0 |
Transforming Growth Factor alpha/analysis/*physiology | 2 | 66.0 |
Diethylstilbestrol/pharmacology | 2 | 13.0 |
Epitopes/immunology | 8 | 1.0 |
Receptors, Growth Factor/*drug effects | 2 | 66.0 |
Liver/cytology/*enzymology | 2 | 10.0 |
Capillary Permeability | 2 | 2.0 |
Oligonucleotide Probes | 12 | 1.0 |
Recombinant Proteins/biosynthesis/metabolism | 8 | 5.0 |
Gelatinases/metabolism | 3 | 9.0 |
Genetic Engineering | 5 | 5.0 |
*Retroviridae | 2 | 8.0 |
Stomach Neoplasms/*genetics/metabolism | 2 | 7.0 |
*Zinc Fingers | 2 | 0.0 |
Cholesterol/analogs & derivatives | 2 | 66.0 |
Phosphatidylethanolamines | 3 | 17.0 |
Inflammation/physiopathology | 2 | 3.0 |
Cell Survival/drug effects/radiation effects | 3 | 7.0 |
Chorionic Villi/metabolism | 2 | 15.0 |
Delivery, Obstetric | 2 | 5.0 |
Drug Evaluation, Preclinical | 5 | 2.0 |
Transforming Growth Factors/*pharmacology | 20 | 83.0 |
Glycoproteins/metabolism/pharmacology | 2 | 40.0 |
Growth Substances/metabolism/pharmacology | 4 | 80.0 |
Receptor, Epidermal Growth Factor/isolation & purification/metabolism | 3 | 100.0 |
Decidua/*metabolism | 3 | 7.0 |
Prolactin/metabolism | 3 | 5.0 |
Metabolic Clearance Rate | 3 | 0.0 |
Recombinant Proteins/administration & dosage/pharmacokinetics | 2 | 20.0 |
Fibroblasts/cytology/*drug effects | 5 | 41.0 |
Melanoma/*genetics/pathology | 2 | 7.0 |
Breast Neoplasms/genetics/metabolism/*pathology | 2 | 5.0 |
Progesterone/*physiology | 2 | 11.0 |
Fibroblasts/cytology/*physiology | 2 | 9.0 |
Nervous System Physiology | 2 | 9.0 |
Aurintricarboxylic Acid/*pharmacology | 2 | 22.0 |
Gene Expression/drug effects/physiology | 2 | 4.0 |
*Membrane Transport Proteins | 3 | 0.0 |
Placenta/cytology | 2 | 11.0 |
Tumor Cells, Cultured/chemistry/drug effects | 2 | 33.0 |
ras GTPase-Activating Proteins | 10 | 9.0 |
Phorbol Esters/*pharmacology | 8 | 20.0 |
Receptor Aggregation | 6 | 6.0 |
Transforming Growth Factor alpha | 2 | 66.0 |
Adjuvants, Immunologic/pharmacology | 2 | 2.0 |
Epithelium/drug effects/metabolism | 11 | 20.0 |
Aspartic Acid/metabolism | 2 | 7.0 |
1-Phosphatidylinositol 4-Kinase | 10 | 47.0 |
Blood Proteins/metabolism | 2 | 0.0 |
Phosphatidylinositols/*metabolism | 10 | 11.0 |
Phospholipid Transfer Proteins | 2 | 10.0 |
Chimeric Proteins/immunology | 2 | 6.0 |
Epidermal Growth Factor/immunology | 7 | 100.0 |
Immunoglobulin G/immunology | 5 | 1.0 |
Immunoglobulins, Heavy-Chain/genetics/immunology | 2 | 20.0 |
African Continental Ancestry Group/*genetics | 2 | 0.0 |
6-Ketoprostaglandin F1 alpha/metabolism | 3 | 20.0 |
Arachidonic Acid/pharmacology | 2 | 4.0 |
Dinoprostone/secretion | 2 | 25.0 |
Epithelium/enzymology | 3 | 7.0 |
Interferon Type II/*pharmacology | 10 | 2.0 |
Receptor, Epidermal Growth Factor/immunology/*physiology | 5 | 71.0 |
Receptors, Transforming Growth Factor beta/metabolism | 2 | 4.0 |
Proteolipids/genetics/*metabolism | 2 | 33.0 |
Pulmonary Surfactants/genetics/*metabolism | 2 | 100.0 |
Heat-Shock Proteins 90/*metabolism | 2 | 8.0 |
Protein-Serine-Threonine Kinases/antagonists & inhibitors/*metabolism | 2 | 2.0 |
Neoplasm Proteins/*pharmacology | 3 | 23.0 |
Peptide Fragments/*pharmacology | 11 | 6.0 |
Receptors, Estradiol/metabolism | 2 | 25.0 |
Follicular Phase/*physiology | 2 | 33.0 |
Delayed-Action Preparations | 2 | 1.0 |
Pelvis | 3 | 11.0 |
Cytokines/*analysis | 6 | 7.0 |
Decidua/cytology | 2 | 50.0 |
Receptors, Cytokine/*analysis | 2 | 12.0 |
Gastric Mucosa/*physiology | 4 | 57.0 |
Skin Neoplasms/pathology/*physiopathology | 2 | 50.0 |
Receptor, IGF Type 1/*metabolism | 2 | 5.0 |
Oligonucleotides, Antisense | 3 | 3.0 |
Receptor Protein-Tyrosine Kinases/genetics/*metabolism | 3 | 2.0 |
RNA, Messenger/genetics/isolation & purification | 3 | 5.0 |
Scattering, Radiation | 3 | 2.0 |
Epidermal Growth Factor/genetics/metabolism/*pharmacology | 2 | 66.0 |
Japan | 6 | 0.0 |
*Polymorphism, Single Nucleotide | 2 | 0.0 |
Ubiquitin-Protein Ligases/metabolism | 2 | 4.0 |
Disease Outbreaks/*statistics & numerical data | 2 | 25.0 |
Dominican Republic/epidemiology | 2 | 33.0 |
Food Microbiology | 2 | 6.0 |
Gastroenteritis/*epidemiology | 2 | 66.0 |
Public Facilities | 2 | 66.0 |
Spain | 2 | 0.0 |
*Travel | 2 | 7.0 |
*Water Microbiology | 2 | 15.0 |
Water Supply/*analysis | 2 | 40.0 |
Transcription Factors/biosynthesis/genetics | 2 | 2.0 |
Carcinoma/pathology | 4 | 9.0 |
*Immunization, Passive | 2 | 3.0 |
Epidermal Growth Factor/administration & dosage/*therapeutic use | 3 | 100.0 |
Sodium Chloride | 2 | 7.0 |
Vitreous Body/*metabolism | 2 | 6.0 |
Epidermal Growth Factor/*biosynthesis/genetics/metabolism | 2 | 100.0 |
Transforming Growth Factor alpha/*biosynthesis/genetics/metabolism | 2 | 100.0 |
*ADP Ribose Transferases | 9 | 11.0 |
Exotoxins/*pharmacology | 5 | 20.0 |
Immunotoxins/*pharmacology | 6 | 14.0 |
Recombinant Fusion Proteins/*pharmacology | 4 | 17.0 |
*Virulence Factors | 9 | 10.0 |
Sialoglycoproteins/*pharmacology | 2 | 14.0 |
Adenoma/*pathology | 2 | 9.0 |
Colon/cytology | 2 | 13.0 |
Muscle, Smooth/drug effects/*physiology | 2 | 33.0 |
Neoplasm Proteins/genetics/metabolism/physiology | 2 | 100.0 |
*Embryonic and Fetal Development | 5 | 4.0 |
Gastrula/*physiology | 2 | 13.0 |
Neoplasm Proteins/biosynthesis/chemistry | 2 | 100.0 |
Cell Membrane Permeability | 6 | 3.0 |
*Wound Healing/drug effects | 2 | 40.0 |
Transforming Growth Factor beta/pharmacology/physiology | 3 | 42.0 |
Tretinoin/*toxicity | 3 | 60.0 |
1-Propanol/pharmacology | 2 | 40.0 |
Catechols/pharmacology | 5 | 27.0 |
Indomethacin/pharmacology | 12 | 5.0 |
Isoflavones/*pharmacology | 5 | 20.0 |
Amnion/metabolism | 3 | 18.0 |
Decidua/metabolism | 3 | 10.0 |
Labor, Obstetric/*physiology | 2 | 13.0 |
Uterus/*metabolism | 3 | 6.0 |
Adenocarcinoma/*chemistry/pathology | 4 | 9.0 |
Transforming Growth Factor alpha/analysis/biosynthesis | 2 | 66.0 |
Immunosuppressive Agents/pharmacology | 4 | 2.0 |
Polyenes/pharmacology | 2 | 7.0 |
Psoriasis/*enzymology | 2 | 28.0 |
Ribosomal Protein S6 Kinases | 8 | 32.0 |
Sirolimus | 4 | 9.0 |
Skin/*enzymology | 2 | 8.0 |
Skin/cytology/*metabolism | 3 | 8.0 |
Cell Communication/drug effects | 2 | 5.0 |
Receptor, Epidermal Growth Factor/analysis/*physiology | 7 | 58.0 |
Submandibular Gland/*metabolism | 2 | 15.0 |
Skin/immunology | 2 | 2.0 |
RNA, Antisense/genetics | 2 | 8.0 |
Guanylyl Imidodiphosphate/pharmacology | 3 | 18.0 |
Oncogene Proteins/*metabolism | 3 | 3.0 |
Stomach Neoplasms/metabolism | 2 | 13.0 |
Frozen Sections | 3 | 3.0 |
Paraffin Embedding | 2 | 0.0 |
Prostatic Hyperplasia/*metabolism/pathology | 3 | 10.0 |
Transforming Growth Factors/*genetics | 4 | 66.0 |
Epidermis/metabolism | 5 | 12.0 |
RNA, Messenger/analysis/*metabolism | 3 | 9.0 |
Receptor, Epidermal Growth Factor/analysis/genetics/*metabolism | 4 | 66.0 |
Epidermal Growth Factor/genetics/*urine | 3 | 100.0 |
Body Fluids/chemistry | 2 | 9.0 |
*Chromosome Mapping | 8 | 0.0 |
Chromosomes, Human, Pair 4/*genetics | 2 | 2.0 |
Oligosaccharides/analysis | 2 | 8.0 |
Cell Membrane | 2 | 3.0 |
Chorionic Gonadotropin/pharmacology | 9 | 7.0 |
Receptor Protein-Tyrosine Kinases/antagonists & inhibitors/physiology | 2 | 50.0 |
Subtilisins/metabolism | 2 | 13.0 |
Transforming Growth Factor alpha/*chemistry | 4 | 66.0 |
Ethylmaleimide/pharmacology | 2 | 3.0 |
RNA, Messenger/analysis/*genetics | 2 | 6.0 |
Cyclic AMP-Dependent Protein Kinases/physiology | 2 | 7.0 |
Endothelium, Vascular/*cytology | 3 | 1.0 |
Plasmin/*physiology | 2 | 28.0 |
Protein C/chemistry/*metabolism | 2 | 25.0 |
Carcinogens/*toxicity | 2 | 1.0 |
Stomach Neoplasms/*chemistry/surgery | 2 | 100.0 |
Genes, fos/drug effects | 4 | 17.0 |
Prostatic Neoplasms/*drug therapy/metabolism/pathology | 2 | 20.0 |
Epithelium/chemistry/drug effects | 3 | 75.0 |
Carbachol/*pharmacology | 3 | 30.0 |
Muscarinic Agonists/*pharmacology | 2 | 33.0 |
Cations | 2 | 2.0 |
Ornithine Decarboxylase/*biosynthesis | 5 | 55.0 |
Calcium/*metabolism/pharmacology | 3 | 11.0 |
Factor IX/*chemistry/isolation & purification/*metabolism | 2 | 100.0 |
Adenoma/*metabolism | 6 | 10.0 |
Gene Rearrangement | 4 | 0.0 |
Adenocarcinoma/enzymology/*pathology | 2 | 22.0 |
Manganese/pharmacology | 6 | 25.0 |
Oligopeptides/pharmacology | 5 | 2.0 |
Skin Neoplasms/*metabolism/pathology | 3 | 4.0 |
Oncogene Proteins v-erbB/metabolism | 2 | 22.0 |
Oxidants/pharmacology | 3 | 4.0 |
Vanadates/pharmacology | 9 | 6.0 |
Fibroblasts/metabolism/*physiology | 2 | 66.0 |
Growth Substances/isolation & purification/*physiology | 2 | 50.0 |
Receptor, Epidermal Growth Factor/biosynthesis/*physiology | 2 | 22.0 |
Brain Neoplasms/*metabolism | 8 | 10.0 |
Cholesterol/blood | 2 | 0.0 |
Hypercholesterolemia, Familial/blood/*genetics | 2 | 20.0 |
Triglycerides/blood | 2 | 0.0 |
Phosphatidylcholines | 2 | 5.0 |
Cyanogen Bromide | 7 | 12.0 |
Disulfides | 5 | 5.0 |
*Protein Structure, Secondary | 2 | 1.0 |
Thrombomodulin/*chemistry | 3 | 100.0 |
Heat-Shock Proteins/metabolism | 2 | 3.0 |
X-Rays | 3 | 2.0 |
Glioma/*metabolism | 4 | 8.0 |
Meningioma/*metabolism | 4 | 21.0 |
Fluoroimmunoassay | 5 | 11.0 |
*Keratoplasty, Penetrating | 2 | 33.0 |
Peptides/physiology | 6 | 16.0 |
Dextrans | 3 | 6.0 |
Succinimides/metabolism | 2 | 18.0 |
Leucine/chemistry | 2 | 5.0 |
Epidermal Growth Factor/biosynthesis/*genetics | 4 | 100.0 |
Kidney Neoplasms/*metabolism/pathology | 2 | 6.0 |
Kidney Tubules/*metabolism/pathology | 2 | 33.0 |
Cell Membrane/chemistry/metabolism | 2 | 4.0 |
Columbidae | 2 | 13.0 |
Breast Neoplasms/drug therapy/pathology | 3 | 42.0 |
Fibroblasts/drug effects/enzymology | 3 | 14.0 |
Proto-Oncogene Proteins c-sis | 2 | 8.0 |
RNA/isolation & purification | 3 | 4.0 |
Cell Adhesion/drug effects/physiology | 4 | 6.0 |
*Intramolecular Oxidoreductases | 2 | 12.0 |
Carcinoma, Transitional Cell/*metabolism/pathology | 2 | 11.0 |
Growth Substances/*secretion | 5 | 50.0 |
Lymphokines/*secretion | 3 | 7.0 |
Esophagitis/metabolism | 2 | 100.0 |
Fetus/*metabolism | 5 | 6.0 |
*Adenocarcinoma | 3 | 42.0 |
Insulin/blood | 3 | 0.0 |
Peptides/blood | 2 | 5.0 |
Ovarian Neoplasms/*metabolism/pathology | 4 | 6.0 |
Carbohydrate Conformation | 5 | 4.0 |
Carbohydrates/chemistry/*metabolism | 2 | 66.0 |
Endometrium/drug effects/*metabolism | 3 | 25.0 |
Gonadal Steroid Hormones/*pharmacology | 2 | 12.0 |
alpha-Fetoproteins/*analysis | 2 | 0.0 |
*Sex Characteristics | 2 | 1.0 |
Oligonucleotide Probes/genetics | 4 | 3.0 |
Testosterone/*biosynthesis | 3 | 15.0 |
Integrin alpha6 | 2 | 10.0 |
Adenocarcinoma/metabolism | 8 | 11.0 |
Recombinant Proteins/drug effects/metabolism | 3 | 13.0 |
Tumor Cells, Cultured/drug effects/secretion | 2 | 16.0 |
Carcinoma, Squamous Cell/metabolism/*pathology | 5 | 18.0 |
Keratinocytes/metabolism/pathology | 2 | 25.0 |
Epithelium/chemistry/immunology | 2 | 25.0 |
Insulin-Like Growth Factor I/metabolism/*pharmacology | 4 | 44.0 |
Receptors, Transforming Growth Factor beta/analysis | 2 | 18.0 |
Electrophoresis/methods | 2 | 2.0 |
TATA Box | 2 | 0.0 |
Drug Tolerance | 2 | 1.0 |
Polyenes/*pharmacology | 2 | 12.0 |
Spectrum Analysis | 2 | 3.0 |
Growth Substances | 5 | 31.0 |
*Liver Regeneration | 6 | 17.0 |
Parathyroid Hormone/*pharmacology | 5 | 16.0 |
Infusions, Parenteral | 2 | 1.0 |
Lactones/pharmacology | 2 | 5.0 |
Prostatic Neoplasms/pathology/physiopathology | 2 | 50.0 |
Mutation/physiology | 3 | 2.0 |
Pancreas/*metabolism | 2 | 5.0 |
Peptides/chemistry/metabolism | 3 | 6.0 |
Kidney/*physiology | 2 | 4.0 |
Leukocytes, Mononuclear/*physiology | 2 | 8.0 |
Piperidines/pharmacology | 3 | 5.0 |
Gene Expression Regulation, Neoplastic/physiology | 5 | 3.0 |
Mitogens/physiology | 2 | 11.0 |
Receptor, erbB-2/*genetics/metabolism | 2 | 20.0 |
Tumor Cells, Cultured/cytology/enzymology | 2 | 12.0 |
Genetic Code | 3 | 7.0 |
Sheep/*genetics | 4 | 7.0 |
Epidermal Growth Factor/analysis/metabolism | 3 | 75.0 |
Saliva/chemistry/*metabolism | 2 | 50.0 |
Cytokines | 3 | 2.0 |
*Chromosomes, Human, Pair 7 | 2 | 0.0 |
*Trisomy | 2 | 1.0 |
Macrophage Colony-Stimulating Factor/pharmacology | 3 | 4.0 |
Trophoblasts/*cytology/drug effects | 2 | 66.0 |
Endometriosis/*metabolism | 3 | 10.0 |
Luteal Phase/metabolism | 3 | 42.0 |
Growth Substances/*immunology/pharmacology | 2 | 66.0 |
Interferon-gamma, Recombinant/pharmacology | 2 | 1.0 |
Recombinant Proteins/biosynthesis/pharmacology | 2 | 6.0 |
Tyrosine | 6 | 5.0 |
Insulin/physiology | 2 | 6.0 |
Carcinoma, Squamous Cell/metabolism/*therapy | 2 | 100.0 |
Nitric Oxide/biosynthesis | 2 | 2.0 |
Antisense Elements (Genetics)/genetics | 2 | 18.0 |
Transcription Factor, Sp1 | 2 | 5.0 |
Protein Kinase C/antagonists & inhibitors/physiology | 2 | 9.0 |
Prostatic Neoplasms/metabolism/pathology | 2 | 25.0 |
Factor IX/*genetics | 5 | 18.0 |
Estradiol/secretion | 3 | 37.0 |
Inhibins/metabolism | 2 | 13.0 |
Ovulation/*metabolism | 2 | 66.0 |
Progesterone/secretion | 2 | 15.0 |
Blood Coagulation Factors/chemistry | 2 | 100.0 |
Epithelium/immunology | 6 | 4.0 |
Recombinant Proteins/biosynthesis/chemistry | 2 | 2.0 |
*Follicular Phase | 2 | 16.0 |
Molecular Probes/genetics | 3 | 3.0 |
Transforming Growth Factor alpha/metabolism/*pharmacology | 3 | 75.0 |
Staurosporine | 14 | 14.0 |
Hybridomas | 2 | 1.0 |
Growth Substances/*genetics/pharmacology | 2 | 28.0 |
Phosphopeptides/chemistry/isolation & purification | 3 | 15.0 |
Phosphothreonine/analysis | 2 | 25.0 |
Recombinant Proteins/biosynthesis/chemistry/metabolism | 4 | 4.0 |
Aneuploidy | 5 | 2.0 |
Esophageal Neoplasms/*pathology | 2 | 11.0 |
Lymphatic Metastasis/*pathology | 2 | 5.0 |
*Blood Coagulation | 3 | 1.0 |
Cesarean Section | 3 | 4.0 |
Dinoprost/metabolism | 3 | 27.0 |
*Gestational Age | 2 | 3.0 |
Ionomycin/pharmacology | 7 | 3.0 |
Duodenal Ulcer/*metabolism | 3 | 42.0 |
Gastric Acid/metabolism | 2 | 40.0 |
Endometrial Neoplasms/metabolism/*pathology | 3 | 30.0 |
Endometrium/*cytology/metabolism | 4 | 44.0 |
Epithelium/drug effects/pathology | 4 | 36.0 |
Kidney/*metabolism/pathology | 2 | 14.0 |
*Models, Biological | 7 | 3.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/immunology/*metabolism | 2 | 50.0 |
Immune Sera | 13 | 4.0 |
Peptides/chemical synthesis/immunology | 2 | 4.0 |
*Culture Media, Serum-Free | 2 | 22.0 |
Transferrin/physiology | 2 | 66.0 |
Aspirin/pharmacology | 4 | 6.0 |
Glycoproteins/analysis | 3 | 5.0 |
Receptors, Progesterone/analysis | 18 | 7.0 |
*Gene Amplification | 14 | 3.0 |
Cervix Uteri/*metabolism | 3 | 23.0 |
Gene Expression/*drug effects | 11 | 5.0 |
Metalloendopeptidases/*biosynthesis | 2 | 9.0 |
Cell Membrane/pathology | 3 | 27.0 |
DNA-Binding Proteins/isolation & purification/*metabolism | 2 | 2.0 |
Deoxyribonuclease I | 2 | 1.0 |
Vascular Endothelial Growth Factor A/*metabolism | 3 | 2.0 |
Adenosine Triphosphate/*analogs & derivatives/pharmacology | 2 | 50.0 |
Phospholipase C/antagonists & inhibitors/metabolism | 3 | 18.0 |
Epithelium/chemistry | 10 | 9.0 |
Fetus/*chemistry | 3 | 37.0 |
Blood Platelets | 4 | 16.0 |
*Complex Mixtures | 2 | 100.0 |
Cytokines/metabolism | 3 | 0.0 |
Pituitary Gland | 2 | 20.0 |
*Skin Transplantation | 3 | 15.0 |
Corticotropin/metabolism | 2 | 5.0 |
Epidermal Growth Factor/*analysis/genetics | 5 | 100.0 |
Growth Hormone/metabolism | 6 | 13.0 |
Immunoassay | 7 | 3.0 |
Pituitary Neoplasms/*metabolism | 4 | 11.0 |
Epidermal Growth Factor/*metabolism/pharmacokinetics | 2 | 100.0 |
Phosphotransferases/metabolism | 7 | 14.0 |
Testicular Hormones/*pharmacology | 4 | 50.0 |
Carcinoma/*genetics | 4 | 3.0 |
Growth Substances/physiology/*therapeutic use | 2 | 66.0 |
Interleukin-3/pharmacology | 4 | 1.0 |
Ethers, Cyclic/pharmacology | 3 | 8.0 |
Okadaic Acid | 5 | 10.0 |
Phosphoprotein Phosphatase/antagonists & inhibitors/*metabolism | 2 | 16.0 |
Cataract/*metabolism/pathology | 2 | 66.0 |
Tumor Necrosis Factor-alpha/biosynthesis | 2 | 0.0 |
Mitosis/*drug effects | 14 | 28.0 |
Aqueous Humor/*metabolism | 2 | 9.0 |
Intracellular Membranes/*metabolism | 2 | 3.0 |
Adenoma/chemistry | 2 | 15.0 |
Intestine, Small/*metabolism | 2 | 7.0 |
Reference Standards | 2 | 0.0 |
Protein C/*chemistry | 4 | 44.0 |
Ovulation/*physiology | 2 | 10.0 |
*Animals, Newborn | 2 | 28.0 |
Oocytes/*growth & development | 2 | 50.0 |
Pancreatic Neoplasms/genetics/*metabolism | 3 | 20.0 |
Keratinocytes/drug effects/enzymology | 2 | 50.0 |
Keratinocytes/cytology/drug effects | 2 | 22.0 |
Skin/cytology/*drug effects | 3 | 37.0 |
Astrocytoma/*metabolism | 2 | 8.0 |
*Immunohistochemistry | 3 | 3.0 |
Labor, Obstetric | 2 | 4.0 |
Breast Neoplasms/*chemistry | 3 | 4.0 |
Colonic Neoplasms/metabolism | 3 | 5.0 |
DNA/*genetics | 3 | 0.0 |
DNA-Binding Proteins/physiology | 4 | 1.0 |
DNA Replication/*drug effects | 18 | 33.0 |
Glioblastoma/*pathology | 2 | 7.0 |
Tumor Cells, Cultured/*drug effects/pathology | 5 | 31.0 |
Carcinoma, Transitional Cell/*drug therapy | 2 | 50.0 |
Infant, Newborn/*growth & development | 2 | 28.0 |
Insulin-Like Growth Factor II/physiology | 3 | 50.0 |
Epidermal Growth Factor/*chemistry/pharmacology | 2 | 100.0 |
Cells, Cultured/cytology/drug effects/metabolism | 3 | 20.0 |
Tetrazolium Salts | 6 | 11.0 |
Carcinoma, Squamous Cell/metabolism/pathology | 5 | 13.0 |
Phorbol Esters/metabolism | 5 | 45.0 |
Genes, myc/drug effects | 2 | 13.0 |
Proto-Oncogenes/*drug effects | 5 | 41.0 |
Plasminogen Activator Inhibitor 1/*biosynthesis | 2 | 18.0 |
Tissue Plasminogen Activator/*biosynthesis | 4 | 50.0 |
Interferon-gamma, Recombinant/*pharmacology | 4 | 3.0 |
Protein Precursors/metabolism | 6 | 4.0 |
Tumor Markers, Biological | 9 | 2.0 |
Body Fluids/metabolism | 4 | 13.0 |
Gastrointestinal Hormones/*pharmacology | 2 | 7.0 |
Peptide YY | 3 | 2.0 |
*Cell Differentiation/drug effects | 3 | 9.0 |
Perylene/*analogs & derivatives/pharmacology | 2 | 100.0 |
Cervix Neoplasms/*pathology | 3 | 13.0 |
Receptors, Estradiol/analysis | 3 | 27.0 |
Intestinal Mucosa/*drug effects | 4 | 44.0 |
Endopeptidases/*metabolism | 2 | 1.0 |
Transforming Growth Factor alpha/analysis/*biosynthesis | 3 | 37.0 |
Skin/*chemistry/cytology | 2 | 50.0 |
Progesterone/pharmacology/physiology | 2 | 66.0 |
DNA/*biosynthesis/drug effects | 5 | 50.0 |
Receptor, Epidermal Growth Factor/biosynthesis/*drug effects/genetics | 2 | 100.0 |
Second Messenger Systems/drug effects | 2 | 10.0 |
Bone Morphogenetic Proteins | 3 | 12.0 |
Proteins/physiology | 2 | 1.0 |
Dinoprostone/*pharmacology | 2 | 3.0 |
Granulosa Cells/*metabolism | 7 | 17.0 |
Glycoconjugates/*metabolism | 2 | 40.0 |
Cell Membrane/*chemistry | 2 | 6.0 |
Fallopian Tubes/chemistry/*metabolism | 3 | 75.0 |
Liver Regeneration/*physiology | 2 | 8.0 |
Nerve Tissue Proteins/metabolism | 5 | 2.0 |
Oncogene Proteins/metabolism | 3 | 3.0 |
Cell Nucleus/physiology | 5 | 7.0 |
Repetitive Sequences, Nucleic Acid/genetics | 2 | 2.0 |
Proto-Oncogene Protein p21(ras)/metabolism | 6 | 7.0 |
Tamoxifen/analogs & derivatives/pharmacology | 8 | 29.0 |
Macaca mulatta | 6 | 1.0 |
Phosphoproteins/isolation & purification/metabolism | 4 | 11.0 |
Epithelium/drug effects/physiology | 6 | 27.0 |
Anticoagulants/metabolism | 2 | 11.0 |
Epidermal Growth Factor/*chemistry/*metabolism | 3 | 75.0 |
Cell Culture Techniques/*methods | 3 | 3.0 |
Dopamine/*metabolism | 2 | 1.0 |
Epidermal Growth Factor/genetics/metabolism/*physiology | 2 | 40.0 |
Melanoma/metabolism | 2 | 7.0 |
Genetic Vectors/genetics | 2 | 0.0 |
Colorectal Neoplasms/genetics/*metabolism/pathology | 2 | 11.0 |
Progesterone/*biosynthesis | 7 | 31.0 |
Culture Media/metabolism | 2 | 8.0 |
*Tissue Donors | 2 | 1.0 |
Diglycerides/*metabolism | 3 | 16.0 |
Phosphatidylcholines/*metabolism | 2 | 4.0 |
Receptor, Epidermal Growth Factor/*analysis/genetics | 15 | 39.0 |
Brain Chemistry | 2 | 0.0 |
Endothelium/metabolism | 6 | 11.0 |
Spectrometry, Mass, Fast Atom Bombardment | 2 | 7.0 |
Antigens, Neoplasm/*analysis | 4 | 1.0 |
Bone Marrow Cells | 5 | 1.0 |
Antigens, Neoplasm/analysis | 9 | 2.0 |
Chromosome Aberrations | 6 | 1.0 |
Proliferating Cell Nuclear Antigen/analysis | 3 | 1.0 |
Swine, Miniature | 5 | 13.0 |
*Ploidies | 5 | 7.0 |
RNA, Messenger/analysis/genetics/metabolism | 2 | 5.0 |
Proline | 2 | 3.0 |
Peptide Fragments/chemistry/isolation & purification | 2 | 5.0 |
Trypsin | 16 | 10.0 |
Oligodeoxyribonucleotides/chemistry | 4 | 1.0 |
Chorionic Gonadotropin/*secretion | 7 | 50.0 |
Placenta/*drug effects/metabolism | 3 | 60.0 |
Factor IXa/*chemistry | 2 | 66.0 |
Chorionic Gonadotropin/therapeutic use | 2 | 6.0 |
Estradiol/analysis | 4 | 21.0 |
Progesterone/analysis | 4 | 21.0 |
Receptors, Estrogen/*physiology | 3 | 9.0 |
Cell Division/genetics/physiology | 4 | 9.0 |
Signal Transduction/genetics/*physiology | 2 | 5.0 |
Choriocarcinoma/*metabolism/pathology | 2 | 66.0 |
Chorionic Gonadotropin/*metabolism | 3 | 20.0 |
Insulin-Like Growth Factor I/*pharmacology/physiology | 2 | 33.0 |
Metribolone/antagonists & inhibitors/*pharmacology | 2 | 100.0 |
Thiazoles | 4 | 7.0 |
Culture Media, Conditioned/chemistry | 4 | 8.0 |
Growth Inhibitors/physiology | 3 | 13.0 |
Tumor Cells, Cultured/enzymology | 5 | 13.0 |
Epithelium/drug effects/ultrastructure | 3 | 60.0 |
Myelin Basic Proteins/isolation & purification/metabolism | 2 | 100.0 |
Colonic Neoplasms/*drug therapy/pathology | 2 | 20.0 |
Receptor, Epidermal Growth Factor/biosynthesis/genetics/*physiology | 2 | 25.0 |
Sepharose | 3 | 5.0 |
Stromal Cells/cytology/drug effects/metabolism | 2 | 20.0 |
Goiter/metabolism | 2 | 20.0 |
Adenocarcinoma/*drug therapy/pathology | 2 | 28.0 |
Interleukin-2/*pharmacology | 2 | 0.0 |
Axilla | 2 | 3.0 |
Breast Neoplasms/pathology/*ultrastructure | 3 | 50.0 |
Menopause | 2 | 0.0 |
Radioligand Assay/methods | 5 | 29.0 |
DNA, Recombinant | 10 | 5.0 |
Esophagoscopy | 2 | 6.0 |
Sclerotherapy/*adverse effects | 3 | 75.0 |
Epidermal Growth Factor/immunology/*physiology | 3 | 100.0 |
Platelet-Derived Growth Factor/immunology/*physiology | 2 | 100.0 |
Liver/*cytology/metabolism | 2 | 15.0 |
Drosophila/*genetics | 2 | 6.0 |
Genes, Insect | 2 | 3.0 |
Anti-Ulcer Agents/*pharmacology | 2 | 9.0 |
Liver/cytology/*metabolism | 4 | 5.0 |
*Fluorescent Dyes | 3 | 9.0 |
Factor X/*metabolism | 3 | 12.0 |
Oligopeptides/metabolism | 3 | 5.0 |
Recombinant Fusion Proteins/administration & dosage/*pharmacology | 2 | 100.0 |
Gastric Juice/chemistry/*metabolism | 2 | 100.0 |
Fetal Blood/chemistry | 2 | 3.0 |
Growth Hormone/pharmacology | 5 | 14.0 |
Placental Lactogen/pharmacology | 2 | 50.0 |
Gastric Juice/*chemistry | 3 | 50.0 |
Endothelium, Vascular/cytology/*drug effects | 4 | 5.0 |
Peptide Fragments/chemistry/*pharmacology | 3 | 10.0 |
Interleukin-1/immunology | 3 | 6.0 |
Thapsigargin | 4 | 14.0 |
*Chemokines, CXC | 3 | 4.0 |
Leukocytes, Mononuclear/*metabolism | 2 | 1.0 |
*Cell Polarity | 2 | 5.0 |
Oncogene Proteins, Viral/*genetics | 3 | 5.0 |
Cell Cycle/radiation effects | 2 | 7.0 |
Cell Survival/radiation effects | 3 | 3.0 |
Radiation Tolerance/*drug effects | 2 | 11.0 |
Granulosa Cells/*cytology | 3 | 60.0 |
Gonadal Steroid Hormones/metabolism | 2 | 10.0 |
Exudates and Transudates/*chemistry | 7 | 70.0 |
Thyrotropin/*pharmacology | 5 | 17.0 |
Prostatic Neoplasms/*metabolism/*pathology | 2 | 11.0 |
Receptor, Epidermal Growth Factor/drug effects/*genetics | 4 | 66.0 |
Receptors, Androgen/metabolism/*physiology | 2 | 50.0 |
Up-Regulation/drug effects/physiology | 2 | 4.0 |
Colonic Neoplasms/*chemistry/pathology | 3 | 33.0 |
Endothelium, Vascular/*metabolism | 6 | 2.0 |
Epitopes/analysis | 7 | 2.0 |
Factor IX/chemistry/*metabolism | 2 | 33.0 |
Protein-Tyrosine Kinase/genetics | 6 | 5.0 |
Oleic Acid | 4 | 6.0 |
Oleic Acids/*pharmacology | 2 | 13.0 |
Peptide Fragments/physiology | 3 | 10.0 |
DNA/*analysis | 2 | 0.0 |
Proto-Oncogene Proteins c-myc/metabolism | 3 | 3.0 |
Vitamin D/*pharmacology | 2 | 11.0 |
Protein-Tyrosine Kinase/*analysis | 5 | 15.0 |
Gonadal Steroid Hormones/*metabolism | 3 | 20.0 |
Colorimetry | 2 | 3.0 |
Collagen/biosynthesis/genetics | 3 | 18.0 |
Spectrometry, Fluorescence/methods | 2 | 7.0 |
Receptor, Epidermal Growth Factor/*biosynthesis/drug effects | 3 | 50.0 |
Aminoisobutyric Acids/pharmacokinetics | 2 | 66.0 |
Glucose/pharmacokinetics | 2 | 25.0 |
Clone Cells/drug effects | 6 | 24.0 |
*Kidney Transplantation | 3 | 0.0 |
DNA, Neoplasm/*genetics | 3 | 1.0 |
Tumor Necrosis Factor-alpha/metabolism/pharmacology | 2 | 5.0 |
Inositol 1,4,5-Trisphosphate/biosynthesis | 3 | 14.0 |
Lithium/*pharmacology | 4 | 25.0 |
Phosphatidylinositol 4,5-Diphosphate | 3 | 18.0 |
Corpus Luteum/metabolism | 2 | 22.0 |
Luteal Phase/*metabolism | 2 | 22.0 |
Ovum/metabolism | 2 | 18.0 |
Decidua/*chemistry | 2 | 28.0 |
Bone Marrow/immunology | 2 | 1.0 |
Hematopoietic Stem Cells/cytology | 2 | 2.0 |
*Second Messenger Systems | 3 | 14.0 |
Cell Death/drug effects | 4 | 2.0 |
Nitric-Oxide Synthase | 2 | 5.0 |
Phosphotyrosine | 59 | 22.0 |
Tyrosine/analogs & derivatives/metabolism | 26 | 22.0 |
Antineoplastic Combined Chemotherapy Protocols/therapeutic use | 3 | 0.0 |
Glycogen/metabolism | 5 | 10.0 |
DNA Probes, HPV | 2 | 10.0 |
Vulvar Neoplasms/*pathology | 2 | 22.0 |
Hysterectomy | 3 | 3.0 |
Leiomyoma/surgery | 2 | 66.0 |
Endothelial Growth Factors/*secretion | 2 | 9.0 |
Fibroblast Growth Factor 2/*physiology | 2 | 9.0 |
Diphtheria Toxin/pharmacology | 2 | 50.0 |
Amino Acids/pharmacology | 2 | 10.0 |
Chromosomes, Human, Pair 7 | 2 | 1.0 |
Cytoskeleton/physiology | 2 | 2.0 |
Epidermal Growth Factor/chemistry/pharmacology/*physiology | 2 | 100.0 |
Receptor, Epidermal Growth Factor/chemistry/metabolism/*physiology | 2 | 100.0 |
Antibody Formation | 2 | 0.0 |
Epidermal Growth Factor/immunology/*pharmacology | 2 | 100.0 |
Gastric Mucosa/*drug effects/pathology | 2 | 66.0 |
Recombinant Proteins/immunology/pharmacology | 2 | 8.0 |
Parotid Gland/physiology | 2 | 100.0 |
Receptors, Muscarinic/physiology | 2 | 22.0 |
E-Selectin | 2 | 2.0 |
Cisplatin/pharmacology | 4 | 2.0 |
Receptor, Epidermal Growth Factor/*genetics/physiology | 5 | 62.0 |
Vinblastine/pharmacology | 3 | 8.0 |
Carrier Proteins/chemistry/*metabolism | 2 | 2.0 |
Polyethylene Glycols/pharmacology | 4 | 8.0 |
Somatostatin/*pharmacology | 3 | 6.0 |
Genes, Structural | 21 | 2.0 |
Apoptosis/*physiology | 4 | 0.0 |
Receptor, Epidermal Growth Factor/drug effects/immunology/*metabolism | 2 | 66.0 |
Coated Pits, Cell-Membrane/*metabolism | 3 | 21.0 |
Lysine | 3 | 6.0 |
Methionine | 2 | 5.0 |
Antigens, Polyomavirus Transforming/biosynthesis | 2 | 33.0 |
Cell Nucleus/*metabolism/ultrastructure | 3 | 10.0 |
Adrenal Cortex Hormones/biosynthesis | 2 | 25.0 |
Blood Coagulation/drug effects | 2 | 1.0 |
Lactation/*metabolism | 3 | 27.0 |
Glutathione Transferase/genetics/metabolism | 3 | 2.0 |
Follicular Phase/metabolism | 3 | 37.0 |
RNA-Directed DNA Polymerase/metabolism | 2 | 2.0 |
Prostate/chemistry | 2 | 10.0 |
*Papillomavirus, Human | 2 | 6.0 |
Tyrosine/analogs & derivatives/analysis | 12 | 30.0 |
Astrocytes/drug effects/*metabolism | 2 | 9.0 |
Hybrid Cells | 6 | 0.0 |
Oligonucleotides, Antisense/genetics | 2 | 5.0 |
Receptor, Epidermal Growth Factor/metabolism/*radiation effects | 2 | 100.0 |
Signal Transduction/*radiation effects | 4 | 21.0 |
Epidermal Growth Factor/*analysis/urine | 4 | 100.0 |
Milk, Human/chemistry | 2 | 13.0 |
Epidermis/drug effects/*metabolism/ultrastructure | 2 | 100.0 |
Potassium/*metabolism | 2 | 4.0 |
Epidermal Growth Factor/*genetics/metabolism/pharmacology | 2 | 100.0 |
Transforming Growth Factor alpha/analysis/*genetics | 3 | 60.0 |
Rectum/*drug effects/pathology | 2 | 100.0 |
Protein Precursors/*genetics | 6 | 4.0 |
Trophoblasts/metabolism | 3 | 8.0 |
*Embryonic Development | 2 | 10.0 |
Receptor, Epidermal Growth Factor | 234 | 91.0 |
Breast/*chemistry | 2 | 8.0 |
Fibrocystic Breast Disease/*chemistry | 4 | 57.0 |
Adenocarcinoma, Scirrhous/*pathology | 2 | 100.0 |
Uterine Neoplasms/metabolism/*pathology | 2 | 33.0 |
Chromosome Disorders | 2 | 0.0 |
Glioma/*genetics/pathology | 2 | 6.0 |
Protein Kinases/genetics | 3 | 5.0 |
Inositol 1,4,5-Trisphosphate/*metabolism | 3 | 30.0 |
RNA-Directed DNA Polymerase | 4 | 3.0 |
Uterus/chemistry/*metabolism | 2 | 100.0 |
DNA, Neoplasm/analysis/genetics | 4 | 4.0 |
Guanine/*analogs & derivatives/pharmacology | 2 | 6.0 |
Digestive System/*cytology | 3 | 60.0 |
Dose-Response Relationship, Immunologic | 3 | 0.0 |
Estradiol/physiology | 3 | 33.0 |
Membrane Fluidity | 2 | 5.0 |
Receptors, Cell Surface/physiology | 2 | 1.0 |
Integrins/*biosynthesis | 2 | 11.0 |
Alkaloids/pharmacology | 12 | 11.0 |
Phorbol 12,13-Dibutyrate/pharmacology | 5 | 8.0 |
Second Messenger Systems | 4 | 4.0 |
Adipocytes/*metabolism | 2 | 4.0 |
DNA, Viral/genetics | 3 | 1.0 |
*Collagen | 2 | 5.0 |
*Proteoglycans | 2 | 10.0 |
Plasmodium falciparum/*immunology | 2 | 4.0 |
Thyroid Neoplasms/*metabolism | 2 | 5.0 |
Adenocarcinoma/genetics | 2 | 2.0 |
Antibodies, Neoplasm/pharmacology | 2 | 66.0 |
Lung Neoplasms/*genetics | 5 | 2.0 |
Interleukin-2/immunology | 2 | 1.0 |
Culture Techniques/methods | 7 | 12.0 |
Tumor Cells, Cultured/drug effects/pathology | 6 | 14.0 |
Clathrin/physiology | 3 | 33.0 |
Recombinant Proteins/chemistry/metabolism/pharmacology | 2 | 11.0 |
Spermine/metabolism | 3 | 37.0 |
Transforming Growth Factor alpha/*genetics/physiology | 4 | 57.0 |
Trophoblasts/physiology | 2 | 25.0 |
*Cell Transformation, Viral | 12 | 7.0 |
Menstrual Cycle | 8 | 7.0 |
Simian virus 40/*genetics | 2 | 3.0 |
Estrogens/analysis | 2 | 66.0 |
Myometrium/*chemistry | 3 | 33.0 |
Ovary/metabolism | 4 | 5.0 |
Testis/metabolism | 2 | 0.0 |
Amnion/cytology/*metabolism | 2 | 33.0 |
Feces/chemistry | 2 | 4.0 |
CDC2 Protein Kinase/*metabolism | 2 | 1.0 |
Pepsin A/pharmacology | 2 | 28.0 |
Air | 2 | 10.0 |
Antigens, Differentiation/analysis | 4 | 1.0 |
Corpus Luteum/*metabolism | 2 | 11.0 |
Oncogene Proteins v-erbB/analysis | 2 | 66.0 |
Protein p53/*analysis | 2 | 1.0 |
Endometrium/metabolism | 5 | 9.0 |
Receptors, Cytokine/drug effects/physiology | 2 | 100.0 |
Recombinant Proteins/genetics/pharmacology | 2 | 6.0 |
Recombinant Proteins/genetics/isolation & purification/metabolism | 2 | 2.0 |
*Variation (Genetics) | 4 | 0.0 |
Gastroesophageal Reflux/*physiopathology | 2 | 33.0 |
Sodium Chloride/pharmacology | 2 | 2.0 |
Tooth Eruption/*physiology | 2 | 50.0 |
DNA/genetics | 37 | 1.0 |
Antigens, Polyomavirus Transforming | 2 | 20.0 |
Receptors, Androgen/genetics | 2 | 3.0 |
Collagen/*physiology | 2 | 10.0 |
Potassium/*analysis | 2 | 66.0 |
Sodium/*analysis | 2 | 40.0 |
Recombinant Proteins/isolation & purification/metabolism | 4 | 2.0 |
*Neoplasm Transplantation | 2 | 20.0 |
RNA, Neoplasm/analysis/genetics | 3 | 15.0 |
Kidney/physiology | 2 | 3.0 |
Transforming Growth Factor alpha/secretion | 4 | 80.0 |
Neoplasms/*drug therapy | 3 | 2.0 |
Thyroid Gland/pathology | 2 | 6.0 |
Thyrotropin/physiology | 3 | 33.0 |
Adenomatous Polyposis Coli/pathology | 2 | 50.0 |
Transforming Growth Factor alpha/*urine | 2 | 100.0 |
Tumor Markers, Biological/*urine | 5 | 19.0 |
Carcinoma, Squamous Cell/*chemistry | 4 | 20.0 |
Protein p53/analysis | 4 | 1.0 |
Proto-Oncogene Protein p21(ras)/analysis | 2 | 33.0 |
Insulin-Like Growth Factor Binding Proteins | 8 | 21.0 |
Somatomedins/*metabolism | 11 | 44.0 |
*Mutagenesis, Site-Directed | 5 | 5.0 |
DNA/chemistry | 4 | 1.0 |
Electrochemistry | 3 | 3.0 |
Microtubules/physiology | 2 | 12.0 |
Melanocytes/*metabolism | 2 | 5.0 |
Melanoma/*metabolism/pathology | 2 | 5.0 |
Rodentia | 3 | 3.0 |
Gastrin-Releasing Peptide | 3 | 3.0 |
Growth Hormone/blood | 3 | 1.0 |
Protein Precursors/analysis | 2 | 4.0 |
Epidermal Growth Factor/*administration & dosage/pharmacology | 2 | 100.0 |
Estradiol/*biosynthesis | 4 | 40.0 |
Hepatocyte Growth Factor/*biosynthesis | 2 | 6.0 |
Estradiol Antagonists/pharmacology | 2 | 66.0 |
Receptors, Estradiol/*metabolism | 2 | 18.0 |
Neoplasm Metastasis/*genetics | 2 | 3.0 |
Cell Division/immunology | 2 | 0.0 |
Heparin Lyase | 2 | 12.0 |
*Brain Chemistry | 2 | 1.0 |
Breast Neoplasms/metabolism/pathology/*physiopathology | 3 | 100.0 |
P-Selectin | 3 | 5.0 |
Umbilical Veins/cytology/drug effects | 2 | 22.0 |
Insulin-Like Growth Factor I/antagonists & inhibitors/*pharmacology | 2 | 50.0 |
Receptors, Androgen/*metabolism | 4 | 3.0 |
Dimethyl Sulfoxide/pharmacology | 3 | 3.0 |
Intermediate Filament Proteins/analysis | 3 | 7.0 |
Glioblastoma/*genetics | 3 | 4.0 |
Dinoprostone/*metabolism | 3 | 7.0 |
Pancreatitis/*metabolism | 2 | 18.0 |
Phosphorus Radioisotopes | 7 | 11.0 |
Phosphoserine/metabolism | 5 | 6.0 |
Phosphothreonine/metabolism | 5 | 11.0 |
Radioisotope Dilution Technique | 3 | 9.0 |
Baculoviridae | 2 | 3.0 |
DNA/*biosynthesis/*drug effects | 2 | 100.0 |
Receptors, Cholecystokinin/*antagonists & inhibitors | 2 | 12.0 |
Cornea/drug effects | 3 | 50.0 |
Ophthalmic Solutions | 7 | 33.0 |
Growth Substances/analysis | 4 | 40.0 |
Ovarian Neoplasms/*chemistry | 2 | 15.0 |
Endothelium, Vascular/*drug effects | 3 | 5.0 |
Microcirculation/cytology | 2 | 10.0 |
Omentum/blood supply | 3 | 75.0 |
Tumor Necrosis Factor-alpha/metabolism/*pharmacology | 2 | 3.0 |
Suramin/pharmacology | 4 | 11.0 |
Phosphoproteins/isolation & purification/*metabolism | 2 | 6.0 |
Epidermal Growth Factor/*administration & dosage/metabolism | 2 | 100.0 |
Cinnamates/*pharmacology | 3 | 33.0 |
Solvents/pharmacology | 2 | 8.0 |
Trypsin/pharmacology | 7 | 4.0 |
Cell Transformation, Neoplastic/*pathology | 2 | 7.0 |
Radioimmunoassay/methods | 6 | 3.0 |
Endometriosis/*metabolism/pathology | 2 | 12.0 |
Catechols/*pharmacology | 3 | 25.0 |
Protein Sorting Signals/genetics | 2 | 2.0 |
Breast/cytology/*metabolism | 2 | 8.0 |
Adrenal Glands/metabolism | 2 | 4.0 |
Androgens/*biosynthesis | 2 | 12.0 |
Testosterone/biosynthesis | 3 | 25.0 |
Factor IXa/metabolism | 5 | 50.0 |
Factor X/metabolism | 2 | 3.0 |
Gingiva/*cytology/metabolism | 2 | 66.0 |
Hyaluronic Acid/biosynthesis | 2 | 20.0 |
Interleukin-1/physiology | 3 | 3.0 |
Prostatic Hyperplasia/*etiology | 2 | 100.0 |
Decidua/*physiology | 3 | 16.0 |
Natriuretic Peptide, Brain | 2 | 9.0 |
Adenocarcinoma/enzymology | 2 | 15.0 |
Breast Neoplasms/enzymology | 2 | 11.0 |
Carcinoma, Squamous Cell/enzymology | 2 | 20.0 |
Thyroid Neoplasms/*pathology | 2 | 10.0 |
Italy | 2 | 0.0 |
Receptors, LDL/*genetics/metabolism | 3 | 10.0 |
Melatonin/*physiology | 2 | 66.0 |
Genes, fos/*drug effects | 2 | 33.0 |
Cricetulus | 9 | 1.0 |
Liver/drug effects/*metabolism | 2 | 2.0 |
Proteoglycans/*genetics | 3 | 5.0 |
Eflornithine/pharmacology | 3 | 21.0 |
Hydrocortisone/*pharmacology | 9 | 23.0 |
Dehydroepiandrosterone/biosynthesis | 2 | 28.0 |
Theca Cells/drug effects/*metabolism | 2 | 33.0 |
Cell Hypoxia | 2 | 1.0 |
Thyroid Gland/cytology/*drug effects/metabolism | 2 | 40.0 |
Granulosa Cells/cytology/*drug effects/metabolism | 2 | 66.0 |
DNA, Satellite/genetics | 2 | 1.0 |
Fertility/*genetics | 2 | 12.0 |
Receptors, Cell Surface | 3 | 9.0 |
Insulin-Like Growth Factor I/metabolism/*physiology | 3 | 33.0 |
*Genes, Immediate-Early | 2 | 6.0 |
Chromatography, Agarose | 3 | 6.0 |
Receptor, erbB-2/*antagonists & inhibitors/genetics/metabolism | 2 | 66.0 |
Receptors, Estrogen/*analysis | 9 | 3.0 |
Receptors, Progesterone/*analysis | 2 | 0.0 |
Moths | 3 | 6.0 |
Stomach Neoplasms/*drug therapy/metabolism/pathology | 2 | 40.0 |
Epidermal Growth Factor/antagonists & inhibitors/metabolism | 2 | 50.0 |
Lewis Blood-Group System/*immunology | 2 | 22.0 |
Tunicamycin/pharmacology | 7 | 8.0 |
Antigens, Polyomavirus Transforming/genetics | 2 | 6.0 |
Cytokines/genetics | 2 | 1.0 |
Proteins/chemistry/*physiology | 2 | 9.0 |
Receptor, Insulin/genetics | 2 | 16.0 |
Anti-Inflammatory Agents, Non-Steroidal/*therapeutic use | 3 | 8.0 |
Genes, p53/genetics | 2 | 0.0 |
Glycoproteins/*analysis | 2 | 2.0 |
*Cysteine | 2 | 5.0 |
Papillomavirus, Human | 2 | 5.0 |
RNA, Messenger/*biosynthesis/genetics | 2 | 3.0 |
Cervix Neoplasms/metabolism | 2 | 22.0 |
DNA Restriction Enzymes/metabolism | 4 | 4.0 |
Muscle, Smooth/chemistry | 2 | 8.0 |
Ovarian Neoplasms/metabolism | 2 | 5.0 |
Enhancer Elements (Genetics) | 4 | 1.0 |
Theophylline/pharmacology | 2 | 5.0 |
Oncogene Proteins, Viral/genetics/*metabolism | 3 | 10.0 |
Neoplasms, Experimental/*pathology | 2 | 18.0 |
Ovary/*chemistry | 3 | 17.0 |
Transforming Growth Factors/*analysis | 2 | 100.0 |
Receptor, Epidermal Growth Factor/*chemistry/isolation & purification | 2 | 100.0 |
*Complement Inactivators | 3 | 3.0 |
Methionine/metabolism | 10 | 7.0 |
Epidermal Growth Factor/antagonists & inhibitors/*physiology | 3 | 100.0 |
Epidermal Growth Factor/chemistry/*physiology | 2 | 66.0 |
Tyrosine/*analogs & derivatives/analysis/metabolism | 2 | 22.0 |
Lipoproteins, LDL/*metabolism | 4 | 2.0 |
Aminoisobutyric Acids/*metabolism | 3 | 75.0 |
Trophoblasts/drug effects/*metabolism | 4 | 50.0 |
*S Phase | 2 | 3.0 |
Furans/*pharmacology | 2 | 16.0 |
Phenols/*pharmacology | 3 | 8.0 |
Proto-Oncogene Proteins/analysis | 5 | 2.0 |
Protein Precursors/*metabolism | 4 | 5.0 |
Proteins/*physiology | 2 | 1.0 |
Choriocarcinoma/*genetics/metabolism/pathology | 2 | 66.0 |
Receptor, Epidermal Growth Factor/analysis/*drug effects | 6 | 66.0 |
Receptors, Androgen/analysis | 2 | 6.0 |
Stromal Cells/physiology | 2 | 3.0 |
Gold | 3 | 13.0 |
Microscopy, Electron/methods | 2 | 3.0 |
RNA Probes | 5 | 3.0 |
Breast Neoplasms/chemistry/*metabolism | 2 | 18.0 |
Sodium Fluoride/pharmacology | 2 | 8.0 |
Tyrosine/*analogs & derivatives/metabolism | 6 | 11.0 |
Keratinocytes/enzymology/metabolism/*radiation effects | 2 | 100.0 |
Receptor, Epidermal Growth Factor/*metabolism/radiation effects | 2 | 100.0 |
*Epidermal Growth Factor/metabolism | 3 | 100.0 |
Transglutaminases/*metabolism | 2 | 6.0 |
Prolactin/biosynthesis | 2 | 14.0 |
Meningeal Neoplasms/*metabolism | 3 | 17.0 |
Arachidonic Acids/pharmacology | 2 | 6.0 |
Carbon Radioisotopes | 2 | 2.0 |
Vitamin E/pharmacology | 2 | 6.0 |
Models, Statistical | 2 | 1.0 |
Oncogene Proteins v-erbB | 5 | 55.0 |
Electrophoresis, Agar Gel | 4 | 0.0 |
Factor IX/*chemistry/metabolism | 2 | 66.0 |
Glutamic Acid | 2 | 2.0 |
Breast Neoplasms/chemistry/*pathology | 3 | 17.0 |
Ribs | 2 | 40.0 |
Saliva/physiology | 2 | 40.0 |
Semen/*chemistry | 2 | 7.0 |
Basement Membrane/drug effects/physiology | 2 | 100.0 |
Neoplasm Proteins/biosynthesis/genetics | 2 | 1.0 |
Receptors, Platelet-Derived Growth Factor/genetics/metabolism | 2 | 28.0 |
Epidermal Growth Factor/chemistry/physiology | 2 | 100.0 |
Ki-67 Antigen | 6 | 2.0 |
Nuclear Proteins/analysis | 5 | 2.0 |
Fibroblasts/chemistry/pathology | 2 | 33.0 |
Fibronectins/*analysis | 3 | 13.0 |
Menotropins/therapeutic use | 2 | 14.0 |
Peritoneal Cavity | 2 | 20.0 |
Vitamin A/pharmacology | 3 | 21.0 |
Adaptor Proteins, Vesicular Transport/metabolism | 2 | 13.0 |
Epidermal Growth Factor/pharmacokinetics/*pharmacology | 5 | 100.0 |
Electron Spin Resonance Spectroscopy | 2 | 0.0 |
Receptor, Epidermal Growth Factor/analysis/biosynthesis/*physiology | 2 | 100.0 |
Breast Neoplasms/pathology/*therapy | 2 | 16.0 |
Carcinoembryonic Antigen/blood | 2 | 3.0 |
Peptides/*antagonists & inhibitors | 3 | 60.0 |
Receptor, Epidermal Growth Factor/analysis/metabolism | 6 | 85.0 |
Gastrointestinal Hormones/*physiology | 2 | 13.0 |
Somatostatin/physiology | 3 | 14.0 |
Antigens, CD15 | 2 | 6.0 |
Transforming Growth Factor alpha/*secretion | 2 | 100.0 |
Follicular Phase/physiology | 4 | 28.0 |
Transforming Growth Factor alpha/*chemistry/metabolism | 2 | 100.0 |
*Gravitation | 3 | 30.0 |
Platelet-Derived Growth Factor/*genetics | 2 | 6.0 |
Receptors, Progesterone/*genetics | 2 | 9.0 |
Epidermal Growth Factor/*genetics/physiology | 3 | 75.0 |
Intercellular Adhesion Molecule-1 | 4 | 1.0 |
Polymerase Chain Reaction/*methods | 2 | 0.0 |
Isoelectric Focusing | 4 | 0.0 |
Bombesin/*analogs & derivatives/pharmacology | 2 | 100.0 |
Immunotoxins/*therapeutic use | 2 | 4.0 |
Pseudomonas aeruginosa | 2 | 11.0 |
Breast Neoplasms/genetics/*pathology | 2 | 4.0 |
Actins/analysis/*physiology | 2 | 66.0 |
Epithelium/physiology/ultrastructure | 2 | 33.0 |
Immunoglobulin G/*metabolism | 2 | 3.0 |
Swine/*physiology | 2 | 66.0 |
Membrane Proteins/isolation & purification/metabolism | 3 | 37.0 |
Reoviridae/*physiology | 2 | 100.0 |
Sulfur Radioisotopes | 3 | 4.0 |
Gonadorelin/pharmacology | 4 | 8.0 |
Proliferating Cell Nuclear Antigen | 10 | 4.0 |
Interferon Type I, Recombinant/*pharmacology | 2 | 4.0 |
RNA, Neoplasm/isolation & purification | 4 | 13.0 |
Epidermal Growth Factor/administration & dosage | 4 | 100.0 |
Esophageal Neoplasms | 2 | 100.0 |
*Epithelial Cells | 4 | 44.0 |
Diethylstilbestrol/*pharmacology | 2 | 12.0 |
Epidermal Growth Factor/genetics/physiology | 3 | 100.0 |
Tooth Abnormalities/genetics | 2 | 25.0 |
Amnion | 2 | 20.0 |
Chromosome Deletion | 17 | 2.0 |
Simian virus 40/genetics | 3 | 2.0 |
Substance P/pharmacology | 2 | 6.0 |
Oocytes/enzymology | 2 | 20.0 |
Serine Endopeptidases/metabolism | 4 | 3.0 |
Chemical Fractionation | 2 | 2.0 |
Cell Division/radiation effects | 3 | 6.0 |
1-(5-Isoquinolinesulfonyl)-2-methylpiperazine | 3 | 5.0 |
Piperazines/pharmacology | 3 | 2.0 |
Tissue Plasminogen Activator/metabolism | 3 | 8.0 |
Neoplasms/*physiopathology | 2 | 7.0 |
Teriparatide | 2 | 12.0 |
Trophoblasts/*cytology/metabolism | 2 | 28.0 |
Cheek | 4 | 14.0 |
Mucins/*physiology | 2 | 15.0 |
Granulocyte-Macrophage Colony-Stimulating Factor/*pharmacology | 2 | 1.0 |
Nuclear Proteins/*analysis | 4 | 2.0 |
Blood Coagulation | 2 | 1.0 |
Actins/drug effects/*metabolism | 2 | 33.0 |
Prostaglandins/pharmacology | 2 | 25.0 |
Transforming Growth Factor alpha/biosynthesis/*pharmacology | 3 | 100.0 |
Methylation | 4 | 0.0 |
alpha-Macroglobulins/*metabolism | 3 | 9.0 |
Fibrinogen/metabolism | 3 | 1.0 |
Cyclic AMP/*physiology | 6 | 7.0 |
*Chromosomes, Human, Pair 4 | 4 | 1.0 |
Recombination, Genetic | 3 | 0.0 |
*Cell Transformation, Neoplastic/drug effects | 2 | 33.0 |
Interferon-beta/*pharmacology | 2 | 3.0 |
Energy Metabolism | 3 | 1.0 |
Adenocarcinoma/metabolism/pathology | 3 | 5.0 |
*Regulatory Sequences, Nucleic Acid | 3 | 0.0 |
Chorion/*metabolism | 2 | 40.0 |
Lung Neoplasms/*secretion | 2 | 66.0 |
Escherichia coli/genetics | 10 | 1.0 |
Potassium/metabolism | 3 | 2.0 |
Anticoagulants | 2 | 10.0 |
Receptors, Thrombin | 11 | 22.0 |
Endometrial Neoplasms/*pathology | 2 | 18.0 |
Receptors, Transforming Growth Factor beta | 4 | 57.0 |
Glycoside Hydrolases | 4 | 15.0 |
Oligosaccharides/*chemistry/isolation & purification | 2 | 25.0 |
Peptide Fragments/isolation & purification | 7 | 12.0 |
*Serine | 3 | 8.0 |
Threonine | 2 | 3.0 |
Meiosis/drug effects | 3 | 75.0 |
Oocytes/drug effects/*physiology | 2 | 28.0 |
Thymus Gland/*metabolism | 2 | 11.0 |
Epidermal Growth Factor/analysis/*genetics | 3 | 100.0 |
Cells, Cultured/drug effects | 4 | 4.0 |
Oleic Acids/metabolism | 2 | 9.0 |
Cats | 3 | 0.0 |
Endothelium, Corneal/*drug effects/injuries/pathology | 2 | 100.0 |
Vitamin A/*pharmacology | 2 | 33.0 |
Pseudogenes | 2 | 1.0 |
Receptor, Epidermal Growth Factor/drug effects/immunology/*physiology | 2 | 100.0 |
Salivary Proteins/analysis/*secretion | 2 | 100.0 |
Secretory Rate | 2 | 6.0 |
Thymidine/diagnostic use | 8 | 57.0 |
Gastrointestinal Hormones/physiology | 2 | 40.0 |
Somatostatin/*therapeutic use | 2 | 50.0 |
Growth Inhibitors/*blood | 2 | 10.0 |
Precipitation | 4 | 2.0 |
DNA/genetics/isolation & purification | 2 | 0.0 |
RNA/genetics/isolation & purification | 8 | 6.0 |
Receptor, TIE-2 | 2 | 3.0 |
Collagenases/secretion | 2 | 40.0 |
Dinoprostone/pharmacology | 4 | 4.0 |
Carcinoma, Hepatocellular/*enzymology | 2 | 8.0 |
Liver Neoplasms/*enzymology | 2 | 8.0 |
Epidermal Growth Factor/*metabolism/*pharmacology | 3 | 75.0 |
Cervix Neoplasms/*metabolism | 5 | 15.0 |
Transforming Growth Factor alpha/*analysis/biosynthesis | 2 | 66.0 |
Endothelium, Vascular/*cytology/drug effects | 5 | 11.0 |
Plasminogen Activators/*metabolism | 4 | 18.0 |
Peptides/*secretion | 2 | 15.0 |
Oxytocin/pharmacology | 2 | 18.0 |
Injections | 5 | 4.0 |
Sphingomyelins/analysis | 2 | 25.0 |
Thyroxine/*pharmacology | 2 | 15.0 |
Culture Techniques/*methods | 3 | 14.0 |
Cytoplasm/*physiology | 2 | 40.0 |
Oocytes/physiology/*ultrastructure | 2 | 100.0 |
Tumor Cells, Cultured/metabolism/pathology | 2 | 4.0 |
Breast Neoplasms/*metabolism/surgery | 2 | 40.0 |
Saliva/metabolism | 4 | 13.0 |
Proteochondroitin Sulfates/*genetics | 2 | 20.0 |
*RNA Splicing | 2 | 0.0 |
Prothrombin/metabolism | 2 | 2.0 |
Chymotrypsin/metabolism | 2 | 5.0 |
Epidermal Growth Factor/analysis/metabolism/*pharmacology | 2 | 100.0 |
Pancreatic Juice/metabolism | 2 | 22.0 |
Endocytosis/drug effects/physiology | 2 | 18.0 |
Chondrocytes/metabolism | 2 | 5.0 |
Lectins | 5 | 5.0 |
Tenascin/*chemistry | 2 | 66.0 |
Embryo Implantation/drug effects/physiology | 2 | 66.0 |
Chromatography, High Pressure Liquid/methods | 2 | 1.0 |
Oncogene Protein p21(ras)/*genetics | 2 | 33.0 |
Collagenases/*biosynthesis | 2 | 14.0 |
Skin Neoplasms/*genetics/pathology | 2 | 3.0 |
*Genes, src | 2 | 5.0 |
Cell Fractionation/methods | 4 | 18.0 |
Carcinoma, Squamous Cell/*chemistry/pathology | 2 | 8.0 |
Mouth Mucosa/chemistry | 2 | 50.0 |
Mouth Neoplasms/*chemistry/pathology | 2 | 22.0 |
*Ear, Middle | 3 | 75.0 |
Triiodothyronine/*pharmacology | 3 | 6.0 |
Centrifugation, Density Gradient | 9 | 2.0 |
Extracellular Space/*metabolism | 2 | 15.0 |
Receptor, Epidermal Growth Factor/analysis/drug effects | 2 | 50.0 |
Tetrazolium Salts/diagnostic use | 3 | 16.0 |
Thiazoles/diagnostic use | 2 | 15.0 |
Receptor, Insulin/*physiology | 2 | 22.0 |
Cyclic AMP/physiology | 3 | 2.0 |
Colorectal Neoplasms/*chemistry/pathology | 2 | 12.0 |
*Embryo Implantation | 3 | 12.0 |
Alanine/chemistry | 2 | 2.0 |
DNA, Neoplasm/genetics/isolation & purification | 4 | 3.0 |
RNA, Neoplasm/genetics/isolation & purification | 5 | 7.0 |
Luteal Cells/*metabolism | 2 | 50.0 |
Histocytochemistry/*methods | 2 | 20.0 |
Salivary Glands/*metabolism | 2 | 14.0 |
Tissue Extracts/*pharmacology | 4 | 16.0 |
Epidermis/*drug effects/metabolism | 4 | 66.0 |
Insulin-Like Growth Factor I/*antagonists & inhibitors | 2 | 66.0 |
Transforming Growth Factor alpha/genetics/pharmacology/*physiology | 3 | 75.0 |
European Continental Ancestry Group/genetics | 3 | 0.0 |
Carcinoma, Squamous Cell/*genetics | 6 | 3.0 |
Platelet-Derived Growth Factor/genetics | 2 | 6.0 |
Placenta/*drug effects/secretion | 2 | 50.0 |
Exudates and Transudates | 2 | 15.0 |
Esophageal Diseases/*metabolism | 2 | 100.0 |
Chorionic Gonadotropin/metabolism | 2 | 6.0 |
Insulin-Like Growth Factor II/*metabolism | 3 | 11.0 |
Lectins/pharmacology | 2 | 5.0 |
Fibroblast Growth Factor 2/*administration & dosage | 3 | 100.0 |
Interleukin-1/*administration & dosage | 2 | 28.0 |
Platelet-Derived Growth Factor/*administration & dosage | 2 | 100.0 |
Cytochalasin B/pharmacology | 7 | 7.0 |
Inositol Phosphates/*biosynthesis | 3 | 37.0 |
Epidermal Growth Factor/*administration & dosage/therapeutic use | 2 | 100.0 |
Lung Neoplasms/*chemistry | 2 | 11.0 |
Xenopus laevis | 2 | 0.0 |
Endoplasmic Reticulum/*metabolism | 3 | 2.0 |
Protein Transport/*physiology | 3 | 6.0 |
Lung Neoplasms/pathology | 4 | 7.0 |
Tumor Virus Infections/*pathology | 2 | 22.0 |
Blood Proteins/physiology | 3 | 16.0 |
Prostate/*cytology | 2 | 22.0 |
Placenta/chemistry | 2 | 6.0 |
Tyrosine/*analogs & derivatives/analysis | 2 | 18.0 |
Endometrium/cytology/*metabolism | 3 | 10.0 |
Epitopes/*immunology | 3 | 1.0 |
Creatinine/metabolism | 2 | 2.0 |
Electrolytes/metabolism | 3 | 16.0 |
Aging/blood | 2 | 3.0 |
Stromelysin 1 | 10 | 26.0 |
Ion Transport | 2 | 2.0 |
Isoelectric Point | 8 | 6.0 |
*Genes, myc | 4 | 1.0 |
Metaplasia | 3 | 3.0 |
Placebos | 2 | 0.0 |
South Africa | 2 | 1.0 |
Chorionic Gonadotropin/secretion | 2 | 15.0 |
Placental Lactogen/*secretion | 2 | 50.0 |
Proto-Oncogene Protein p21(ras)/*analysis | 2 | 40.0 |
Proto-Oncogene Proteins/*analysis | 6 | 3.0 |
Proto-Oncogene Proteins c-myc/*analysis | 2 | 15.0 |
Pancreas/chemistry | 2 | 8.0 |
Retroviridae Proteins, Oncogenic/*genetics | 2 | 9.0 |
Haplorhini | 2 | 0.0 |
Na(+)-K(+)-Exchanging ATPase/*metabolism | 3 | 7.0 |
Receptors, Vasoactive Intestinal Peptide | 2 | 3.0 |
Anti-Inflammatory Agents, Non-Steroidal/pharmacology | 2 | 2.0 |
Membrane Glycoproteins/*analysis | 3 | 2.0 |
P-Glycoprotein | 2 | 4.0 |
Tamoxifen/analogs & derivatives/therapeutic use | 2 | 100.0 |
Receptors, Fibroblast Growth Factor/*metabolism | 2 | 3.0 |
Insulin-Like Growth Factor Binding Protein 1 | 2 | 9.0 |
Eye Proteins/metabolism | 2 | 7.0 |
Diet | 2 | 0.0 |
Plant Lectins | 3 | 6.0 |
Receptors, Estradiol/physiology | 2 | 66.0 |
Glucagon/pharmacology | 3 | 10.0 |
Histocompatibility Antigens Class I/analysis | 2 | 2.0 |
Carbohydrates/analysis | 3 | 4.0 |
Fetal Blood | 3 | 2.0 |
Carrier Proteins/*analysis/genetics | 2 | 8.0 |
Growth Substances/chemistry/*physiology | 2 | 66.0 |
Amnion/cytology/*drug effects/metabolism | 2 | 100.0 |
Growth Substances/*isolation & purification/pharmacology | 2 | 50.0 |
Receptors, Neurotransmitter/*metabolism | 2 | 7.0 |
Receptors, Somatostatin | 7 | 46.0 |
Cyclic AMP/*biosynthesis | 2 | 7.0 |
Receptors, Somatomedin | 23 | 53.0 |
Cross-Linking Reagents/*pharmacology | 2 | 8.0 |
Alprostadil/pharmacology | 2 | 7.0 |
Inositol Phosphates/isolation & purification/*metabolism | 2 | 50.0 |
Phosphotransferases/*metabolism | 5 | 12.0 |
Receptors, Cell Surface/drug effects/*physiology | 2 | 16.0 |
Vasopressins/pharmacology | 4 | 25.0 |
*Mitogens | 10 | 38.0 |
Food | 2 | 1.0 |
Calcium Radioisotopes/diagnostic use | 2 | 40.0 |
Ouabain/pharmacology | 5 | 8.0 |
Receptor, Epidermal Growth Factor/genetics/metabolism/*physiology | 2 | 33.0 |
Peptide Fragments/analysis | 11 | 4.0 |
Neoplasms/immunology/*therapy | 2 | 3.0 |
Vaccination | 2 | 1.0 |
Somatostatin/*physiology | 3 | 27.0 |
Blood Proteins/*metabolism | 2 | 1.0 |
Recombinant Fusion Proteins/*genetics/metabolism | 2 | 22.0 |
Cell Membrane/enzymology/metabolism | 2 | 9.0 |
Isoenzymes/isolation & purification/*metabolism | 2 | 18.0 |
Oligopeptides/chemical synthesis | 3 | 37.0 |
Phospholipase C/isolation & purification/*metabolism | 2 | 50.0 |
Receptors, Platelet-Derived Growth Factor | 18 | 58.0 |
Epidermal Growth Factor/analysis/*blood | 2 | 100.0 |
Skin Neoplasms/metabolism/pathology | 2 | 25.0 |
Semen/*metabolism | 2 | 11.0 |
Cell Hypoxia/*drug effects | 2 | 40.0 |
Somatomedins/*biosynthesis | 3 | 60.0 |
Receptors, Aryl Hydrocarbon | 3 | 18.0 |
Receptors, Estrogen/drug effects/metabolism | 2 | 14.0 |
Phosphothreonine/*metabolism | 2 | 40.0 |
Antigens, Differentiation/*analysis | 2 | 1.0 |
1-Carboxyglutamic Acid/chemistry | 3 | 33.0 |
Transforming Growth Factor alpha/genetics/physiology | 2 | 40.0 |
Maxillary Neoplasms/metabolism/*pathology | 2 | 100.0 |
Milk/*analysis | 3 | 50.0 |
Luteal Phase/physiology | 2 | 9.0 |
Cytological Techniques | 2 | 5.0 |
Blood Platelets/physiology | 2 | 3.0 |
Plasminogen Inactivators/*metabolism | 2 | 11.0 |
Thyroid Neoplasms/*metabolism/pathology | 2 | 4.0 |
Heterozygote | 2 | 0.0 |
Insulin/metabolism | 7 | 5.0 |
Receptor, Insulin/*genetics/metabolism | 2 | 22.0 |
*Tumor Stem Cell Assay | 2 | 15.0 |
Epidermal Growth Factor/physiology/*therapeutic use | 2 | 100.0 |
Receptors, Thyroid Hormone/genetics/*metabolism | 2 | 9.0 |
Colon/metabolism | 2 | 1.0 |
Receptors, Progesterone/*metabolism | 2 | 1.0 |
Cornea/*metabolism | 2 | 15.0 |
Mathematics | 3 | 1.0 |
Cyclins/analysis | 2 | 4.0 |
Alkaloids/*pharmacology | 2 | 3.0 |
Receptors, Cell Surface/immunology/*metabolism | 6 | 19.0 |
Epidermal Growth Factor/*analysis/pharmacology | 2 | 100.0 |
*Threonine | 8 | 40.0 |
Thrombin/*metabolism | 3 | 3.0 |
Radiotherapy Dosage | 2 | 1.0 |
Steroids/*pharmacology | 3 | 15.0 |
Phospholipids/analysis | 2 | 5.0 |
Epithelium/metabolism/physiology | 2 | 28.0 |
Cell Nucleus/chemistry | 2 | 1.0 |
Amylases/metabolism | 3 | 15.0 |
Nucleotidases/metabolism | 2 | 25.0 |
Vulvar Neoplasms/pathology | 4 | 66.0 |
Bacteriophage lambda/genetics | 2 | 4.0 |
Protein Kinase C/genetics | 2 | 16.0 |
Protein-Serine-Threonine Kinases | 3 | 15.0 |
Receptors, Fibroblast Growth Factor | 3 | 13.0 |
Adenoviruses, Human/*genetics | 2 | 1.0 |
Oligosaccharides/metabolism | 3 | 6.0 |
Chlorides/pharmacology | 4 | 11.0 |
Fluorides/pharmacology | 2 | 7.0 |
Phosphates/pharmacology | 2 | 18.0 |
Receptor, Epidermal Growth Factor/*analysis/drug effects | 2 | 100.0 |
Microscopy, Immunoelectron/methods | 2 | 12.0 |
Oligodeoxyribonucleotides/chemical synthesis | 2 | 14.0 |
Hepatocyte Growth Factor | 4 | 8.0 |
Liver/*cytology/drug effects/metabolism | 2 | 25.0 |
Prostaglandins/physiology | 2 | 11.0 |
Receptors, Neurotransmitter/*physiology | 2 | 25.0 |
Pituitary Gland/physiology | 2 | 7.0 |
Virus Replication | 2 | 0.0 |
Cytoskeleton/*drug effects | 2 | 20.0 |
Bladder Neoplasms/*urine | 3 | 60.0 |
Carcinoma, Transitional Cell/*urine | 2 | 66.0 |
Kidney Neoplasms/*urine | 2 | 100.0 |
Lactation | 10 | 19.0 |
Hela Cells/metabolism | 7 | 4.0 |
Enzyme Precursors/biosynthesis | 3 | 33.0 |
Penis | 2 | 50.0 |
Monocyte Chemoattractant Protein-1/metabolism | 2 | 3.0 |
*Apolipoproteins | 2 | 6.0 |
Fibrocystic Breast Disease/*metabolism | 4 | 100.0 |
Thyrotropin/*physiology | 2 | 18.0 |
Blood Coagulation Tests | 2 | 1.0 |
Second Messenger Systems/*drug effects | 2 | 50.0 |
Triptorelin | 6 | 42.0 |
Drosophila/genetics | 3 | 2.0 |
Epoprostenol/*biosynthesis | 4 | 16.0 |
Epithelium/metabolism/physiopathology | 2 | 40.0 |
Transforming Growth Factor beta/biosynthesis/*pharmacology | 2 | 40.0 |
Carcinogenicity Tests | 2 | 2.0 |
Insulin-Like Growth Factor II/*pharmacology | 3 | 23.0 |
Receptor, IGF Type 2 | 2 | 28.0 |
Receptors, Transferrin/drug effects/*metabolism | 2 | 100.0 |
Parathyroid Hormone/metabolism | 2 | 10.0 |
*Antibodies, Monoclonal | 9 | 3.0 |
Keratinocytes/drug effects | 2 | 33.0 |
Estrone/metabolism | 2 | 15.0 |
RNA, Messenger/drug effects/genetics | 3 | 13.0 |
Inositol 1,4,5-Trisphosphate/*biosynthesis | 2 | 50.0 |
Epidermal Growth Factor/biosynthesis/*physiology | 2 | 100.0 |
Microvilli/enzymology | 2 | 9.0 |
Ovarian Neoplasms/pathology/*physiopathology | 2 | 25.0 |
Cornea/metabolism | 3 | 20.0 |
Endothelium, Corneal/metabolism | 2 | 28.0 |
*Cell Line | 3 | 6.0 |
Lovastatin/*pharmacology | 2 | 9.0 |
Plasminogen Inactivators/metabolism | 3 | 18.0 |
Ethers, Cyclic/*pharmacology | 2 | 16.0 |
Cytarabine/pharmacology | 2 | 4.0 |
Fetus/*cytology | 2 | 11.0 |
Biopsy, Needle | 3 | 0.0 |
Cell Size/drug effects/physiology | 2 | 10.0 |
Laminin/biosynthesis | 2 | 15.0 |
Progestins/pharmacology | 3 | 27.0 |
Polymers/metabolism | 3 | 6.0 |
Protein Kinase C | 8 | 53.0 |
Eye Diseases/metabolism | 2 | 50.0 |
Lacrimal Apparatus/*metabolism | 2 | 28.0 |
Peplomycin | 2 | 40.0 |
Poly A/genetics/isolation & purification | 3 | 8.0 |
Electric Stimulation | 2 | 0.0 |
Fibroblast Growth Factors/*biosynthesis | 2 | 28.0 |
Membrane Potentials | 2 | 0.0 |
Receptors, Retinoic Acid | 2 | 3.0 |
Medroxyprogesterone 17-Acetate | 4 | 13.0 |
Sodium-Hydrogen Antiporter | 10 | 43.0 |
Immune Sera/immunology | 3 | 1.0 |
Transforming Growth Factors/pharmacology | 9 | 50.0 |
Receptor, Insulin/drug effects | 3 | 60.0 |
Mannans/metabolism | 2 | 13.0 |
Carcinoma, Hepatocellular/*chemistry | 2 | 9.0 |
Liver Neoplasms/*chemistry | 2 | 8.0 |
Lysosomes/*drug effects/metabolism | 2 | 66.0 |
Epidermal Growth Factor/chemistry/*genetics/physiology | 2 | 100.0 |
Amnion/drug effects/*metabolism | 4 | 57.0 |
Prostaglandins/*biosynthesis | 3 | 6.0 |
Goserelin | 3 | 30.0 |
Progesterone/physiology | 2 | 20.0 |
*Skin, Artificial | 2 | 20.0 |
Glioma/*radiotherapy | 2 | 50.0 |
Receptor, Epidermal Growth Factor/*analysis/physiology | 3 | 42.0 |
Leydig Cells/drug effects/*physiology | 2 | 50.0 |
Proto-Oncogene Proteins c-fos | 4 | 7.0 |
Ascorbic Acid/*pharmacology | 2 | 6.0 |
Tenascin | 2 | 18.0 |
Protein Kinases/*isolation & purification | 4 | 100.0 |
Glioblastoma/*physiopathology | 2 | 50.0 |
Growth Substances/*isolation & purification | 4 | 36.0 |
Sertoli Cells/*secretion | 2 | 66.0 |
Phosphoproteins/analysis | 3 | 8.0 |
*Genes | 2 | 0.0 |
Oligonucleotides/chemistry | 2 | 1.0 |
*Receptor Aggregation | 2 | 15.0 |
*Tyrosine/analogs & derivatives/analysis | 2 | 66.0 |
Protein C/*physiology | 2 | 3.0 |
Protein S | 4 | 7.0 |
Fibroblasts/*cytology/metabolism | 2 | 12.0 |
Neoplasms, Experimental/etiology | 2 | 20.0 |
Proto-Oncogene Proteins/pharmacology | 2 | 9.0 |
Periodontitis/*metabolism | 2 | 20.0 |
Carbohydrates/metabolism | 3 | 5.0 |
Serum Albumin/pharmacology | 3 | 8.0 |
Autoantigens/metabolism | 2 | 4.0 |
Epithelium/immunology/metabolism | 2 | 7.0 |
Receptors, Cell Surface/drug effects/metabolism | 4 | 28.0 |
Genes, Regulator | 3 | 2.0 |
Evolution | 5 | 1.0 |
Kidney Tubules, Proximal/cytology/*metabolism | 2 | 18.0 |
Mitogen-Activated Protein Kinase 1/antagonists & inhibitors/metabolism | 2 | 8.0 |
Carcinoma, Hepatocellular/metabolism/*pathology | 2 | 11.0 |
Liver Neoplasms/metabolism/*pathology | 2 | 11.0 |
Breast Neoplasms/*genetics/metabolism | 4 | 3.0 |
*Chemotaxis | 2 | 6.0 |
Antigens/immunology | 2 | 1.0 |
Carboxylic Acids/metabolism | 2 | 28.0 |
Corticotropin/pharmacology | 5 | 8.0 |
Potassium/pharmacology | 3 | 5.0 |
*Endopeptidases | 2 | 6.0 |
Infertility, Male/metabolism | 2 | 33.0 |
Receptor, Epidermal Growth Factor/*biosynthesis/genetics/metabolism | 3 | 75.0 |
Breast Neoplasms/pathology/*physiopathology | 2 | 25.0 |
Methotrexate/pharmacology | 3 | 3.0 |
Phosphopeptides/isolation & purification | 5 | 27.0 |
Receptors, Nerve Growth Factor | 4 | 8.0 |
Medroxyprogesterone/analogs & derivatives/pharmacology | 2 | 33.0 |
Progestins/*pharmacology | 7 | 30.0 |
Carcinoma/*genetics/metabolism | 2 | 6.0 |
Protein-Tyrosine-Phosphatase | 6 | 35.0 |
Immunoglobulin G/metabolism | 3 | 1.0 |
Annexins | 8 | 61.0 |
Calcium-Binding Proteins/metabolism | 2 | 2.0 |
Gonadorelin/analogs & derivatives/metabolism | 2 | 50.0 |
Carcinoma, Squamous Cell/immunology | 2 | 7.0 |
Carcinoma, Squamous Cell/genetics/*pathology | 2 | 11.0 |
*Milk, Human | 2 | 15.0 |
Interleukin-2/pharmacology | 2 | 0.0 |
Bacitracin/pharmacology | 2 | 40.0 |
Carcinoma, Hepatocellular/enzymology/pathology | 2 | 28.0 |
Liver Neoplasms/enzymology/pathology | 2 | 28.0 |
Protein-Tyrosine Kinase/analysis | 4 | 16.0 |
Growth Plate/cytology/*metabolism | 2 | 66.0 |
Gonadorelin/*analogs & derivatives/*pharmacology | 2 | 50.0 |
Membrane Proteins/isolation & purification/*metabolism | 2 | 16.0 |
Cytoplasmic Granules/*metabolism | 2 | 8.0 |
Ovary/drug effects/*metabolism | 2 | 28.0 |
Breast Neoplasms/*drug therapy/metabolism/pathology | 2 | 14.0 |
Indium Radioisotopes/*diagnostic use | 2 | 11.0 |
Choline O-Acetyltransferase/metabolism | 2 | 1.0 |
*Colonic Neoplasms/pathology | 2 | 100.0 |
Epidermal Growth Factor/*blood/urine | 2 | 100.0 |
Triamcinolone Acetonide/*pharmacology | 3 | 60.0 |
Pentagastrin/pharmacology | 2 | 18.0 |
Serine Endopeptidases | 2 | 8.0 |
Spermine/pharmacology | 2 | 22.0 |
Receptors, G-Protein-Coupled/metabolism | 2 | 11.0 |
Hydroxyproline/analysis | 2 | 18.0 |
Ointments | 2 | 18.0 |
Skin Neoplasms/metabolism | 2 | 11.0 |
Dehydroepiandrosterone Sulfate | 5 | 5.0 |
*Serpins | 2 | 12.0 |
Tyrosine/analogs & derivatives/immunology/*metabolism | 2 | 100.0 |
Carcinoma, Squamous Cell/metabolism/ultrastructure | 2 | 66.0 |
Sulfur Radioisotopes/diagnostic use | 3 | 10.0 |
Plasminogen Activators/*biosynthesis | 2 | 40.0 |
Phosphoproteins/isolation & purification | 3 | 42.0 |
Animals, Suckling | 3 | 17.0 |
Fibroblast Growth Factors/*physiology | 2 | 10.0 |
Receptor, Epidermal Growth Factor/*analysis/biosynthesis/genetics | 2 | 50.0 |
Thyrotropin/pharmacology | 3 | 4.0 |
Hydroquinones/*pharmacology | 2 | 11.0 |
Bucladesine/*pharmacology | 2 | 12.0 |
Hydrogen | 4 | 19.0 |
Magnetic Resonance Spectroscopy/methods | 4 | 8.0 |
Melanoma | 2 | 2.0 |
Adenocarcinoma/metabolism/*ultrastructure | 2 | 100.0 |
Agar | 7 | 22.0 |
Receptors, Cell Surface/analysis | 7 | 8.0 |
Edetic Acid/pharmacology | 3 | 1.0 |
Thermolysin | 2 | 33.0 |
Viral Proteins/*genetics | 3 | 3.0 |
Hypophysectomy | 4 | 7.0 |
Bone Marrow/metabolism | 2 | 1.0 |
Megakaryocytes/*metabolism | 2 | 6.0 |
Receptors, Cell Surface/*isolation & purification | 5 | 62.0 |
Melanocytes/metabolism | 2 | 5.0 |
Blood Platelets/metabolism | 3 | 1.0 |
Plasma | 2 | 3.0 |
Receptors, Cell Surface/*biosynthesis | 4 | 7.0 |
Thyroxine/pharmacology | 3 | 15.0 |
beta-Galactosidase/metabolism | 3 | 1.0 |
Methods | 2 | 0.0 |
Prolactin/*secretion | 2 | 1.0 |
Saliva/*analysis | 4 | 33.0 |
Deoxyglucose/metabolism | 3 | 23.0 |
Palate/*embryology/metabolism | 2 | 50.0 |
Transforming Growth Factors/*biosynthesis/genetics | 3 | 100.0 |
Epidermis/*metabolism | 2 | 8.0 |
Brain Neoplasms/*genetics | 3 | 2.0 |
*Chromosome Deletion | 2 | 0.0 |
Body Fluids/*metabolism | 3 | 14.0 |
Immunologic Techniques | 9 | 2.0 |
Proto-Oncogene Proteins c-myc | 4 | 10.0 |
Protein Kinase C/*physiology | 7 | 8.0 |
Vasoactive Intestinal Peptide/*physiology | 2 | 10.0 |
RNA, Messenger/*analysis/genetics | 2 | 4.0 |
Receptors, Steroid/analysis | 3 | 27.0 |
Polysorbates | 2 | 66.0 |
Antibodies/analysis | 2 | 1.0 |
Proto-Oncogene Protein p21(ras) | 2 | 15.0 |
Skin Neoplasms/analysis/*pathology | 3 | 100.0 |
Brain/enzymology | 2 | 1.0 |
Factor IX/*metabolism | 3 | 42.0 |
Skin Neoplasms/*pathology | 2 | 2.0 |
Cell Membrane/analysis | 6 | 18.0 |
Placenta/analysis | 5 | 22.0 |
Chorionic Gonadotropin/*analysis | 2 | 5.0 |
RNA, Messenger/*drug effects | 2 | 22.0 |
Skin Diseases/metabolism | 2 | 33.0 |
Carcinoma, Non-Small-Cell Lung/*genetics | 2 | 2.0 |
Lymph Nodes/*immunology | 3 | 8.0 |
Receptors, Immunologic/*genetics | 2 | 1.0 |
Receptors, Lymphocyte Homing | 4 | 11.0 |
Antigens, Surface/analysis | 3 | 0.0 |
Tumor Cells, Cultured/*cytology/drug effects | 4 | 40.0 |
Glycoproteins/immunology/*metabolism | 2 | 11.0 |
Lung Neoplasms/*analysis | 4 | 40.0 |
Fibroblast Growth Factors | 7 | 50.0 |
Transforming Growth Factors/metabolism | 2 | 66.0 |
Culture Media/analysis | 3 | 15.0 |
Amyotrophic Lateral Sclerosis/*cerebrospinal fluid | 2 | 40.0 |
Epidermal Growth Factor/*cerebrospinal fluid | 2 | 100.0 |
Tumor Cells, Cultured/cytology/drug effects/*metabolism | 2 | 28.0 |
Gingiva/*cytology/drug effects | 2 | 100.0 |
Phenytoin/*pharmacology | 2 | 22.0 |
Gastric Juice/*metabolism | 2 | 33.0 |
DNA/isolation & purification | 3 | 2.0 |
*DNA, Recombinant | 3 | 7.0 |
*Radiation Tolerance | 3 | 5.0 |
Saliva/analysis | 4 | 36.0 |
Receptors, Cell Surface/metabolism/*physiology | 2 | 10.0 |
Pancreatic Juice/analysis | 2 | 66.0 |
Enzyme Precursors/*genetics | 2 | 1.0 |
Skin/*embryology | 2 | 28.0 |
Amniotic Fluid/*analysis | 2 | 2.0 |
Fetal Growth Retardation/urine | 2 | 100.0 |
Recombinant Proteins/*pharmacology | 6 | 6.0 |
Skin/*analysis | 2 | 18.0 |
Breast Neoplasms/*urine | 3 | 75.0 |
Phospholipases/*antagonists & inhibitors | 2 | 40.0 |
Phosphorus Radioisotopes/diagnostic use | 4 | 23.0 |
Antibodies, Monoclonal/*diagnostic use | 6 | 2.0 |
Breast Neoplasms/*analysis | 8 | 20.0 |
Prostatic Neoplasms/*secretion | 2 | 50.0 |
Transforming Growth Factors/biosynthesis/*genetics | 2 | 66.0 |
Epidermis/*cytology | 11 | 36.0 |
Transforming Growth Factors/*genetics/metabolism | 2 | 100.0 |
Circadian Rhythm | 6 | 2.0 |
Salivation | 2 | 40.0 |
Amniocentesis | 2 | 2.0 |
Epidermal Growth Factor/*metabolism/urine | 3 | 100.0 |
Fetus/physiology | 2 | 4.0 |
Neoplasms/*metabolism | 3 | 3.0 |
Intestinal Mucosa/pathology | 3 | 5.0 |
Epidermal Growth Factor/*genetics/immunology | 3 | 100.0 |
Growth/*drug effects | 2 | 22.0 |
Hypothyroidism/*metabolism | 2 | 20.0 |
Gene Amplification/*genetics | 2 | 1.0 |
Antigen-Antibody Complex | 9 | 5.0 |
Antigens, Surface/*analysis | 2 | 1.0 |
Epitopes/*analysis | 3 | 1.0 |
Immunoglobulin G | 4 | 3.0 |
*Base Sequence | 3 | 8.0 |
Tumor Cells, Cultured/drug effects/*pathology | 2 | 66.0 |
Transforming Growth Factors/metabolism/*pharmacology | 2 | 100.0 |
Interleukin-3/*pharmacology | 2 | 1.0 |
*Insulin Resistance | 3 | 1.0 |
Sphingosine/pharmacology | 4 | 22.0 |
Calmodulin/*antagonists & inhibitors | 4 | 17.0 |
Receptor, Epidermal Growth Factor/analysis/*immunology | 2 | 50.0 |
Exudates and Transudates/*analysis | 2 | 50.0 |
RNA, Messenger/analysis/drug effects | 2 | 25.0 |
Hydrocortisone/metabolism | 2 | 6.0 |
Thymidine/metabolism/pharmacokinetics | 2 | 66.0 |
Amyloid beta-Protein Precursor | 2 | 13.0 |
Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase | 4 | 12.0 |
Peptide Fragments/immunology | 2 | 0.0 |
Chemistry | 2 | 0.0 |
Protein Engineering/*methods | 2 | 9.0 |
Stomach Neoplasms/*analysis/pathology | 4 | 66.0 |
Carcinoma, Squamous Cell/*physiopathology | 3 | 42.0 |
Immune Sera/pharmacology | 2 | 2.0 |
Cartilage/metabolism | 2 | 6.0 |
Receptors, Cell Surface/*analysis/metabolism | 5 | 55.0 |
Leukocytes, Mononuclear/metabolism | 2 | 0.0 |
Receptors, Neurotransmitter/analysis | 2 | 50.0 |
Trifluoperazine/pharmacology | 3 | 5.0 |
Carcinoma/analysis/secretion | 2 | 100.0 |
Gastric Acid/*secretion | 2 | 3.0 |
Placenta/*analysis | 3 | 11.0 |
Adenocarcinoma/analysis | 2 | 15.0 |
Carcinoma/analysis | 2 | 25.0 |
Carcinoma, Small Cell/analysis | 2 | 40.0 |
Carcinoma, Squamous Cell/analysis | 5 | 55.0 |
Lung Neoplasms/*analysis/pathology | 2 | 28.0 |
Interleukin-6 | 2 | 4.0 |
Receptors, Cell Surface/*drug effects | 2 | 16.0 |
Ovary | 3 | 7.0 |
Dehydroepiandrosterone/*analogs & derivatives/analysis | 2 | 100.0 |
Fibrocystic Breast Disease/*analysis | 2 | 100.0 |
Bone Marrow/*physiology | 2 | 11.0 |
Tears/*analysis | 2 | 66.0 |
Peptides/pharmacology/physiology | 3 | 75.0 |
CA-15-3 Antigen | 2 | 2.0 |
Calcitonin/pharmacology | 2 | 9.0 |
Vasoactive Intestinal Peptide/*pharmacology | 3 | 3.0 |
Transforming Growth Factors/*metabolism | 4 | 80.0 |
*Polymorphism, Restriction Fragment Length | 2 | 0.0 |
DNA Repair | 2 | 0.0 |
Ammonium Sulfate/pharmacology | 2 | 66.0 |
Glucosamine/metabolism | 3 | 11.0 |
Mannose/metabolism | 3 | 10.0 |
Duodenum/analysis | 3 | 25.0 |
Fixatives | 2 | 2.0 |
Colony-Stimulating Factors/pharmacology | 2 | 4.0 |
Tumor Cells, Cultured/analysis | 2 | 13.0 |
Transforming Growth Factors/*biosynthesis | 2 | 100.0 |
Autoradiography/methods | 2 | 13.0 |
Kidney/analysis | 2 | 13.0 |
Submandibular Gland/analysis | 6 | 85.0 |
Kidney Neoplasms/*metabolism | 3 | 10.0 |
Hepatitis B virus/genetics | 2 | 15.0 |
Skin/analysis | 2 | 28.0 |
Phospholipid Ethers/*pharmacology | 2 | 33.0 |
Carcinoma, Squamous Cell/*analysis/mortality/pathology | 2 | 100.0 |
Glioma/*analysis | 2 | 40.0 |
Ethanol | 2 | 9.0 |
Pituitary Gland/*metabolism | 2 | 5.0 |
Receptors, Mitogen/metabolism | 2 | 10.0 |
Thiocyanates | 3 | 13.0 |
Colon/pathology | 3 | 7.0 |
Somatomedins/*analysis | 2 | 18.0 |
Cell Membrane/*analysis | 4 | 50.0 |
Fibroblast Growth Factor 2 | 2 | 66.0 |
*Keratin | 6 | 66.0 |
Deoxy Sugars/*metabolism | 2 | 66.0 |
Deoxyglucose/*metabolism | 2 | 33.0 |
Cell Compartmentation/drug effects | 2 | 10.0 |
Magnesium/metabolism | 2 | 2.0 |
Adenosine Triphosphate/*metabolism | 2 | 2.0 |
Protein-Tyrosine Kinase/genetics/*physiology | 2 | 9.0 |
Body Fluids/analysis | 3 | 42.0 |
Adenoviridae/physiology | 2 | 20.0 |
Ammonium Chloride/pharmacology | 6 | 15.0 |
Hela Cells/drug effects/*physiology | 2 | 100.0 |
Ricin/*pharmacology | 3 | 18.0 |
Golgi Apparatus/metabolism | 7 | 3.0 |
Succinimides | 2 | 11.0 |
Antigen-Antibody Reactions | 5 | 1.0 |
Infant, Premature/*metabolism | 2 | 10.0 |
Cell Transformation, Neoplastic/*physiopathology | 2 | 66.0 |
Receptors, Cell Surface/*immunology | 7 | 8.0 |
Peptide Fragments/metabolism/*pharmacology | 2 | 11.0 |
*Protein Precursors | 2 | 11.0 |
Receptors, Cell Surface/metabolism/*pharmacology | 2 | 100.0 |
Sugar Phosphates/*metabolism | 2 | 28.0 |
Cause of Death | 2 | 1.0 |
Chlorpromazine/*pharmacology | 2 | 9.0 |
Plant Extracts/*pharmacology | 2 | 2.0 |
Inositol 1,4,5-Trisphosphate | 4 | 23.0 |
Cytoplasm/analysis | 3 | 14.0 |
Nerve Growth Factors/*metabolism | 2 | 2.0 |
Peptides/isolation & purification/*pharmacology | 3 | 50.0 |
Stomach Neoplasms/*analysis | 3 | 42.0 |
Salivary Glands/physiology | 2 | 50.0 |
Pregnenediones/pharmacology | 2 | 18.0 |
Isotope Labeling/*methods | 2 | 22.0 |
Piperazines/*pharmacology | 2 | 3.0 |
Magnesium Chloride | 2 | 14.0 |
Phosphoproteins/metabolism/*physiology | 2 | 11.0 |
Teratogens/*toxicity | 2 | 11.0 |
Genes, Synthetic | 2 | 3.0 |
Somatostatin/metabolism | 2 | 4.0 |
Amiloride/analogs & derivatives/*pharmacology | 2 | 100.0 |
Melitten/pharmacology | 2 | 15.0 |
Keratin/*metabolism | 3 | 9.0 |
Neoplasms, Experimental/*therapy | 2 | 8.0 |
Growth Substances/pharmacology/*secretion | 2 | 50.0 |
Lithium/pharmacology | 3 | 15.0 |
Lithium Chloride | 2 | 22.0 |
Aspartic Acid/analogs & derivatives/analysis | 3 | 60.0 |
Genes, Structural/*drug effects | 2 | 20.0 |
RNA/genetics | 5 | 4.0 |
Psoriasis/metabolism/*pathology | 2 | 50.0 |
Fetus/*drug effects/metabolism | 2 | 66.0 |
Glioma/*genetics | 2 | 2.0 |
Skin/*cytology/drug effects | 2 | 50.0 |
Transforming Growth Factors | 85 | 89.0 |
Muscle, Smooth, Vascular/metabolism | 2 | 3.0 |
Carcinoma, Squamous Cell/*analysis | 3 | 42.0 |
Receptor, Insulin/immunology/*metabolism | 2 | 100.0 |
Aspergillus Nuclease S1 | 3 | 9.0 |
Deoxyribonuclease I/metabolism | 2 | 1.0 |
Nuclear Proteins/physiology | 2 | 2.0 |
Serine/*analysis | 2 | 100.0 |
Threonine/*analysis | 2 | 100.0 |
Kidney Diseases/metabolism | 2 | 7.0 |
Epidermis/*cytology/drug effects/metabolism | 2 | 100.0 |
Keratin | 5 | 27.0 |
*Growth Inhibitors | 3 | 5.0 |
Oocytes/*cytology/drug effects | 2 | 100.0 |
Protein-Tyrosine Kinase/isolation & purification/*metabolism | 2 | 10.0 |
Drug Delivery Systems/methods | 2 | 13.0 |
Deoxyribonuclease HindIII | 2 | 4.0 |
Milk Proteins/analysis | 3 | 60.0 |
Milk, Human/*analysis | 8 | 36.0 |
Arachidonic Acid | 2 | 3.0 |
Dinoprostone | 6 | 8.0 |
Prostaglandins E/*biosynthesis | 3 | 18.0 |
*Exertion | 2 | 1.0 |
Parathyroid Hormone/pharmacology | 2 | 7.0 |
Membrane Proteins/*analysis | 3 | 4.0 |
Melanoma/analysis | 3 | 100.0 |
Peptides/*urine | 3 | 50.0 |
Intercellular Signaling Peptides and Proteins/pharmacology | 2 | 7.0 |
DNA Restriction Enzymes | 7 | 1.0 |
Phorbol 12,13-Dibutyrate | 5 | 35.0 |
*Hydrogen-Ion Concentration | 2 | 7.0 |
Protein Kinases/analysis | 3 | 21.0 |
Ribosomal Proteins/*metabolism | 3 | 15.0 |
Intestine, Small/*analysis | 2 | 66.0 |
Ribosomal Protein S6 | 2 | 13.0 |
Dipeptides/pharmacology | 2 | 4.0 |
Asparagine/*analogs & derivatives/analysis | 2 | 100.0 |
Receptor, Epidermal Growth Factor/*biosynthesis/drug effects/metabolism | 2 | 100.0 |
Elasticity | 3 | 6.0 |
Body Fluids/*analysis | 2 | 25.0 |
Peptides/*analysis | 7 | 10.0 |
Contraceptives, Oral | 2 | 14.0 |
Oncogenes/*drug effects | 2 | 40.0 |
Coated Pits, Cell-Membrane/*physiology | 2 | 50.0 |
Endosomes/*physiology | 2 | 12.0 |
Fetus/*physiology | 2 | 5.0 |
Carcinoma, Hepatocellular/*genetics | 2 | 2.0 |
Liver Neoplasms/*genetics | 2 | 1.0 |
Carcinoma/*analysis | 3 | 33.0 |
Colonic Neoplasms/*analysis | 2 | 33.0 |
Oncogene Protein pp60(v-src) | 4 | 50.0 |
Retroviridae Proteins/metabolism | 2 | 15.0 |
Fibroblasts/enzymology/metabolism | 2 | 11.0 |
Benzofurans/*poisoning | 2 | 100.0 |
*Food Contamination | 2 | 10.0 |
Polychlorinated Biphenyls/*poisoning | 2 | 28.0 |
Phosphopeptides/analysis | 5 | 26.0 |
Concanavalin A/pharmacology | 3 | 1.0 |
Tumor Cells, Cultured/*analysis | 2 | 50.0 |
*Peptide Biosynthesis | 5 | 16.0 |
Peptides/genetics/pharmacology | 2 | 40.0 |
Ornithine Decarboxylase/biosynthesis | 2 | 33.0 |
Mass Fragmentography | 2 | 0.0 |
Lipids/*biosynthesis | 2 | 13.0 |
Coated Pits, Cell-Membrane | 2 | 66.0 |
Proline/chemistry | 2 | 4.0 |
Tissue Engineering/*methods | 3 | 17.0 |
Milk/*physiology | 2 | 100.0 |
KB Cells/drug effects | 2 | 28.0 |
Epidermis/*drug effects | 2 | 100.0 |
Peptides/pharmacology/*physiology | 2 | 66.0 |
Methylamines/pharmacology | 6 | 28.0 |
*Collagenases | 2 | 100.0 |
Insulin/metabolism/*pharmacology | 2 | 28.0 |
Lung Neoplasms/*analysis/genetics | 2 | 100.0 |
Encephalomyocarditis virus/drug effects | 2 | 50.0 |
Tumor Necrosis Factor-alpha | 3 | 1.0 |
Apoptosis/radiation effects | 2 | 5.0 |
Proto-Oncogene Proteins/physiology | 2 | 1.0 |
Phorbol Esters/*metabolism | 2 | 40.0 |
*Receptors, Drug | 2 | 22.0 |
*Immunity, Cellular | 2 | 1.0 |
Receptor, Insulin/isolation & purification/*metabolism | 2 | 100.0 |
Colchicine/pharmacology | 7 | 10.0 |
Sulfhydryl Compounds/analysis | 2 | 10.0 |
Chemistry, Physical | 2 | 1.0 |
Poly A/genetics | 2 | 4.0 |
Colonic Neoplasms/pathology | 2 | 3.0 |
Cytoplasm/physiology | 2 | 5.0 |
Epidermal Growth Factor/urine | 2 | 100.0 |
Neoplasm Proteins/*urine | 2 | 28.0 |
Skin/cytology/drug effects | 3 | 30.0 |
Methylglucosides/metabolism | 4 | 57.0 |
Postpartum Period | 2 | 2.0 |
Blood Platelets/analysis | 2 | 12.0 |
Growth Substances/isolation & purification/*pharmacology | 2 | 66.0 |
Terminology | 2 | 1.0 |
Adipose Tissue/cytology | 2 | 66.0 |
*Cytological Techniques | 2 | 10.0 |
Immunoglobulin G/*immunology | 2 | 2.0 |
Cloning, Molecular/*methods | 2 | 3.0 |
Protein-Tyrosine Kinase/immunology/*metabolism | 2 | 10.0 |
Antibodies/*immunology | 3 | 2.0 |
Receptors, Cell Surface/analysis/*immunology | 2 | 50.0 |
Cell Membrane/ultrastructure | 3 | 6.0 |
Translocation, Genetic | 2 | 0.0 |
Chromosomes, Human, 4-5 | 2 | 33.0 |
Protein Precursors | 2 | 16.0 |
Receptors, Transferrin | 4 | 20.0 |
Transferrin/*metabolism | 4 | 6.0 |
Dioxins/*pharmacology | 2 | 14.0 |
Receptors, Cell Surface/*analysis/immunology | 3 | 42.0 |
Receptor, erbB-2/*antagonists & inhibitors | 3 | 20.0 |
Neoplasms, Experimental/metabolism | 2 | 16.0 |
Phorbols/*pharmacology | 14 | 41.0 |
Receptors, Calcitonin | 2 | 22.0 |
Muscle, Smooth/metabolism | 2 | 3.0 |
Submandibular Gland | 2 | 40.0 |
Receptors, Cell Surface/genetics/immunology/*metabolism | 3 | 30.0 |
Peptides/*isolation & purification/pharmacology | 2 | 66.0 |
Vanadates | 4 | 57.0 |
Colostrum/analysis | 3 | 75.0 |
Milk, Human/analysis | 3 | 33.0 |
Prostatic Neoplasms/*enzymology/metabolism/pathology | 2 | 33.0 |
Photochemistry | 2 | 3.0 |
Protein Kinases/isolation & purification/*metabolism | 3 | 15.0 |
Staphylococcal Protein A | 2 | 13.0 |
Cytoskeleton/*analysis | 2 | 28.0 |
Aminoisobutyric Acids/metabolism | 3 | 75.0 |
Wheat Germ Agglutinins | 2 | 12.0 |
*Chromosomes, Human, 6-12 and X | 2 | 1.0 |
Fetal Membranes/*metabolism | 2 | 25.0 |
Proteoglycans/*biosynthesis | 2 | 16.0 |
Clone Cells/pathology | 2 | 3.0 |
Vaccinia virus/*genetics | 2 | 10.0 |
Protein Kinases/isolation & purification | 2 | 50.0 |
Receptors, LDL | 3 | 30.0 |
Peptides/*immunology | 2 | 2.0 |
Amiloride/*pharmacology | 3 | 60.0 |
*Protein Kinase Inhibitors | 4 | 6.0 |
Pyrazines/*pharmacology | 4 | 12.0 |
Neoplasms | 2 | 13.0 |
Lymph Nodes/metabolism | 2 | 3.0 |
Diglycerides/*pharmacology | 2 | 15.0 |
Glycerides/*pharmacology | 2 | 28.0 |
Glomerular Mesangium/*cytology/*physiology | 2 | 100.0 |
Chromatography, Affinity/methods | 2 | 2.0 |
Receptors, Cell Surface/isolation & purification/*metabolism | 6 | 42.0 |
MAP Kinase Kinase Kinases/genetics/*metabolism | 2 | 22.0 |
Interleukin-6/analysis | 2 | 2.0 |
Viral Proteins/*immunology | 2 | 5.0 |
Salivary Glands/*physiology | 2 | 100.0 |
Submandibular Gland/physiology | 2 | 100.0 |
Asialoglycoprotein Receptor | 2 | 8.0 |
Gerbillinae | 3 | 7.0 |
Organoids/*physiology | 3 | 100.0 |
Chromosomes, Human, 6-12 and X | 4 | 9.0 |
Sarcoma Viruses, Avian | 2 | 20.0 |
Affinity Labels/*pharmacology | 3 | 75.0 |
Cervix Uteri/drug effects/*physiology | 2 | 100.0 |
Receptors, Cell Surface/*immunology/metabolism | 2 | 14.0 |
Oxygen/*metabolism/pharmacology | 2 | 100.0 |
Peptides/isolation & purification/*metabolism | 2 | 40.0 |
Colostrum/*analysis | 2 | 100.0 |
Insulin/*pharmacology/physiology | 2 | 28.0 |
Somatomedins/pharmacology/physiology | 2 | 100.0 |
Skin Diseases/urine | 2 | 100.0 |
Sarcoma Viruses, Murine | 2 | 100.0 |
Insulin-Like Growth Factor I | 2 | 22.0 |
Adenosine/*analogs & derivatives/pharmacology | 2 | 18.0 |
Lens, Crystalline/*cytology | 2 | 66.0 |
Kidney/drug effects | 2 | 4.0 |
Epidermis/*physiology | 2 | 25.0 |
Cadaverine/analogs & derivatives/pharmacology | 2 | 66.0 |
Uterine Neoplasms/*secretion | 2 | 100.0 |
Cholesteatoma, Middle Ear/metabolism/*pathology | 2 | 66.0 |
Cell Proliferation/*drug effects | 2 | 11.0 |
Intercellular Signaling Peptides and Proteins/physiology | 2 | 11.0 |
Platelet-Derived Growth Factor | 3 | 50.0 |
Binding Sites/drug effects/physiology | 2 | 7.0 |
Pseudopodia/drug effects/metabolism/ultrastructure | 2 | 100.0 |
Receptors, Drug/*metabolism | 3 | 12.0 |
Electrophoresis, Paper | 2 | 25.0 |
Mouth Neoplasms/*drug therapy | 2 | 40.0 |
Pituitary Hormones/*pharmacology | 2 | 100.0 |
Epidermal Growth Factor/*administration & dosage/pharmacokinetics | 2 | 100.0 |
Dynamins/physiology | 2 | 100.0 |
Matrix Metalloproteinases/*metabolism | 2 | 5.0 |
Breast Neoplasms/*enzymology/pathology | 2 | 6.0 |
Immunodominant Epitopes/chemistry/*immunology | 2 | 33.0 |
Iodide Peroxidase/chemistry/*immunology | 2 | 18.0 |
Intercellular Signaling Peptides and Proteins/*pharmacology | 2 | 6.0 |
Gingiva/cytology/*metabolism | 2 | 20.0 |
Glutathione Transferase/genetics | 2 | 0.0 |
Insulin-Like Growth Factor Binding Protein 3/*pharmacology | 2 | 66.0 |
8-Bromo Cyclic Adenosine Monophosphate/metabolism | 2 | 20.0 |
